Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39693,0.187007909925531,0.00437295991599074,0.178436908490189,0.195578911360872,0
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39668,0.125176437171371,0.00250552012370693,0.120265617728906,0.130087256613837,0
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39721,0.10421710895185,0.00270804663290839,0.0989093375513497,0.109524880352351,1.14994331130691e-308
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39651,0.0709556383760101,0.00273347583230805,0.0655980257446863,0.0763132510073339,1.63621492808169e-145
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37220,0.0802823580606546,0.00316518878080383,0.0740785880502791,0.0864861280710301,1.16665270856165e-138
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39865,0.052266958677524,0.00226589508892758,0.047825804303226,0.0567081130518221,7.67484231628384e-116
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,39564,0.148363046169596,0.00665401960851052,0.135321167736915,0.161404924602276,1.90279613777926e-108
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,39865,0.102245155468503,0.00465194281838312,0.0931273475444718,0.111362963392534,1.6538052322208e-105
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39836,0.0609089623207809,0.00285555214435292,0.0553120801178491,0.0665058445237126,1.45662291337941e-99
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39646,0.0491050160918988,0.00251015314551315,0.044185115926693,0.0540249162571045,3.19895840123259e-84
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFP,Properdin,37285,0.0373263287372262,0.00202886804601787,0.0333497473670311,0.0413029101074212,1.13304408482234e-74
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,39836,0.103657813558492,0.00580362334252531,0.0922827118071425,0.115032915309842,1.15655066763791e-70
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39557,0.0554340979082831,0.00315139311947816,0.0492573673941059,0.0616108284224603,1.32858488034041e-68
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39401,0.0841161430557529,0.00478420712913759,0.0747390970826432,0.0934931890288626,1.55696351004054e-68
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39721,0.0607668763549325,0.00348243276470871,0.0539413081361034,0.0675924445737615,1.48269357476827e-67
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39668,0.0397032411678302,0.00243698458701797,0.034926751377275,0.0444797309583854,3.41649264516045e-59
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39594,0.0429090370956285,0.00265490687192394,0.0377054196266576,0.0481126545645994,2.74687615505878e-58
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39658,0.160812313505215,0.00999303948709177,0.141225956110516,0.180398670899915,8.30370967621745e-58
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39738,0.0598019079703555,0.00375215505260843,0.052447684067243,0.067156131873468,9.50632170391589e-57
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,36984,0.0419799527064044,0.00270990530852851,0.0366685383016886,0.0472913671111203,1.1847632669492e-53
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,39865,0.0560344025722231,0.00363053467787579,0.0489185546035866,0.0631502505408597,2.33555827373383e-53
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,37166,0.047171941238102,0.00305580871394668,0.0411825561587665,0.0531613263174375,2.68030494002718e-53
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,39865,0.0529885612400735,0.0035336756397213,0.0460625569862197,0.0599145654939272,1.73514023806079e-50
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,39671,0.0407580213048497,0.00277790609384664,0.0353133253609103,0.0462027172487891,2.02141525534096e-48
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,39680,0.0805278262171944,0.00551540551384545,0.0697176314100573,0.0913380210243315,5.71637249898956e-48
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39865,0.0368427570055253,0.00253993391281744,0.0318644865364031,0.0418210274746474,2.23716254666499e-47
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39836,0.0359001979097732,0.00248049023361926,0.0310384370518795,0.040761958767667,3.5666824222059e-47
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,37285,-0.0344580221029736,0.00239621888098138,-0.0391546111096972,-0.0297614330962501,1.5277188076355e-46
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,39500,0.0636727588046059,0.00444813102188831,0.0549544220017048,0.072391095607507,3.47791576005377e-46
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37220,0.0967621183486229,0.00676731793381855,0.0834981751983385,0.110026061498907,4.89013120910111e-46
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,39680,-0.0590911748243809,0.00416232429496667,-0.0672493304425155,-0.0509330192062462,1.82693276778857e-45
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37203,-0.0694915497204096,0.0049176621379083,-0.0791301675107099,-0.0598529319301093,5.16336678217263e-45
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,39594,0.0364342770900769,0.00259543924077205,0.0313472161781637,0.0415213380019901,1.69771949726057e-44
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39401,0.0485090601532588,0.00349459277043913,0.0416596583231982,0.0553584619833195,1.4988423865749e-43
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,39743,0.0499030706361539,0.0036260770031138,0.0427959597100508,0.0570101815622569,7.57012985419699e-43
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39521,0.0872783025974858,0.00634572713356664,0.0748406774156952,0.0997159277792764,8.55946759955293e-43
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39302,0.0615826915425093,0.00449842093145569,0.0527657865168562,0.0703995965681625,2.06473681919397e-42
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,36601,0.0280976798319982,0.0020775255663523,0.0240257297219477,0.0321696299420487,2.16068726508288e-41
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,39860,0.0318714211292277,0.00236287417927434,0.02724018773785,0.0365026545206054,3.07488387540448e-41
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,39805,0.0486911496378326,0.00361959112821589,0.0415967510265295,0.0557855482491358,5.00849710036916e-41
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36958,0.0493118057015049,0.00366434493993836,0.0421296896192257,0.0564939217837841,5.22935964936294e-41
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37241,0.0849369121952841,0.00634381225373343,0.0725030401779665,0.0973707842126016,1.2809017157313e-40
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,36958,0.137210589797543,0.0102617084488332,0.11709764123783,0.157323538357256,1.64357602245909e-40
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,36877,0.0942707891987379,0.0070613177093392,0.0804306064884331,0.108110971909043,2.17383601527805e-40
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,39680,0.0307116681782036,0.00231544007636729,0.0261734056285237,0.0352499307278835,6.12902806528991e-40
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,39658,0.0446842376754144,0.00337949001610657,0.0380604372438455,0.0513080381069833,1.06187991174931e-39
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36880,0.0302075607547407,0.00228811889715492,0.025722847716317,0.0346922737931643,1.53484538452516e-39
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,39680,0.0449731859899535,0.00341942780545208,0.0382711074912674,0.0516752644886395,2.65566684041793e-39
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39860,0.0278265383467346,0.00215703260808305,0.0235987544348919,0.0320543222585774,6.91918656977848e-38
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39860,0.0329874782807888,0.00255954644254543,0.0279707672533997,0.0380041893081778,8.10916309961971e-38
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39508,0.0335753795974327,0.00262989831538931,0.0284207788992696,0.0387299802955957,3.85002138202014e-37
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39594,0.0975968786969432,0.0076787967752603,0.082546437017433,0.112647320376453,7.90332490315677e-37
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39491,0.0521444001318236,0.0041143063738547,0.0440803596390684,0.0602084406245788,1.24906360046095e-36
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,39720,0.033879596463219,0.00270549268828013,0.02857683079419,0.0391823621322481,8.30327946842926e-36
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39836,0.0351729468790921,0.00281226794621927,0.0296609017045023,0.0406849920536818,1.0052604523507e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,39680,0.0263669521970836,0.00211085761034428,0.0222296712808088,0.0305042331133584,1.2294350480516e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39595,-0.0698357187830478,0.00559850463413858,-0.0808087878659594,-0.0588626497001362,1.52425037828323e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39817,0.029624933553513,0.00237833263110131,0.0249634015965544,0.0342864655104715,1.89175356371379e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39673,0.0676152544041404,0.00543033121691053,0.0569718052189958,0.0782587035892851,2.01409420425159e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39809,0.0361190201794684,0.00290311312296976,0.0304289184584477,0.0418091219004891,2.27065939692037e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36880,0.034247500242754,0.0027569912873685,0.0288437973195118,0.0396512031659963,3.14113831730379e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39673,0.0443878973013366,0.00357544482330471,0.0373800254476594,0.0513957691550139,3.17596167109333e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELN,Elastin,37268,0.0367209427661772,0.00296347053306211,0.0309125405213755,0.042529345010979,4.5373655015027e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,39860,0.0212174543015463,0.00171454459216593,0.0178569469009011,0.0245779617021916,5.1623210476818e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37215,0.0319497767082268,0.00258727198130884,0.0268787236248614,0.0370208297915921,7.65668881211581e-35
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39680,0.0317706598705088,0.00260663092870878,0.0266616632502396,0.036879656490778,5.09212802746841e-34
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39860,0.0521789140601275,0.00428847318120225,0.0437735066249711,0.0605843214952839,6.55803909616143e-34
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39668,0.0387890615899945,0.00319098776728502,0.0325347255661159,0.0450433976138732,7.56477916394798e-34
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,39543,0.03027597151514,0.00249195168228397,0.0253917462178634,0.0351601968124166,8.18898172181919e-34
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,39817,0.0243048987528217,0.00201124137974509,0.0203628656485214,0.0282469318571221,1.78534490684715e-33
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39557,-0.0627450582117035,0.00520402367067616,-0.0729449446062287,-0.0525451718171782,2.49990306494024e-33
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39836,0.0624655191557233,0.00518736803173421,0.0522982778135243,0.0726327604979224,2.98263667750145e-33
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,39743,0.0345787736512856,0.00287892954781152,0.028936071737575,0.0402214755649962,4.32816354578965e-33
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39756,0.0500245784650995,0.00417686777705143,0.0418379176220786,0.0582112393081203,6.53149497711156e-33
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39865,0.0454154715758462,0.00379375163151658,0.0379797183780737,0.0528512247736187,6.9558669752381e-33
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,39673,0.0345242715361355,0.00290322360185872,0.0288339532764924,0.0402145897957785,1.79780374317877e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37268,0.0289905506928522,0.00244051756217042,0.0242071362709981,0.0337739651147062,2.21558106693042e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39594,0.0469236099666211,0.00398679565099436,0.0391094904906722,0.0547377294425701,7.60064177130734e-32
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,39705,0.02758282741383,0.0023515748482224,0.0229737407113141,0.0321919141163459,1.21604693604953e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,39680,0.0264131507420745,0.00225838824770598,0.0219867097765708,0.0308395917075783,1.80937878674346e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,39784,-0.0370990370144811,0.00317502469851653,-0.0433220854235735,-0.0308759886053887,2.05166654342332e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39743,0.0679950123987354,0.00582919487819802,0.0565697904374673,0.0794202343600036,2.59489230511873e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,39785,0.0610894179353104,0.00524875727174511,0.05080185368269,0.0713769821879308,3.49796085880974e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39860,0.0161159408201125,0.00138499363081089,0.0134013533037232,0.0188305283365018,3.60554953145695e-31
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39689,0.0400604856910541,0.00347876945746574,0.0332420975544213,0.0468788738276869,1.45538026390028e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37267,0.0253956025678532,0.00220898166910591,0.0210659984964056,0.0297252066393008,1.90752048554307e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,39302,0.0476936149401577,0.00419169017718797,0.0394779021928693,0.0559093276874461,7.06752654230058e-30
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,39797,0.0386455618047955,0.00340610665637434,0.0319695927583018,0.0453215308512892,1.00986781120229e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,39680,0.0336609635592665,0.0029712053579235,0.0278374010577364,0.0394845260607965,1.22544908813842e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,39817,0.023916569720598,0.00212370105646904,0.0197541156499186,0.0280790237912773,2.61497678280715e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39680,0.0324469690900289,0.00289085162617599,0.026780899902724,0.0381130382773339,4.00473534927408e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39817,0.0579783227090768,0.00519478639411466,0.0477965413766121,0.0681601040415415,8.10208155576011e-29
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,39721,0.0544000722813704,0.00490408263779778,0.0447880703112868,0.0640120742514541,1.73040332441385e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39401,0.0534297196764462,0.00483036236577417,0.0439622094395288,0.0628972299133636,2.46762177763203e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39848,0.051220097526595,0.0046400639551992,0.0421255721744046,0.0603146228787854,3.14525575318219e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,39668,0.0241978214407283,0.00219464840668467,0.0198963105636264,0.0284993323178303,3.63339935839972e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39680,0.0426409554094704,0.00387993971834106,0.0350362735615219,0.0502456372574189,5.38386263681422e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39296,0.0278118833648538,0.00253876626995127,0.0228359014757493,0.0327878652539583,7.97123894207792e-28
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39836,0.0328283666401782,0.00300332062210996,0.0269418582208427,0.0387148750595137,1.03069273191198e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39594,0.0375957609625411,0.00344207305699166,0.0308492977708374,0.0443422241542448,1.13216488154908e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39594,0.022594625856186,0.00206967915341431,0.0185380547154939,0.026651196996878,1.20160631109454e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,39594,0.0274034072466437,0.00251306455879057,0.0224778007114141,0.0323290137818732,1.37869724814505e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,37285,0.0191500557315902,0.00176314590595329,0.0156942897559217,0.0226058217072586,2.29006976933006e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39385,0.0288037246856962,0.00265739963790876,0.0235952213953951,0.0340122279759974,2.8144433697431e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39401,0.0400298610211802,0.00370129477547582,0.0327753232612476,0.0472843987811128,3.6482496979264e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39673,0.0316764230759868,0.00294222426383764,0.025909663518865,0.0374431826331086,6.16683397239059e-27
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36880,0.0434139183310002,0.00405113998796157,0.0354736839545955,0.0513541527074048,1.10063745348804e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37215,0.0245045493679054,0.00229357932067168,0.0200091338993889,0.0289999648364219,1.54833481183904e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,37208,0.0601502826213413,0.00563155054801631,0.0491124435472293,0.0711881216954533,1.59951634337837e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39594,0.0628846203268739,0.00589931041097357,0.0513219719213657,0.0744472687323821,1.93470990604197e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,37267,0.0263555214215575,0.00247489010834742,0.0215047368091966,0.0312063060339184,2.24246758571468e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,39594,0.0308596309821085,0.00290030206039019,0.0251750389437438,0.0365442230204733,2.38229066328615e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39727,0.0311979252378647,0.00293252489308056,0.0254501764474268,0.0369456740283025,2.41794008309609e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36924,0.0363890671589392,0.00342091305204638,0.0296840775769283,0.0430940567409501,2.56225294336559e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37215,0.0278807729672837,0.00262540378066931,0.0227349815571718,0.0330265643773955,3.07371146831016e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,37252,0.0333753465846375,0.00314998144400269,0.0272013829543922,0.0395493102148828,3.9710869436502e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39721,0.0239370610080844,0.00225995089521139,0.0195075572534701,0.0283665647626988,3.97461379524617e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,37267,0.0213909834214782,0.00202228927331427,0.0174272964457822,0.0253546703971742,4.79376915901855e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37268,0.0664010529955804,0.00628243919852755,0.0540874721664664,0.0787146338246944,5.23344200523222e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39668,0.0248353839298269,0.00235112091781809,0.0202271869309034,0.0294435809287503,5.38734485787782e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39865,0.0716633711948837,0.0067890663686822,0.0583568011122666,0.0849699412775008,5.81836291884275e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,39619,0.0378002955742271,0.00358293589201567,0.0307777412258764,0.0448228499225778,6.19296993538333e-26
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,39666,0.0366293687392064,0.00349194059237662,0.0297851651781482,0.0434735723002645,1.16980975573746e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36600,0.0461256831209172,0.00439643058076113,0.0375086791826254,0.054742687059209,1.20081515566754e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39848,0.0465025632832087,0.00444217568779855,0.0377958989351236,0.0552092276312939,1.45931764394334e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39383,0.0313900026642304,0.00300020731457532,0.0255095963276628,0.0372704090007981,1.5597997150123e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,39680,0.0368165494075716,0.00352291785612295,0.0299116304095706,0.0437214684055725,1.76283566430993e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39288,0.0765520484700873,0.00733143765607827,0.0621824306641738,0.0909216662760007,1.94571315590607e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,39689,0.017929033900257,0.00172435465939717,0.0145492987678385,0.0213087690326754,3.06798697535199e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37220,0.0280702312883891,0.00271434084179971,0.0227501232384617,0.0333903393383165,5.68342430755303e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,36958,-0.0203777796123266,0.00197282241676787,-0.0242445115491916,-0.0165110476754616,6.47606349371372e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39700,0.0321464713427527,0.00311791951383397,0.0260353490956381,0.0382575935898673,7.59088794884855e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39865,0.0243599104828755,0.00236430991242278,0.0197258630545268,0.0289939579112241,8.14949764693628e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39627,0.029675639386801,0.00288395743968984,0.0240230828050089,0.0353281959685931,9.37176038723819e-25
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37223,0.0180422616198284,0.00175467807372592,0.0146030925953256,0.0214814306443312,1.04591193499794e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39738,0.0386345548215862,0.00376192489641663,0.0312611820246096,0.0460079276185628,1.15041269865091e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,38989,0.019185830005136,0.00187132967038677,0.0155180238511779,0.0228536361590941,1.38765258935839e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39394,0.13128088472848,0.0128317061084718,0.106130740755875,0.156431028701085,1.72277911521673e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39860,0.0258647629430739,0.00253131550642237,0.020903384550486,0.0308261413356617,1.95950676301697e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39401,0.0372951432297572,0.00368405748286683,0.0300743905633382,0.0445158958961762,5.16479199360474e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,37277,-0.0424606592131697,0.00420948550869024,-0.0507112508102026,-0.0342100676161369,7.67772277415625e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,37285,-0.0586676547864765,0.00581712921605093,-0.0700692280499363,-0.0472660815230167,7.79979031337108e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36958,0.0325152867384617,0.00322513967190108,0.0261940129815356,0.0388365604953879,8.12024100355481e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39679,-0.084796323225313,0.00841597286208789,-0.101291630035005,-0.0683010164156208,8.35284705674241e-24
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39557,0.0659167771340209,0.00656094054759531,0.0530573336607341,0.0787762206073077,1.11842220800494e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HLA_E,,39673,0.0243825997733968,0.00242846019756207,0.0196228177861752,0.0291423817606185,1.19263331396304e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39571,0.0251996005170485,0.00251176413608536,0.0202765428103212,0.0301226582237758,1.29045415036663e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,39557,0.0225437935057623,0.00224817798126238,0.0181373646624881,0.0269502223490366,1.35787495284866e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,39680,-0.0328006059249319,0.0032813613771011,-0.0392320742240501,-0.0263691376258138,1.86188888500027e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,39594,0.0647089097041716,0.00647552826034718,0.0520168743138911,0.077400945094452,1.92423225031574e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,39865,0.0402245629271174,0.00402597374147769,0.0323336543938211,0.0481154714604137,1.94957910920671e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,37285,0.0234683844827719,0.00234875352607033,0.018864827571674,0.0280719413938697,1.9977215683946e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,37268,0.0605927622894023,0.00607266470232798,0.0486903394728395,0.0724951851059651,2.29630449990157e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,39817,0.022489714515808,0.0022562454930144,0.0180674733494998,0.0269119556821163,2.46816064640788e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,39302,0.0305467233433889,0.00306450497620463,0.0245402935900279,0.03655315309675,2.47725317176183e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37240,0.0127115235394211,0.00127688704556576,0.0102088249301122,0.01521422214873,2.88672905662923e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39557,0.0338971442033222,0.0034066459262143,0.0272201181879421,0.0405741702187022,2.94640007787995e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,39673,0.0348043654925155,0.00349992097759812,0.0279445203764232,0.0416642106086078,3.12371528442204e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39848,0.0316646261940196,0.00318515458286203,0.02542172321161,0.0379075291764291,3.21358026523161e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37220,0.0223810510789595,0.00225660195846522,0.0179581112403677,0.0268039909175514,4.17678383926402e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39817,0.0400396451343193,0.00404309099211921,0.0321151867897657,0.047964103478873,4.697540833587e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39860,0.0239546426347699,0.0024245130771277,0.0192025970035996,0.0287066882659401,5.90271100983162e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39594,0.0285240540498837,0.00289787986355878,0.0228442095173085,0.0342038985824589,8.5449884708552e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37244,0.0307263964786328,0.00312160654956839,0.0246080476414788,0.0368447453157869,8.76928520802606e-23
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,39715,0.0224250200434447,0.00228480051874412,0.0179468110267062,0.0269032290601832,1.12746114967748e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,36958,0.0501695315380275,0.00511285538526484,0.0401483349829084,0.0601907280931466,1.19142056505464e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39631,0.0247051394403282,0.00251941131693376,0.019767093259138,0.0296431856215183,1.23237280087662e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FST,Follistatin,39720,0.0442388565703692,0.00455596922033994,0.0353091568985029,0.0531685562422355,3.1493930764453e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,39720,0.0708341550500139,0.00729658769690412,0.0565328431640818,0.085135466935946,3.21894814905365e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,37133,0.0243816469986011,0.00251532538217091,0.0194516092495461,0.0293116847476561,3.81469545934229e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,39706,0.0431326510722459,0.00445141901542898,0.0344078698020051,0.0518574323424867,3.84410689987603e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,39612,0.0260890103481729,0.00269498971842893,0.0208068305000522,0.0313711901962937,4.20267030649992e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37220,0.030540166599833,0.00315876611151571,0.0243489850212622,0.0367313481784038,4.85098854237811e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,36958,0.0430359222826849,0.00446014824585967,0.0342940317208,0.0517778128445699,5.87353671253942e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39594,0.0270161751991377,0.0028018801270537,0.0215244901501124,0.0325078602481629,6.10169790786355e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,39452,0.0234074800281494,0.00242819940127092,0.0186482092016584,0.0281667508546404,6.24757967172542e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,39673,0.0497689431861331,0.00516941476555863,0.0396368902456382,0.059900996126628,7.02178788855062e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,36880,0.0554945292143163,0.00576562735798383,0.044193899592668,0.0667951588359646,7.40987911086003e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,39524,0.0600878931133687,0.00625808865148861,0.047822039356451,0.0723537468702863,9.03319352001991e-22
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39288,0.0936909999814212,0.00977776724961491,0.074526576172176,0.112855423790666,1.09332520842718e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37058,0.0114110912587972,0.00119083454713945,0.00907705554640388,0.0137451269711905,1.1150236580326e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,36896,0.0361786693721975,0.00378403540772882,0.028761959973049,0.043595378771346,1.37440820975426e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37104,0.0350100607644682,0.00366392114037545,0.0278287753293324,0.0421913461996041,1.44542286034489e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39668,0.0241824576997721,0.0025330268686505,0.0192177250372171,0.0291471903623271,1.52812439732425e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39529,0.0196208993452944,0.00205713502015432,0.0155889147057919,0.0236528839847969,1.66605093599439e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39538,0.0798081035999005,0.00840114643265582,0.0633418565918951,0.0962743506079059,2.4032508316303e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39865,0.02733130929732,0.00287918484537135,0.0216881070003922,0.0329745115942479,2.5610297017582e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39668,0.040105631354287,0.00422767027742711,0.0318193976105299,0.0483918650980441,2.7230550000482e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,39675,0.0208503198597523,0.00219975831890039,0.0165387935547075,0.025161846164797,2.93870540916649e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,39817,0.0308236776851241,0.00325203980790307,0.0244496796616341,0.0371976757086141,2.94091340406449e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39720,-0.0647037003762056,0.00683651869002636,-0.0781032770086573,-0.051304123743754,3.35766970603546e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,39557,0.0278914371548113,0.00295142265962407,0.0221066487419481,0.0336762255676745,3.8501012198917e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,37268,0.0225788234445537,0.00239097114716547,0.0178925199961094,0.027265126892998,4.19787935967161e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37268,0.0220754649569081,0.0023399209391693,0.0174892199161362,0.0266617099976799,4.57569657066672e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,39648,0.0751656897355892,0.00798106005381003,0.0595228120301215,0.0908085674410569,5.21929044399511e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39632,0.0445846164336167,0.00474539922608556,0.035283633950489,0.0538855989167444,6.46836449342034e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39504,0.0218844401574895,0.00233011561597399,0.0173174135501805,0.0264514667647985,6.68236303931418e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39738,0.0227030369384197,0.00241813380600407,0.0179634946786517,0.0274425791981877,6.88346370260206e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39721,0.0282630480526712,0.00301300218362503,0.0223575637727661,0.0341685323325762,7.44521090437196e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39452,0.0447576036651182,0.0047720785043815,0.0354043297965305,0.054110877533706,7.55334842032803e-21
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39817,0.0241128542471364,0.00258379718234766,0.019048611769735,0.0291770967245378,1.1690067422203e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37268,0.0267323584306795,0.00286577878333484,0.0211154320153432,0.0323492848460157,1.24417239600618e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39799,0.0209469514641052,0.00225396177257848,0.0165291863898514,0.0253647165383591,1.68377393307045e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,39860,0.045814253207835,0.00494209643670525,0.0361277441918927,0.0555007622237773,2.08980790886519e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37098,0.024421585370258,0.00263546756086259,0.0192560689509673,0.0295871017895486,2.2165266005683e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,39529,0.0226516276131539,0.00245169944809642,0.0178462966948849,0.0274569585314229,2.79723615641923e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39721,0.0295554905192612,0.00320482078024435,0.0232740417899823,0.0358369392485402,3.26959675972316e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,37268,0.0359301315770327,0.00389521612380343,0.028295507974378,0.0435647551796875,3.27911434582534e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,39697,0.0192355231062414,0.00209122907289129,0.0151367141233745,0.0233343320891083,4.0849526342139e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39673,0.0403809178736248,0.0043939181835921,0.0317688382337843,0.0489929975134654,4.39975566424889e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39697,0.0217080783747754,0.00236481635814232,0.0170730383128164,0.0263431184367343,4.85086298212525e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,39836,0.0285060202780661,0.00311385909472383,0.0224028564524074,0.0346091841037248,6.10539382056142e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39288,0.0446957506318953,0.00488271225594789,0.0351256346102375,0.0542658666535532,6.16850604848286e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,37220,0.0244792739066841,0.00267928144614076,0.0192278822722482,0.02973066554112,7.3673708858604e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,39673,0.0720495751510522,0.0078959599813801,0.0565734935875472,0.0875256567145572,8.03240290972789e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37285,0.0210498183274434,0.00230729354530196,0.0165275229786515,0.0255721136762352,8.32201138895168e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,39594,0.0414204044465741,0.00454628244101488,0.032509690862185,0.0503311180309633,9.14170785464349e-20
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,39680,0.0219280834679959,0.00240970381185078,0.0172050639967683,0.0266511029392234,1.0097950725215e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39674,0.0323678665108433,0.00356002501478629,0.0253902174818621,0.0393455155398244,1.08533248037089e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,39302,0.0490827226238828,0.00539857173303893,0.0385015220271265,0.0596639232206391,1.09055757199628e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39594,0.0308491597432669,0.00339389361076265,0.0241971282661721,0.0375011912203617,1.11031734832386e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37268,0.0269798086657965,0.00296920714047047,0.0211601626704743,0.0327994546611186,1.16396819139866e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39288,0.0283549311976684,0.00312319155733761,0.0222334757452867,0.0344763866500501,1.22795514899902e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39770,0.0276718116028449,0.00305105914981262,0.0216917356692122,0.0336518875364777,1.33177281327736e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39594,0.0164869651799781,0.00181865081910902,0.0129224095745244,0.0200515207854318,1.3840173102732e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,39594,0.0591833891414457,0.00653448940837305,0.0463757899010345,0.0719909883818569,1.49440761041219e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,39668,0.0228992018046836,0.00252881841786699,0.0179427177056643,0.0278556859037029,1.51811614446434e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,36896,0.0314205473990684,0.00346944030736095,0.024620444396641,0.0382206504014959,1.5382589324974e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,39673,0.036693011420253,0.00405413234845095,0.0287469120172892,0.0446391108232169,1.58203441123312e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,39302,0.0232820722945536,0.00257935783271742,0.0182265309424274,0.0283376136466797,1.98153942855085e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39673,-0.0278073703570748,0.00308080899062162,-0.0338457559786932,-0.0217689847354564,1.98202900985052e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,36958,0.0431442644669639,0.00478394958147989,0.0337677232872633,0.0525208056466645,2.1680962498437e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37215,0.112567059074844,0.0124960055384748,0.0880748882194332,0.137059229930254,2.37448573325431e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39817,0.0355439493216933,0.00394754552679826,0.0278067600891687,0.0432811385542178,2.41632297105124e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39401,0.0512056736834789,0.00569123930394335,0.0400508446477499,0.0623605027192079,2.57672815524511e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37267,0.0283199250675468,0.00314707440450593,0.0221516592347152,0.0344881909003785,2.5850217261798e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,39588,-0.026744270493824,0.0029730530944575,-0.0325714545589607,-0.0209170864286873,2.61390937199852e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39401,0.0322421786388258,0.00359373255840647,0.0251984628243491,0.0392858944533024,3.24526705558111e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,39865,0.0393657614939653,0.00439233749028113,0.0307567800130143,0.0479747429749163,3.5222010487945e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39673,0.050267044945215,0.00561289526157031,0.0392657702325372,0.0612683196578928,3.74756445500729e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,39710,0.0233672511490889,0.00261187660490135,0.0182479730034822,0.0284865292946955,4.06691035469862e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,39371,0.030101327010377,0.00337186336477877,0.0234924748154106,0.0367101792053434,4.85052120033828e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,36972,0.0165923035358355,0.0018694785407821,0.0129281255959025,0.0202564814757684,7.8655885993884e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,36896,0.0233189160024553,0.00263291797078071,0.0181583967797251,0.0284794352251854,9.29888048894735e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36896,0.0250346841728481,0.00282780611370706,0.0194921841899823,0.030577184155714,9.60548583755925e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37267,0.0174499242795499,0.00197122505351066,0.013586323174669,0.0213135253844308,9.63500353672638e-19
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39817,-0.108296981906876,0.0122590227722073,-0.132324666540403,-0.0842692972733502,1.11281752656137e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,39817,0.0326817947095696,0.00371361200687508,0.0254031151760945,0.0399604742430448,1.49889591032039e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,39585,0.0304042008957224,0.00345523853767193,0.0236319333618854,0.0371764684295593,1.51559830608917e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,39430,0.0329832808660936,0.00375076482483228,0.0256317818094223,0.0403347799227649,1.59571457874412e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39668,-0.0304929658753901,0.00346846516115788,-0.0372911575912595,-0.0236947741595206,1.62561016013975e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,39557,0.0505835464825475,0.00575624182282781,0.039301312509805,0.06186578045529,1.68370394698167e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39668,0.0258001495480545,0.00293602217870056,0.0200455460778014,0.0315547530183076,1.68477827787355e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39668,0.0687786010054177,0.00783402315586974,0.053423915619913,0.0841332863909224,1.80803086711598e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,36958,0.0226423319041662,0.00257948845601466,0.0175865345303774,0.0276981292779549,1.87104124739875e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,37285,0.017559047471162,0.00200145002458682,0.0136362054229718,0.0214818895193521,1.94447743687809e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39673,0.0426759213489201,0.00486605558899743,0.0331384523944851,0.052213390303355,1.9637746105671e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39721,0.0182418883685697,0.00208210924802819,0.0141609542424345,0.0223228224947049,2.12326779532708e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,36390,0.0188977686324786,0.00216518026916015,0.0146540153049247,0.0231415219600325,2.91687859225613e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,39594,0.0219708008864776,0.00252035709656583,0.0170309009772086,0.0269107007957466,3.12849921020643e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,37257,0.0173873002212254,0.00199716688892078,0.0134728531189407,0.0213017473235101,3.51304186758115e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,37215,0.0256443322659168,0.00294798270322475,0.0198662861675963,0.0314223783642373,3.73792343331514e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,37285,0.0161063060802942,0.00185262082504422,0.0124751692632075,0.0197374428973809,3.90808442576688e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39673,0.03344833227569,0.00385632112309879,0.0258899428744164,0.0410067216769636,4.58658910305549e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36439,-0.0833494641965626,0.00961148481272551,-0.102187974429505,-0.0645109539636206,4.76880130256756e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,39594,0.0223402730604469,0.00258067322110822,0.0172821535470748,0.027398392573819,5.31761014845315e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,39721,0.0206471570251807,0.00238819578664421,0.0159662932833581,0.0253280207670034,5.86198959475502e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,37285,-0.0270302007876183,0.00312702259605138,-0.033159165075879,-0.0209012364993576,6.03319704327159e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36896,0.0659188500304949,0.00762586252449649,0.0509721594824817,0.080865540578508,6.0497849122365e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39508,0.0307767339628099,0.00356268415005926,0.0237938730286938,0.0377595948969261,6.23109256526396e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39656,0.0170428092066165,0.00197328700264273,0.0131751666814368,0.0209104517317963,6.32830795263164e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39697,0.0243100924495225,0.0028166611251543,0.0187894366442201,0.029830748254825,6.66275879765278e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,39802,0.0286857315948463,0.00332576378486581,0.0221672345765093,0.0352042286131833,6.98599371360425e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39721,0.0191977659418705,0.00222671062941631,0.0148334131082146,0.0235621187755265,7.21927662251678e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39673,0.028062373365332,0.00325697432493608,0.0216787036884573,0.0344460430422067,7.5744061331329e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,39817,0.0168505961018471,0.00196007439341532,0.013008850290753,0.0206923419129411,8.93842066198699e-18
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36896,0.0237383273978914,0.00276681371830357,0.0183153725100164,0.0291612822857664,1.05826336206231e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,39594,0.0426906065967986,0.00498009760938518,0.0329296152824036,0.0524515979111935,1.10807563089513e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37277,0.020161885433124,0.00236104638014018,0.0155342345280492,0.0247895363381987,1.49340339996167e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39594,0.080729871124117,0.0094646030331551,0.062179249179133,0.099280493069101,1.59978850867943e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39701,0.0170115055836842,0.00200028858537045,0.0130909399563581,0.0209320712110103,1.98431025501704e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39790,0.025538590035112,0.0030053166429848,0.0196481694148618,0.0314290106553622,2.10108883520536e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39288,0.0509381579371555,0.00600253596646668,0.0391731874428808,0.0627031284314302,2.32886307725224e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39836,0.0223043445492033,0.00263531129340664,0.0171391344141263,0.0274695546842803,2.81367782547194e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37244,0.0358669935261033,0.00424003469145505,0.0275565255308514,0.0441774615213552,2.97108547514229e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,39817,0.0224231508262903,0.00265207487217587,0.0172250840768256,0.027621217575755,3.03090066650183e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36863,0.0430359343160746,0.00509325600622752,0.0330531525438687,0.0530187160882805,3.23185244751677e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39680,0.0225167430860045,0.00267544574363671,0.0172728694284765,0.0277606167435324,4.22278321698204e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37220,0.04862871674619,0.00577721237004474,0.0373053805009023,0.0599520529914777,4.24060256970835e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39594,0.025440572028108,0.00302668600403042,0.0195082674602084,0.0313728765960076,4.6243602814341e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,39609,0.033768840893469,0.00403577350947799,0.0258587248148921,0.0416789569720459,6.38078000121296e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,39680,0.0335495599288672,0.00401853605512537,0.0256732292608215,0.041425890596913,7.46707624544975e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39782,0.0504188189286463,0.00604040617735573,0.0385796228210291,0.0622580150362636,7.57591304917745e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,36958,0.0340924341752483,0.00408533846584859,0.0260851707821851,0.0420996975683115,7.82549718677032e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,39721,-0.0298410039926402,0.00357901694523686,-0.0368558772053044,-0.0228261307799759,8.18593506172448e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39758,0.0229253403884,0.00275021665990689,0.0175349157349825,0.0283157650418175,8.31882480640671e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,39591,0.0304486531933279,0.00365647647581814,0.0232819593007243,0.0376153470859314,8.94345973022307e-17
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C3,Complement C3,36653,0.0339785577182678,0.00408630871371771,0.0259693926393811,0.0419877227971545,1.00786127246742e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39288,0.0363720463143914,0.00437722970744459,0.0277926760878,0.0449514165409828,1.04140394163702e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,39673,0.0284807273075411,0.00342884843665378,0.0217601843716997,0.0352012702433825,1.06739419765799e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39401,0.0621662979811013,0.00749020182277044,0.0474855024084713,0.0768470935537314,1.1289259753478e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39569,0.0769678306876552,0.00928647951419386,0.0587663308398352,0.0951693305354752,1.24225214585333e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39816,0.0603201579612304,0.00729976896656374,0.0460126107867654,0.0746277051356953,1.52734333142486e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,39817,0.0390634710048185,0.00472751729493837,0.0297975371067392,0.0483294049028977,1.53113646097909e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37203,0.0308001067575198,0.0037335928037307,0.0234822648622076,0.0381179486528319,1.73930147743907e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37277,0.0200851467861225,0.00243642911103755,0.0153097457284889,0.0248605478437561,1.82401684636737e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39594,0.0152386947445555,0.00185110359416341,0.0116105316999952,0.0188668577891158,1.98066302191085e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39721,0.0157575359480378,0.00191574817778054,0.0120026695195879,0.0195124023764876,2.09730639920573e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37244,-0.0327725762757855,0.00398983563501011,-0.0405926541204053,-0.0249524984311657,2.33410498432018e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,39673,0.0388404134274971,0.00474146200566582,0.0295471478963921,0.0481336789586021,2.77199869221506e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,39860,0.0232442531756226,0.00283932854790262,0.0176791692217335,0.0288093371295117,2.8895166647235e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39594,0.0497098534033367,0.00607619497205016,0.0378005112581184,0.061619195548555,3.0263381923523e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37215,0.0386165187556989,0.00472154361652876,0.0293622932673025,0.0478707442440952,3.12443050298487e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39594,0.0163087368393773,0.00199771492104147,0.012393215594136,0.0202242580846186,3.49350131717041e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37277,0.0284726361386613,0.00349230609879835,0.0216277161850166,0.0353175560923061,3.86435782336133e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,37215,0.0430544663860719,0.00528464721732877,0.0326965578401075,0.0534123749320363,4.05740539415671e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39594,0.0245720920341947,0.00301838253240153,0.0186560622706877,0.0304881217977017,4.21804052302825e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,37220,0.0476595321064316,0.00585649253097329,0.0361808067457239,0.0591382574671392,4.37559502732548e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37215,0.0430779853917963,0.00530248279850725,0.0326851191067221,0.0534708516768705,4.89989022722383e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39673,0.0540949827455942,0.00666302043555582,0.0410354626919048,0.0671545027992836,5.05704507843347e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,39302,0.0372134792949285,0.00458404736729663,0.0282287464550271,0.0461982121348299,5.09259667042165e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39865,0.0300836175201742,0.00370814538712372,0.0228156525614117,0.0373515824789367,5.30070539075605e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37215,0.0737267749197189,0.00908998337525245,0.0559104075042241,0.0915431423352137,5.46627015021973e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,39836,0.0269060457922674,0.00332127730979207,0.020396342265075,0.0334157493194598,5.83631340676135e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39680,0.0244420114696729,0.00302029636731309,0.0185222305897392,0.0303617923496066,6.26234284261984e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39793,0.0200863558766197,0.00248213086624061,0.0152213793787881,0.0249513323744513,6.26967066006128e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,39697,0.0211672077338361,0.00261906861498758,0.0160338332484605,0.0263005822192118,6.83011925772035e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39401,0.0609964040697519,0.00755857195563397,0.0461816030367093,0.0758112051027945,7.55074451270605e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39408,0.0161611632590401,0.00200870804125255,0.0122240954981851,0.0200982310198951,9.20145272036163e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,37215,0.0501996786954192,0.00623987223930331,0.0379695291063847,0.0624298282844537,9.34925850128272e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,39288,0.0527677361409066,0.00656357363058174,0.0399031318249664,0.0656323404568468,9.67195595103579e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39668,-0.0260143904053182,0.0032360073604468,-0.0323569648317939,-0.0196718159788425,9.69068503960804e-16
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,37220,0.019491714208084,0.00242648769068002,0.0147357983343512,0.0242476300818168,1.0313622887242e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39673,0.0266766381674805,0.0033216068934006,0.0201662886564153,0.0331869876785456,1.03238532109075e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39529,0.0637445835205334,0.00794504672284933,0.0481722919437487,0.0793168750973181,1.1028433559668e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,39836,0.0792594315409428,0.00989606786058923,0.0598631385341879,0.0986557245476977,1.23375753859402e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39785,0.0408281955353568,0.00510588365658083,0.0308206635684584,0.0508357275022552,1.36957570945735e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37236,0.0159600964237038,0.0019974135995141,0.0120451657686562,0.0198750270787514,1.45479858966142e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,37267,0.0610849153075524,0.00764858840219353,0.0460936820392531,0.0760761485758517,1.50167492156687e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,37042,0.0194596902025365,0.00243668589704609,0.0146837858443262,0.0242355945607469,1.50731261930525e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39865,0.0323171972142399,0.00405433336996398,0.0243707038091105,0.0402636906193693,1.67906834343351e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39594,0.0287587643779697,0.00360909724718123,0.0216849337734945,0.0358325949824449,1.71676458760599e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,39865,0.0269092188264705,0.00337802786150965,0.0202882842179116,0.0335301534350294,1.7491006556104e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,37285,0.0103500126632406,0.00130140965505885,0.00779924973932524,0.0129007755871559,1.96660486018562e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39865,0.0368534277571404,0.00463707364236907,0.0277647634180971,0.0459420920961838,2.02813153474169e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39490,0.0224657980038592,0.00282722200603277,0.016924442872035,0.0280071531356835,2.05285366236066e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,39557,-0.101792902708444,0.0128412719661558,-0.126961795762109,-0.0766240096547784,2.39488614251647e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,39548,0.0408919810858197,0.00515872098888209,0.0307808879476108,0.0510030742240286,2.39965562524717e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,36958,0.0447241073841766,0.00564583158757818,0.0336582774725234,0.0557899372958299,2.53284121489072e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36880,0.0594415288100764,0.00750446778445278,0.0447327719525489,0.0741502856676038,2.55022661099896e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39675,0.0280483893895704,0.0035515971435457,0.0210872589882208,0.0350095197909199,3.03381475093309e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,39743,0.0535695913209448,0.00678391196365921,0.0402731238721728,0.0668660587697169,3.05337337820656e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,39743,0.0304015686815584,0.00385116505670456,0.0228532851704175,0.0379498521926993,3.11348510846186e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,39865,0.0179872239677467,0.00228104329920448,0.0135163791013059,0.0224580688341874,3.33304811531057e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39498,0.0296378467326698,0.00376064474691535,0.0222669830287157,0.0370087104366239,3.45904272272362e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,39865,0.0384935629756901,0.00489245390684592,0.0289043533182721,0.0480827726331081,3.83425206953224e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37215,0.0633657573544188,0.0080678987344438,0.047552675834909,0.0791788388739287,4.3341603312717e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,39594,0.0412953389070993,0.0052658275885372,0.0309743168335663,0.0516163609806322,4.7121738574657e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39673,0.0423041728682218,0.00539669096191784,0.0317266585828628,0.0528816871535808,4.83287259038831e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39288,0.0353703421941134,0.00451819475044232,0.0265146804832464,0.0442260039049803,5.25974696532874e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,37220,0.0645424743849468,0.00824505979185227,0.0483821571929164,0.0807027915769772,5.32794722132862e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,37011,0.0250581877767006,0.00320191488893332,0.0187824345943912,0.0313339409590099,5.41989145960905e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,36888,0.0180383285957283,0.00230719292950265,0.0135162304539031,0.0225604267375535,5.7641798437104e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39594,0.0301153576059525,0.00386119924901785,0.0225474070778775,0.0376833081340274,6.60423299911823e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39401,0.0237475635618,0.00304871899199879,0.0177720743374824,0.0297230527861177,7.15868415732528e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,39809,0.0133441828416688,0.00171350705977646,0.00998570900450689,0.0167026566788306,7.24478114953014e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,39680,0.0369042314601925,0.0047391763085889,0.0276154458953582,0.0461930170250267,7.28194484415754e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39630,0.0272775171475835,0.0035049263641931,0.020407861473765,0.034147172821402,7.54226909651997e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37215,0.0665862217008821,0.00855671204937254,0.0498150660841119,0.0833573773176522,7.67649513206379e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37220,0.0280085560590168,0.00360032624046505,0.0209519166277053,0.0350651954903283,7.81672962670405e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39288,0.0464365522310909,0.00597126569747956,0.034732871464031,0.0581402329981509,7.9147186473101e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37203,0.0552343487817494,0.00710156688466521,0.0413152776878056,0.0691534198756932,7.92145442500757e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39675,0.0192920896992737,0.00248090165321461,0.014429522458973,0.0241546569395743,7.9295389178505e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39673,0.039081888994947,0.00502679201722064,0.0292293766411946,0.0489344013486995,8.02524646558045e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,39865,0.0233912928719454,0.00300982430449183,0.0174920372351414,0.0292905485087494,8.21563469021346e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,37245,0.0308190761072047,0.00396564100756848,0.0230464197323705,0.0385917324820389,8.31833363771236e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,39668,0.0311867605052519,0.00401714140383462,0.0233131633537361,0.0390603576567678,8.77095040811047e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39594,0.021223281025824,0.00273475585490888,0.0158631595502026,0.0265834025014454,8.9717021494536e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,36896,0.0581272529692961,0.0074990999586844,0.0434290170502747,0.0728254888883175,9.77316999062612e-15
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,39721,0.0195194433937989,0.00252092267797895,0.0145784349449602,0.0244604518426377,1.02955493848367e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,39478,0.031755547672985,0.0041051779474292,0.0237093988960238,0.0398016964499462,1.09276251223948e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39265,0.0299828442561123,0.00387782512491227,0.0223823070112843,0.0375833815009404,1.12504685856379e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39721,0.0188464405960556,0.00244221222249657,0.0140597046399623,0.0236331765521489,1.26208508975426e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",37285,0.0111309162801093,0.00144245136140174,0.00830371161176193,0.0139581209484567,1.27817997999014e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,39557,0.0382206863838287,0.00495718135417011,0.0285046109296552,0.0479367618380021,1.33160940448867e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BSG,Basigin,39848,0.0132983099889579,0.00172530366781485,0.00991671480004077,0.016679905177875,1.35490387303873e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39673,0.0224180926278278,0.00291018261863154,0.0167141346953099,0.0281220505603456,1.40397912741996e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37215,0.0599310611096623,0.00777855445437531,0.0446850943790867,0.0751770278402379,1.40427285103016e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,39817,0.0394977970874645,0.0051357940583363,0.0294316407331254,0.0495639534418037,1.54852287808443e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39738,0.0201542988737084,0.00262188451822591,0.0150154052179856,0.0252931925294312,1.59469986237343e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,37268,0.0207498489320555,0.00270755704337089,0.0154430371270486,0.0260566607370625,1.93065609696952e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,39603,0.073028995294159,0.00953744615582603,0.05433560082874,0.0917223897595781,2.01222615708786e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,39314,0.0334512371182782,0.00436951279436129,0.0248869920413301,0.0420154821952263,2.03761817632629e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,39796,0.0204082463710179,0.0026661172186604,0.0151826566224435,0.0256338361195922,2.04880613106021e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,39673,0.0581295640552943,0.00759684179519651,0.0432397541367091,0.0730193739738795,2.09568303409388e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39594,0.0845222707938742,0.0110692430738119,0.0628265543692029,0.106217987218546,2.37324117356029e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37244,0.0776726656865397,0.0101741473757968,0.0577313368299781,0.0976139945431014,2.42369810461442e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39817,0.0181190313983532,0.0023742716284557,0.01346545900658,0.0227726037901264,2.45290859057362e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39680,0.0187126230833534,0.00245801553724022,0.0138949126303626,0.0235303335363442,2.83103438438249e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36855,0.0413491027479152,0.00543642483020413,0.0306937100807151,0.0520044954151153,3.02265649591034e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37215,0.0510810874933482,0.00672992801930921,0.0378904285755021,0.0642717464111942,3.4071335771605e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36958,0.033035020727492,0.00435559044151442,0.0244980634621237,0.0415719779928602,3.56212665808799e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,39646,0.0463846676697145,0.00612513875786658,0.034379395704296,0.058389939635133,3.85332284911456e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36855,0.0459350920478159,0.0060710501121469,0.034035833828008,0.0578343502676238,4.09966108634365e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,37267,0.0268377561873402,0.00355151221526882,0.0198767922454133,0.033798720129267,4.40152221863073e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39680,0.0171120070759217,0.00226547712817916,0.0126716719046906,0.0215523422471529,4.47238874970497e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37215,0.0359286961334143,0.00475642064694245,0.0266061116654071,0.0452512806014215,4.50435541447663e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37244,0.0612186680948489,0.00810774784734044,0.0453274823140616,0.0771098538756362,4.61135794012217e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39697,0.0196053831951091,0.00259977442643251,0.0145098253193014,0.0247009410709169,4.90921708836705e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39288,0.0376693929211721,0.0050012565032223,0.0278669301748564,0.0474718556674878,5.27390419437236e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39401,0.0488261312600955,0.00650483718296501,0.0360766503814841,0.061575612138707,6.42005736210589e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39557,0.0355192237150338,0.00473859126084848,0.0262315848437708,0.0448068625862968,6.94421122184494e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,39675,-0.0350285762231417,0.00467587787858669,-0.0441932968651716,-0.0258638555811118,7.17733059831995e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,39302,0.02805730948855,0.00374679844131029,0.0207135845435818,0.0354010344335181,7.35146031800569e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,37277,0.0352677880462015,0.00471102175677074,0.0260341854029308,0.0445013906894721,7.52960095028051e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36896,0.0587036123854898,0.00784778974521786,0.0433219444848628,0.0740852802861168,7.89119166248268e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39865,0.0371425810368499,0.0049706328386649,0.0274001406730667,0.0468850214006331,8.28055211419239e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36880,0.048062441249828,0.00643123503105272,0.0354572205889647,0.0606676619106914,8.32083730026366e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36958,0.0503030553512139,0.00673830730386602,0.0370959730356365,0.0635101376667913,8.83997443754084e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36896,0.033092384039123,0.00443364582904358,0.0244024382141975,0.0417823298640484,8.93089098942218e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36958,0.0183330164653682,0.00245884192305972,0.0135136862961711,0.0231523466345652,9.48229393811069e-14
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39557,0.0330020650328151,0.00443189270686916,0.0243155553273516,0.0416885747382787,1.00828370832184e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,39743,0.0275580160577551,0.00370112202940632,0.0203038168801187,0.0348122152353915,1.01256919748312e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39557,0.0221667327935164,0.00297797430177297,0.0163299031620414,0.0280035624249914,1.03086099556167e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,39275,0.0389229352521051,0.00524249654473025,0.0286476420244338,0.0491982284797764,1.19118686797052e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39557,0.0227943181142028,0.00307231128608002,0.016772587993486,0.0288160482349197,1.23787670342525e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37197,0.0274346596042773,0.00369739023076762,0.0201877747519728,0.0346815444565819,1.24195876643524e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39557,0.0273161298836946,0.00368350212236085,0.0200964657238673,0.0345357940435219,1.27060616192302e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,39817,0.0218295417059305,0.00294648649006887,0.0160544281853956,0.0276046552264655,1.33953212736152e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,39379,0.0325145908055596,0.00439019938802682,0.023909800005027,0.0411193816060921,1.36672041309855e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37244,0.0396535191229128,0.0053609296532341,0.029146097002574,0.0501609412432516,1.47846908520906e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,39720,0.0189712470727306,0.00256542250921633,0.0139430189546666,0.0239994751907947,1.48493862997411e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39653,0.0557025988510361,0.00754061682741121,0.0409229898693101,0.070482207832762,1.57669533446295e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,36958,0.0177947007511031,0.00240913660351115,0.0130727930082212,0.0225166084939849,1.60053619918417e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,37220,0.0248000303437224,0.00335984662091388,0.0182147309667312,0.0313853297207136,1.66016750937663e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39594,0.0232655060171742,0.00315353337408027,0.0170845806039768,0.0294464314303715,1.69208202251302e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,39694,0.0405969324948395,0.00551979039445548,0.0297781433217068,0.0514157216679722,2.0057819462278e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,39698,0.0182595847164686,0.00248302861977918,0.0133928486217014,0.0231263208112358,2.02139208598989e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37277,0.0164636038963516,0.00224028377099302,0.0120726477052053,0.0208545600874979,2.11408473315145e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,39865,0.0220177020738361,0.00299984881516657,0.0161379983961096,0.0278974057515625,2.24512104642096e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,37182,0.0377824171502225,0.00514923989050454,0.0276899069648336,0.0478749273356114,2.30255721644816e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,39668,-0.0234593750741666,0.00320004751039663,-0.029731468194544,-0.0171872819537892,2.39593178273017e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,36958,0.0710607271643125,0.00970259447106317,0.0520436420010287,0.0900778123275963,2.54962293390883e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,36958,0.0359186259632726,0.00490924075393385,0.0262965140855622,0.0455407378409829,2.69267637702885e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39836,0.038736662641085,0.00529553813691311,0.0283574078927353,0.0491159173894347,2.69670661122256e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39561,0.0150379002746373,0.0020584166064907,0.0110034037259155,0.0190723968233591,2.89368004478389e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39288,0.0221822717164225,0.0030379819221179,0.0162278271490714,0.0281367162837736,2.98143498909505e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,39401,0.0301507617260549,0.00412994633414403,0.0220560669111326,0.0382454565409772,3.00535999867262e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39296,0.0313096940497837,0.00429082964688508,0.0228996679418889,0.0397197201576784,3.08836392783512e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,39423,0.0483179286199854,0.0066382124317772,0.0353070322537021,0.0613288249862687,3.53009732207936e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39358,-0.0483943378581359,0.00664942467093848,-0.0614272102131754,-0.0353614655030965,3.55124658417617e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39668,0.037157916771277,0.0051107963735281,0.0271407558791619,0.0471750776633921,3.74993931056821e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39546,0.0237800220106985,0.00327300719604233,0.0173649279064555,0.0301951161149414,3.8915822046291e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39743,0.0129990830617445,0.00178944786891285,0.00949176523867534,0.0165064008848137,3.92387981590257e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39288,0.0187952247115311,0.0025899252687496,0.0137189711847819,0.0238714782382803,4.14458671937821e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,39493,0.024775521504182,0.00341468044307719,0.0180827478357507,0.0314682951726133,4.18692840466953e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39680,0.0402376645915267,0.00554836833804277,0.0293628626489629,0.0511124665340905,4.29163152740497e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39743,0.0180567963481444,0.00249602555607538,0.0131645862582367,0.0229490064380522,4.89592240013193e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,37244,0.0275610825504826,0.00381085352523588,0.0200918096410203,0.0350303554599449,5.00830113643413e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39621,0.0123643962754354,0.00171091819618337,0.00901099661091603,0.0157177959399548,5.17319924004865e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,39743,-0.0411940777842799,0.0057039242691049,-0.0523737693517255,-0.0300143862168343,5.35284809798129e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C2,Complement C2,39715,0.0151344175866214,0.00209586549355286,0.0110265212192578,0.019242313953985,5.39172902015041e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39738,0.0192382676831862,0.00266469348185943,0.0140154684587417,0.0244610669076307,5.4465914149441e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39652,0.0155643861738543,0.00215635044135908,0.0113379393087905,0.0197908330389181,5.5187338932059e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39288,0.035385343675278,0.00490370970372509,0.0257740726559769,0.0449966146945792,5.60171825653808e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39680,-0.0250041342395925,0.00346759430114639,-0.0318006190698394,-0.0182076494093455,5.81405098850273e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36958,0.0445289971131207,0.00617431227289092,0.0324273450582545,0.0566306491679869,5.81739262029496e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39594,0.0509372630653378,0.007064452395687,0.0370909363697913,0.0647835897608844,5.83417094407003e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39302,0.0174174330392137,0.00241714372499426,0.0126798313382249,0.0221550347402024,6.03768904669838e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39817,0.0413824056523292,0.00575182538014179,0.0301088279072513,0.0526559833974071,6.54019968618872e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39594,0.055234382393556,0.00768181060380797,0.0401780336100923,0.0702907311770196,6.7566490437222e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39860,0.0173008934499978,0.00242225470360712,0.0125532742309278,0.0220485126690677,9.56121377683861e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39508,0.0179988269505474,0.00252112355628236,0.013057424780234,0.0229402291208608,9.79967288013299e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36880,0.0290109930600263,0.00406293840217497,0.0210476337917634,0.0369743523282893,9.80016748133475e-13
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36896,-0.0763427080932711,0.0106987879063789,-0.0973123323897737,-0.0553730837967685,1.01430935511946e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39302,0.0425365337613907,0.00596757515995435,0.0308400864478802,0.0542329810749013,1.06391570673453e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37264,0.0121352949239453,0.00170335899910448,0.00879671128570051,0.0154738785621901,1.09927162121194e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,39721,0.0340444706530309,0.00478440005760506,0.024667046540125,0.0434218947659369,1.16090974818941e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39836,0.0243408826233793,0.00342076885179859,0.0176361756738541,0.0310455895729046,1.16145490040234e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,39700,0.0281216505364668,0.00396417874674263,0.0203518601928513,0.0358914408800824,1.35863077280081e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37220,0.0190262404042035,0.00268176644790061,0.0137699781663183,0.0242825026420887,1.36195907436622e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39810,0.0311558245223848,0.00439563115977517,0.0225403874492254,0.0397712615955441,1.41858928713413e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,37267,0.0294650600093125,0.00415890624173195,0.0213136037755179,0.0376165162431071,1.46186297281347e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39594,0.0136785903760576,0.00193174464996005,0.00989237086213594,0.0174648098899793,1.49225113500715e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,39865,0.0187743809184216,0.00265151900000253,0.0135774036784167,0.0239713581584266,1.49483955346513e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,36958,0.0180484658239528,0.00255057970607308,0.0130493296000496,0.0230476020478561,1.55675515740633e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,39604,0.0272804343747994,0.00385699345388394,0.0197207272051869,0.034840141544412,1.58025013027726e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37277,0.0136763412932608,0.00193547069641137,0.00988281872829447,0.017469863858227,1.67144374172928e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,36896,0.0580103100200853,0.00821174793049043,0.0419152840763241,0.0741053359638466,1.6961628027899e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39743,0.0156163199031409,0.00221346727366399,0.0112779240467594,0.0199547157595223,1.79548587282135e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,39865,0.0280108367901474,0.00397238763377662,0.0202249570279452,0.0357967165523496,1.84388140059289e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37215,0.0523069635192577,0.00743709279851029,0.0377302616341775,0.0668836654043379,2.11592222505725e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39594,0.0455348349576805,0.00647926584799806,0.0328354738956043,0.0582341960197567,2.18464760326672e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,39594,0.0260807177069235,0.00371898175023029,0.0187915134764721,0.0333699219373748,2.42990352293029e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39809,0.018827077336569,0.00268571666510565,0.0135630726729619,0.0240910820001761,2.47736266858533e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39860,0.0198837856004649,0.00283825723618246,0.0143208014175473,0.0254467697833825,2.55671830963339e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,39380,0.0335702372019752,0.00479209329632271,0.0241777343411827,0.0429627400627677,2.56515230072593e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,37122,0.0619101198912365,0.00886714126354339,0.0445305230146915,0.0792897167677816,3.04923862441571e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,39673,0.0520415365927117,0.00747297020176229,0.0373945149972576,0.0666885581881658,3.43844156303294e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,39401,0.0319097782106278,0.00458361137367646,0.022925899918222,0.0408936565030337,3.49621199277081e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39810,0.0196719628725331,0.00282603359688777,0.0141329370226331,0.0252109887224332,3.51082711244897e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39401,0.0446613550524368,0.00642086467377111,0.0320764602918454,0.0572462498130282,3.64912502512392e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39695,0.0145697467877902,0.00209573145694875,0.0104621131321707,0.0186773804434098,3.73929509441464e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,39401,0.0144369911377088,0.00207723900440742,0.0103656026890703,0.0185083795863474,3.79578254075342e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39738,-0.0280479026131882,0.0040429860280805,-0.035972155228226,-0.0201236499981504,4.14741067552479e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39860,0.0132049226250558,0.00190370158569119,0.00947366751710105,0.0169361777330105,4.17488751624043e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37285,0.0150608843831225,0.00217114111821441,0.0108054477914222,0.0193163209748227,4.1929978593423e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39842,0.0162967099343971,0.00235152787045179,0.0116877153083116,0.0209057045604827,4.36105098003952e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,39836,0.027246883254369,0.00393194674595238,0.0195402676323023,0.0349534988764356,4.38107020149737e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37268,0.0382938393924468,0.00553049023147287,0.02745407853876,0.0491336002461336,4.58632362664503e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36958,-0.0184656669647423,0.00266710131598802,-0.0236931855440788,-0.0132381483854058,4.61169184267861e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39743,0.0399270039635159,0.0057749351165625,0.0286081311350534,0.0512458767919784,4.89658662362751e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39288,0.0383947848427254,0.00555478624252053,0.0275074038073852,0.0492821658780657,4.96531696774962e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37220,0.038453833607354,0.00556338876678944,0.0275495916244467,0.0493580755902613,4.99748157564676e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,39401,0.0207088897940994,0.00299749555361833,0.0148337985090075,0.0265839810791914,5.0799611633315e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39658,-0.0297568353213824,0.00431022052952346,-0.0382048675592484,-0.0213088030835165,5.25629657341837e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36867,0.0223209752289797,0.00323278167407639,0.01598472314779,0.0286572273101694,5.26930852443958e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39798,0.0282330229513688,0.00409489038667047,0.0202070377934947,0.0362590081092429,5.60065938060469e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39192,0.0752502711390851,0.0109140453094247,0.0538587423326126,0.0966417999455576,5.60430203812031e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,39288,0.0230942950623198,0.00335451172568339,0.0165194520799804,0.0296691380446592,6.02076987138758e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36958,0.0325729703252947,0.00473349610372629,0.0232953179619911,0.0418506226885982,6.19732512040131e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39401,0.022803613538932,0.00331493061194439,0.016306349539521,0.029300877538343,6.25473528734539e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39628,0.012148619819982,0.00176788386385595,0.00868356744682431,0.0156136721931396,6.57513760766419e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39817,0.0324771743902509,0.00472691694094891,0.023212417185991,0.0417419315945107,6.62551778559969e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,37177,0.0170356529652561,0.00248022967463319,0.012174402802975,0.0218969031275371,6.7723369108754e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,39673,0.0381041609472247,0.00555041745814677,0.0272253427292571,0.0489829791651924,6.89170733924237e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39557,0.0353159866394681,0.00514617197920065,0.0252294895602348,0.0454024837187013,7.01614391558288e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39557,0.028703543889388,0.00418707117715742,0.0204968843821595,0.0369102033966165,7.38252480422169e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39817,0.0317780337916084,0.00463946813217021,0.0226846762525548,0.040871391330662,7.68155651991132e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,37257,0.00881496977953396,0.00128712142777418,0.00629221178109657,0.0113377277779713,7.78328913392259e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39302,0.030610740339328,0.00447349507335349,0.0218426899955552,0.0393787906831008,8.06428361658889e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39594,0.0326841044100291,0.00477691216200709,0.0233213565724952,0.042046852247563,8.09201988098475e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39521,0.0183561831759941,0.00268312734150376,0.0130972535866467,0.0236151127653415,8.13631005561823e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,39597,0.0149910941315795,0.00219134704876131,0.0106960539160074,0.0192861343471517,8.15178690868796e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39288,0.0465133187633001,0.00679916645922908,0.0331869525032111,0.0598396850233891,8.15814662402023e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37215,0.0243966951446722,0.0035667733476076,0.0174058193833613,0.0313875709059831,8.26462836213935e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37056,0.0339272057177734,0.00496027730966358,0.0242050621908328,0.043649349244714,8.28096600802451e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,36896,0.0194629731263372,0.00284803969109082,0.0138808153317992,0.0250451309208752,8.63623787127106e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39680,0.0170000191279523,0.00249257917324464,0.0121145639483928,0.0218854743075118,9.41724811745081e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,36958,0.0175002084775808,0.00256618000882263,0.0124704956602884,0.0225299212948731,9.53290799359097e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39557,0.0299021384034397,0.00438730409815659,0.0213030223710528,0.0385012544358266,9.72846273474231e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,39832,0.0415271648208398,0.00609378187158973,0.0295833523525239,0.0534709772891556,9.78526236325689e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,39841,0.0245770283991903,0.00360705876151754,0.0175071932266159,0.0316468635717647,9.85905082088358e-12
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36877,0.0733230432112071,0.0107728467561046,0.052208263569242,0.0944378228531722,1.04540455711764e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39817,0.0402880758777399,0.00592656652446078,0.0286720054897968,0.0519041462656831,1.09933862977501e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36958,-0.0148050842309392,0.00217817203710603,-0.019074301423667,-0.0105358670382114,1.11427928188368e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,37203,0.0217837601667829,0.00320627215423045,0.0154994667444913,0.0280680535890746,1.13607230728227e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,36855,0.0359894275010848,0.00529928265912232,0.0256028334892051,0.0463760215129646,1.15899982216712e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,39507,-0.0286707832400727,0.00422267888503784,-0.0369472338547469,-0.0203943326253985,1.1639824438623e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,36896,0.0100257441599464,0.00147681874201555,0.00713117942559586,0.0129203088942968,1.18011590291725e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,39531,0.0296064581713238,0.00436423431044221,0.0210525589228571,0.0381603574197905,1.2117565002906e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,39669,-0.0352683742847486,0.00521098317239656,-0.0454819013026459,-0.0250548472668514,1.35086212710703e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39564,0.0156399194691819,0.00231184188955916,0.011108709365646,0.0201711295727179,1.37891894756986e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39630,0.0243741954083533,0.00360513800292379,0.0173081249226227,0.0314402658940839,1.41890857351842e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39233,0.0327228577076069,0.00484060617443926,0.023235269605706,0.0422104458095078,1.42885731783417e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36958,0.0170382231917516,0.00252062370965444,0.0120978007208289,0.0219786456626744,1.44306657630473e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36880,0.0318186467501083,0.00470736633891057,0.0225922087258436,0.041045084774373,1.4453691062212e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39673,0.0153866643573224,0.00228446305025479,0.010909116778823,0.0198642119358217,1.69170393000484e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,39585,0.0334732102563834,0.00497093363305599,0.0237301803355936,0.0432162401771731,1.71028381522932e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36896,0.0246742213071391,0.00366477127035166,0.0174912696172498,0.0318571729970284,1.73384367528746e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39614,0.0200407918590246,0.00298268093686111,0.0141947372227768,0.0258868464952724,1.89177981682486e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,37268,0.0544000702093851,0.00809783182054839,0.0385283198411103,0.07027182057766,1.91858172838871e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39617,0.0206029521803775,0.00306963227454159,0.014586472922276,0.026619431438479,1.98711136333707e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39672,0.0157516417659136,0.0023469268075499,0.0111516652231158,0.0203516183087114,1.99041359530132e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39817,0.0138584324086669,0.00206613273936142,0.0098088122395185,0.0179080525778153,2.04742768095318e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,36896,0.0206717127011444,0.00308243776122043,0.0146301346891523,0.0267132907131364,2.07870747030269e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,39706,0.0213903275584278,0.00319078553214277,0.0151363879154279,0.0276442672014276,2.09951796101456e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37277,0.0434676907026713,0.00648445956957455,0.0307581499463052,0.0561772314590375,2.11817375414584e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39401,0.0232395067493418,0.0034694433182779,0.0164393978455171,0.0300396156531664,2.18037994564481e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37199,0.0524949458533917,0.00783889556051705,0.0371307105547782,0.0678591811520051,2.21675663557601e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,39594,0.0262225830489079,0.00391818562751512,0.0185429392189782,0.0339022268788375,2.26751310057262e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,39836,0.0267637113450689,0.00400634682961032,0.0189112715590327,0.0346161511311052,2.46280518864718e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37268,0.0320229647713565,0.00479445933986447,0.0226258244652221,0.0414201050774909,2.49789534424895e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39680,0.015868469512334,0.00238131182365178,0.0112010983379766,0.0205358406866915,2.75740227235229e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,36880,0.0306747898879329,0.00460324477297476,0.0216524301329024,0.0396971496429634,2.77705292280425e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39401,0.0449159526115239,0.00674176993215962,0.0317020835444911,0.0581298216785568,2.78559314545664e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36896,0.0156885014702566,0.00235529769232236,0.0110721179933047,0.0203048849472084,2.82997321396201e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,39673,0.039094194168726,0.00587116963805334,0.0275867016781415,0.0506016866593106,2.8541388267568e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,39495,0.0339595105441306,0.00510113283379016,0.0239612901899019,0.0439577308983593,2.88288938553626e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39288,0.0490341766128123,0.00737641858121628,0.0345763961936284,0.0634919570319962,3.08274364309066e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37203,0.0324405202596258,0.00488465426189694,0.0228665979063078,0.0420144426129438,3.22942980681102e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37174,0.0264531659241659,0.00398925823176232,0.0186342197899118,0.0342721120584201,3.46053034695989e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,39636,0.0392975940799714,0.00592727168222922,0.0276801415828021,0.0509150465771406,3.4666774956934e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,39865,0.0204449103120867,0.00308378491131414,0.014400691885911,0.0264891287382624,3.46867125189121e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39401,0.0548466871629806,0.00827376784587724,0.0386301021850612,0.0710632721409,3.49133469320801e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39697,0.0194506217831074,0.00293457958533379,0.0136988457958532,0.0252023977703617,3.51068330855405e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37215,0.0523978005311238,0.00791541189079741,0.0368835932251609,0.0679120078370868,3.736310138004e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",39836,0.0431280898440634,0.0065207675834833,0.0303473853804361,0.0559087943076907,3.86050538615996e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39790,0.0347234399668938,0.00526315391586882,0.024407658291791,0.0450392216419967,4.31447508528985e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37220,0.0182932476087296,0.00277278641503713,0.0128585862352568,0.0237279089822024,4.34125885417971e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39865,0.0148107286373113,0.00224613750869464,0.0104082991202698,0.0192131581543528,4.41931948103464e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,37215,0.0209999269917983,0.00319219088099841,0.0147432328650414,0.0272566211185552,4.9282322467884e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,39302,0.0259529861647938,0.00394999628675185,0.0182109934427602,0.0336949788868274,5.17921111591962e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37203,0.0404657888721025,0.00616587591254658,0.0283806720835112,0.0525509056606938,5.47350807552661e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39605,0.0151410900421041,0.00230837643537234,0.0106166722287743,0.0196655078554339,5.57851075723295e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37244,0.0492777631270854,0.00751202337737536,0.0345541973074297,0.0640013289467411,5.58412490947738e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37244,0.0394857243349405,0.00602672410120824,0.0276733450965724,0.0512981035733087,5.89382446554731e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39594,0.0474221067747603,0.00724532787491259,0.0332212641399317,0.061622949409589,6.12538260402849e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,39668,0.0358153617142859,0.0054725453344369,0.0250891728587896,0.0465415505697822,6.15094547883218e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,39401,0.0278596917142115,0.00426184940454689,0.0195064668812996,0.0362129165471234,6.47223607597728e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,39790,0.0358083272596997,0.00548057646953685,0.0250663973794075,0.0465502571399919,6.61194098169589e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,37220,0.0214733533422515,0.00329122903499986,0.0150225444336518,0.0279241622508513,7.07268444228856e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,36827,0.0228853100955034,0.00351276840137515,0.0160002840288081,0.0297703361621987,7.54285908673329e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39288,0.0305435683086131,0.00469170193389721,0.0213478325181745,0.0397393040990516,7.740664854303e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39860,0.0237713563630498,0.0036518542914431,0.0166137219518213,0.0309289907742782,7.7699404054237e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36999,0.0252370239826718,0.00387758551592129,0.0176369563714661,0.0328370915938776,7.86932584348086e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38834,0.0206511870235347,0.00317878734288119,0.0144207638314875,0.0268816102155818,8.47705243543282e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39644,0.0205824836105866,0.00317350812798859,0.014362407679729,0.0268025595414443,9.09344585894184e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39634,0.015828104793494,0.00244578919465808,0.0110343579719642,0.0206218516150238,9.98475939968024e-11
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39842,0.0133312761507037,0.00206104540630796,0.00929162715434008,0.0173709251470673,1.02050076953351e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39817,0.0321414927416521,0.0049704813347718,0.0223993493254993,0.0418836361578048,1.03230253295749e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,39628,-0.0364510443046467,0.00563745947702095,-0.0475004648796078,-0.0254016237296857,1.0368286111976e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39538,0.0192118633986645,0.00297201323322584,0.0133867174615418,0.0250370093357871,1.04803385399863e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,37215,0.0106837151454129,0.00165304146878178,0.00744375386660059,0.0139236764242252,1.06166293381329e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39594,0.0343244446512497,0.00531314756351843,0.0239106754267536,0.0447382138757458,1.07574798221375e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,37268,0.0430485602534027,0.00666313586816829,0.0299888139517928,0.0561083065550125,1.07815435560556e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39865,0.0327094944228389,0.00506814700652465,0.0227759262900506,0.0426430625556272,1.12114912264445e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,39529,0.0294430356316575,0.00456372028697561,0.0204981438691853,0.0383879273941297,1.13964354429619e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39668,0.0157038563378074,0.00243682085989512,0.010927687452413,0.0204800252232018,1.19414617055397e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37215,0.0316832976090035,0.00491877562920071,0.0220424973757701,0.0413240978422369,1.22515550969365e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39594,0.0507545934953637,0.00789313526709648,0.0352840483718546,0.0662251386188728,1.31092388223081e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,39865,0.0478648489392878,0.00744957409157301,0.0332636837198047,0.0624660141587709,1.35434051210655e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39401,0.0528421550429579,0.00822593508199007,0.0367193222822574,0.0689649878036585,1.36734875522253e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36880,0.0552877624053546,0.00861021640415406,0.0384117382532126,0.0721637865574966,1.39916672197303e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,39594,0.0511995459502139,0.00798045520921662,0.0355578537401493,0.0668412381602785,1.44259813821144e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,39809,0.0343577461923196,0.00535904471048255,0.0238540185597738,0.0448614738248654,1.48464726422951e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,39680,0.0435890024544065,0.0068064677586592,0.0302483256474345,0.0569296792613785,1.55569931780305e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39738,0.0244720905369138,0.00382244255330452,0.0169801031324369,0.0319640779413906,1.57439647128335e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37244,0.0329898920460768,0.00515286729817715,0.0228902721416496,0.043089511950504,1.58224326498831e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36848,0.0487421653474121,0.00761733316133257,0.0338121923512003,0.063672138343624,1.61927997456277e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,39636,0.0149459743393686,0.00233661194579773,0.0103662149256051,0.0195257337531322,1.63529565092286e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37215,0.0238238776542396,0.00373214924709278,0.0165088651299378,0.0311388901785415,1.78901052527183e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,37053,0.018649180716037,0.0029248110341619,0.0129165510890797,0.0243818103429943,1.87584938434139e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,37268,0.0257990782461076,0.00404968744102046,0.0178616908617075,0.0337364656305077,1.94397527851495e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39401,0.020835308321606,0.00327338553905747,0.0144194726650534,0.0272511439781586,2.00680533691851e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36880,0.0516064488063641,0.00810900447374351,0.0357128000378268,0.0675000975749013,2.03033335592968e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,39769,0.0386950945911669,0.006083369697566,0.0267716899839375,0.0506184991983963,2.06186406816445e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39673,0.0413685869227505,0.00650519033896981,0.0286184138583696,0.0541187599871313,2.08210812657223e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39836,0.018875200672954,0.00297250436208277,0.0130490921232717,0.0247013092226362,2.21227138541413e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36880,0.049083504050255,0.00773670599154226,0.0339195603068322,0.0642474477936779,2.30929148310531e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39680,0.0178514712004909,0.00281435510243242,0.0123353351997233,0.0233676072012584,2.31443740686163e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39401,0.0297277934367923,0.00468786335787938,0.0205395812553487,0.0389160056182359,2.33918617145218e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,39594,-0.0262926111994315,0.00414838016702516,-0.0344234363268008,-0.0181617860720622,2.39036823261194e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,39557,0.023600842376011,0.00373482217220757,0.0162805909184842,0.0309210938335379,2.70125952192154e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39817,0.0384358497042275,0.00608583443899435,0.0265076142037986,0.0503640852046564,2.76192043466114e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,39521,0.0360836411614087,0.00571497083301898,0.0248822983286915,0.0472849839941259,2.79455817003188e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37205,0.0333441884442313,0.00528082898376762,0.0229937636360468,0.0436946132524158,2.80174897428809e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39288,0.0323960966281272,0.00513124394426941,0.0223388584973591,0.0424533347588952,2.8025831012529e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39662,0.0317553723819847,0.00503163965280949,0.0218933586624781,0.0416173861014913,2.84373240791439e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39673,0.0633385183692549,0.0100528302040835,0.0436349711692513,0.0830420655692585,3.04407108796765e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39842,0.0311183636688217,0.00494075567879645,0.0214344825383806,0.0408022447992627,3.08792057415729e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,39715,0.0304905952917673,0.0048444905282824,0.0209953938563338,0.0399857967272008,3.17782527124629e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39288,0.0319811593285969,0.00508435482177616,0.0220158238779157,0.0419464947792782,3.25786473498588e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39594,0.047230337447715,0.00751645077735986,0.0324980939240896,0.0619625809713403,3.39534367057314e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39743,0.0211616920214868,0.00336923528255586,0.0145579908676774,0.0277653931752963,3.45466591382668e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39401,0.0191041737654458,0.00304274086721195,0.0131404016657104,0.0250679458651812,3.50692247540774e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,39401,0.0288433816159113,0.00459571463736709,0.0198357809266718,0.0378509823051508,3.56268048907191e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,39810,0.0149515437092914,0.00238751567773317,0.0102720129809344,0.0196310744376484,3.88839578257822e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39260,0.0156777843610746,0.00250677268467351,0.0107645098991145,0.0205910588230347,4.10180815073354e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39817,0.0431264948663123,0.00690018923269226,0.0296021239702355,0.0566508657623892,4.2075401867256e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39643,0.0196625535347657,0.0031466219343096,0.0134951745435189,0.0258299325260125,4.24280077395472e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36958,0.0357325537483814,0.00572251501007655,0.0245164243286313,0.0469486831681314,4.39123472645585e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36872,0.0154717541832342,0.00248397196848295,0.0106031691250076,0.0203403392414608,4.85008203832542e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39681,0.031769855011741,0.00510745165444267,0.0217592497690334,0.0417804602544486,5.08695116851243e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,39860,0.00885148608983611,0.00142303651907816,0.00606233451244292,0.0116406376672293,5.09055537898807e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,39573,0.029060115039227,0.004672542988401,0.019901930781961,0.0382182992964929,5.11892457192208e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39302,0.0439257639829432,0.00706367863169393,0.0300809538648231,0.0577705741010633,5.14716343746561e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39521,0.042134548918829,0.00677763551893232,0.0288503833017216,0.0554187145359363,5.20573221113812e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,37220,0.0360185804086833,0.00580403893078927,0.0246426641043363,0.0473944967130302,5.60352072085962e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37268,0.0161084749257276,0.00259631756563996,0.0110196924970733,0.0211972573543819,5.65375281889961e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37220,0.0453559864146812,0.00731427631361889,0.0310200048399882,0.0596919679893742,5.77505632064811e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,39266,0.0216452908961884,0.00349159962147651,0.0148017556380945,0.0284888261542824,5.8179161951945e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36958,0.0334344735081316,0.005395173805207,0.0228599328499259,0.0440090141663373,5.92345544529656e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,37125,0.0237412656534349,0.0038323193948708,0.0162299196394882,0.0312526116673817,6.00034328878148e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,39668,0.0240468967509139,0.00388362966073095,0.0164349826158813,0.0316588108859466,6.0926825213808e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,37213,0.0139903864245099,0.00226011392985919,0.00956056312198588,0.0184202097270339,6.18766075098743e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39865,0.054662720014994,0.00883615291482817,0.0373438603019308,0.0719815797280572,6.31070939710623e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39764,0.0152407000028891,0.00246430354470757,0.0104106650552623,0.020070734950516,6.37871293072278e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39401,0.0306968626572286,0.00496580089376167,0.0209638929054558,0.0404298324090015,6.50175690536895e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,39529,0.0282901741578686,0.00458555850784738,0.0193024794824877,0.0372778688332495,7.02312576669529e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37244,0.0424396778936589,0.00688754485299343,0.0289400899817918,0.0559392658055261,7.39851641547017e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39401,0.0361581240707913,0.00587015036173896,0.024652629361783,0.0476636187797997,7.46969114391954e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39817,0.0184779058992168,0.00300193967248208,0.012594104141152,0.0243617076572817,7.67163802615805e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAX,Protein max,39302,0.0575946043243387,0.00935777853815844,0.0392533583895482,0.0759358502591292,7.70632714681598e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37285,0.0101118642143821,0.00164418572404021,0.00688926019526328,0.0133344682335009,7.96444389065932e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36958,0.0692493573946705,0.0112601856221379,0.0471793935752803,0.0913193212140607,7.97721014090622e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,39518,0.0248488131861953,0.00404188170745328,0.0169267250395869,0.0327709013328037,8.04538086198785e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,39673,0.0266081051938318,0.00433108404936191,0.0181191804570824,0.0350970299305811,8.26448640325727e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39594,0.0131378044543634,0.00213871434766757,0.00894592433293496,0.0173296845757918,8.30030682030561e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37268,0.0130822496437488,0.00213087836373641,0.00890572805082543,0.0172587712366722,8.51875733528015e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,39673,0.0306708670453787,0.00499841714066018,0.0208739694496848,0.0404677646410727,8.65788714780816e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39372,0.022329070988243,0.00364323091288002,0.0151883383989982,0.0294698035774878,9.06176863059654e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37220,0.0250563726552007,0.00408882625927679,0.0170422731870182,0.0330704721233832,9.14861799519117e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39668,0.0222002697884003,0.00362710412212306,0.0150911457090391,0.0293093938677615,9.53884759248154e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37203,0.0464764848063499,0.0075930536132654,0.0315940997243497,0.0613588698883501,9.56428755651847e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,39557,0.0336835731262917,0.0055058410656273,0.0228921246376622,0.0444750216149212,9.71341869176932e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,39697,0.0161368165455931,0.00263779885450279,0.0109667307907677,0.0213069023004186,9.72708687355635e-10
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37215,0.0800957077259538,0.0131050433681733,0.0544098227243341,0.105781592727573,1.01240845527798e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37230,0.0218283787335028,0.00357461045735605,0.014822142237085,0.0288346152299207,1.04657563911146e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37005,0.0291321083785435,0.00477341598812226,0.0197762130418239,0.0384880037152631,1.07030169697295e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36958,0.0468803592062429,0.00769138971564913,0.0318052353635706,0.0619554830489152,1.1238827580053e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,36877,0.0246245183343572,0.00404085801287687,0.0167044366291186,0.0325446000395959,1.13315412852846e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,39401,0.0257753675293336,0.00423022836282191,0.0174841199382027,0.0340666151204646,1.13330171100327e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39594,0.0458689428010659,0.00752897200933795,0.0311121576627635,0.0606257279393683,1.13874060007028e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39401,0.0524035417491849,0.0086046900983988,0.0355383491563232,0.0692687343420465,1.15487113670094e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,39836,0.035122756784776,0.00577028272857044,0.023813002636778,0.0464325109327741,1.17796266523446e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,39594,0.0409529015107712,0.00672954718962627,0.0277629890191037,0.0541428140024387,1.18794075691369e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39288,0.042312960134394,0.00695919784113383,0.0286729323657717,0.0559529879030163,1.22900597988565e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,39836,0.0296093901533646,0.00487182034837776,0.0200606222705441,0.039158158036185,1.24699437829694e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,36907,0.0354849136817292,0.00584012369399523,0.0240382712414985,0.0469315561219598,1.26604884107153e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,39401,0.0261897696759715,0.00431894955963407,0.0177246285390887,0.0346549108128542,1.35917430458634e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,39302,0.038196793444568,0.00630386610754191,0.0258412158737858,0.0505523710153501,1.3992155785685e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,37285,-0.0117089311115787,0.00193231391342268,-0.0154962663818872,-0.00792159584127027,1.40165879359753e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,37268,0.0530705339670357,0.0087674511410171,0.0358863297306422,0.0702547382034292,1.45847754889717e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39836,0.0341935290485614,0.0056540947543886,0.0231115033299597,0.0452755547671631,1.50322937345417e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36948,0.0255045088047464,0.0042252333486715,0.0172230514413503,0.0337859661681425,1.62016215826774e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,39594,0.029628178501121,0.0049140257301185,0.0199966880700887,0.0392596689321532,1.68343014454292e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37244,0.0137528021015466,0.00228133550268736,0.00928138451627941,0.0182242196868139,1.69947160182913e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39680,0.00940403453865878,0.00156077499884596,0.00634491554092069,0.0124631535363969,1.72609014307972e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,39836,0.0242757557593595,0.00403581357459772,0.016365561153148,0.0321859503655711,1.83714717278055e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37236,0.0328572118637082,0.00546195178771294,0.0221517863597909,0.0435626373676256,1.83838543209831e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,37244,0.0155860032808321,0.00259259595897105,0.0105045152012488,0.0206674913604153,1.88322579345132e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,36855,0.0252182987716278,0.00419527550146192,0.0169955587887625,0.0334410387544932,1.89184763671619e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,39836,0.0143530231355753,0.00239092638999065,0.0096668074111936,0.0190392388599569,1.97746882930447e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,39738,0.0241432806826098,0.00402531923286814,0.0162536549861883,0.0320329063790314,2.04279053072993e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39474,0.0192004796018105,0.0032054718140202,0.0129177548463309,0.0254832043572901,2.14569461136476e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,39401,0.0149479144751403,0.00249562607602676,0.0100564873661279,0.0198393415841528,2.14936997115888e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,39617,-0.0213124862366907,0.00355828425187264,-0.0282867233703611,-0.0143382491030203,2.15011259554401e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,39721,0.0115169581860344,0.00192333914558705,0.00774721346068375,0.015286702911385,2.17019066988978e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,39624,0.0253565532852297,0.00423499509907208,0.0170559628910484,0.033657143679411,2.17867768055124e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,37285,0.00968382374989269,0.00161748413648948,0.00651355484237331,0.0128540926574121,2.19246557322239e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,39594,0.0441474042995844,0.00738652199634917,0.02966982118674,0.0586249874124288,2.32547166495928e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,37268,0.0297135923212657,0.0049745371770456,0.0199634994542563,0.039463685188275,2.38627424463577e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39817,0.0347071201823276,0.00581135899247127,0.0233168565570839,0.0460973838075712,2.38912699996201e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,39675,0.0117692683904749,0.00197066245101367,0.00790676998648812,0.0156317667944617,2.39031085510878e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,39680,-0.0163118889476945,0.00273171790352914,-0.0216660560386116,-0.0109577218567774,2.40417128028974e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37220,0.0575270718047255,0.00963705221984871,0.038638449453822,0.0764156941556289,2.44218271931185e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39673,0.0183579985366172,0.00307593076496877,0.0123291742372784,0.024386822835956,2.44899242327189e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,39594,0.037534880815698,0.00629084517600737,0.0252048242707235,0.0498649373606724,2.4746309724573e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37220,0.0240938417746868,0.0040417847780819,0.0161719436096462,0.0320157399397273,2.56723357009077e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,39680,0.0185503650057397,0.00311517897097023,0.0124446142226381,0.0246561157888414,2.65851377667331e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37215,0.0627652442369526,0.0105393942356953,0.0421080315349899,0.0834224569389153,2.6611917241569e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,39401,0.0265770109963924,0.00446389294970797,0.0178277808149648,0.03532624117782,2.67671446431357e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39680,-0.0489176365540164,0.00822094439479176,-0.0650306875678083,-0.0328045855402246,2.73188621514777e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39570,0.0141352992356361,0.00237727072660028,0.00947584861149959,0.0187947498597727,2.80563560049747e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36880,0.0281555097982453,0.0047362068154226,0.018872544440017,0.0374384751564736,2.83987339087245e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,39817,0.0314276753195357,0.00528921090460421,0.0210608219465114,0.0417945286925599,2.87694260817997e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,39594,0.0542836907799174,0.00913839537843442,0.0363724358381859,0.0721949457216488,2.90715368103511e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,39865,0.0047457774479408,0.00079926416343036,0.00317921968761729,0.0063123352082643,2.95057615434862e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39668,0.0624224344011736,0.0105239430806262,0.0417955059631462,0.0830493628392009,3.0650048048325e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39652,0.0498096873721573,0.00839952456595468,0.0333466192228861,0.0662727555214285,3.09140783605029e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39529,0.0207953334603641,0.00350814290498859,0.0139193733665864,0.0276712935541417,3.13594238897887e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36877,0.035521500494499,0.00599943175554395,0.0237626142536328,0.0472803867353651,3.28431679054201e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,39817,-0.0195168758989086,0.00329797067627775,-0.025980898424413,-0.0130528533734042,3.32868644539459e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37257,0.00985228268058156,0.00166613510964728,0.0065866578656729,0.0131179074954902,3.43580581364926e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39743,0.0662307606535445,0.0112099188690367,0.0442593196702326,0.0882022016368565,3.52875558110036e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,37285,0.0161226735460699,0.00273013239236583,0.0107716140570328,0.0214737330351069,3.60178298895662e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39743,0.0137200948377659,0.00232421822545793,0.00916462711586835,0.0182755625596634,3.63999443373699e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39268,0.0400198128131069,0.00678644353461725,0.0267183834852571,0.0533212421409567,3.77862016671814e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,39668,-0.013938219786995,0.00236373175983715,-0.0185711340362758,-0.00930530553771416,3.7839954831295e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,39585,0.0148447403559031,0.00251765956825944,0.00991012760211462,0.0197793531096916,3.79482124167282e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,37267,0.0158055298563665,0.00268250424832382,0.0105478215296518,0.0210632381830812,3.90515756242414e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37244,0.0335928810567169,0.00570536255899917,0.0224103704410785,0.0447753916723552,4.00392405325262e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36880,0.0168977177058388,0.00287101337464821,0.0112705314915283,0.0225249039201493,4.06303898539286e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,39589,0.0349876717890788,0.0059481618692912,0.0233292745252681,0.0466460690528896,4.13316608591247e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39288,0.0314550160076445,0.0053514748882719,0.0209661252266315,0.0419439067886574,4.24275048558264e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,36880,0.0315138778141507,0.00536125182038563,0.0210058242461948,0.0420219313821065,4.25210626085533e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37005,0.0292342889876005,0.0049742569629505,0.0194847453402175,0.0389838326349835,4.27591713458445e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37244,0.0180224214304836,0.00306777170072074,0.012009588897071,0.0240352539638963,4.3351922290135e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39743,0.0675199571950646,0.0114976588884592,0.0449845457736846,0.0900553686164446,4.37850627979763e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37220,0.0200077392467969,0.00341045861109803,0.0133232403690447,0.026692238124549,4.55399042903092e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39798,0.0209249146292045,0.00356784431007886,0.01393193978145,0.0279178894769591,4.58402077684717e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37215,0.0111364188310716,0.001900560560371,0.00741132013274441,0.0148615175293987,4.75079620688153e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39302,0.0268578713447882,0.00458404724772078,0.0178731387392554,0.0358426039503209,4.75177755911194e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36880,0.0534272842970956,0.00912535536808718,0.0355415877756448,0.0713129808185465,4.89048362298606e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39401,0.0191998589720721,0.00328014279963283,0.0127707790847917,0.0256289388593524,4.91441900434966e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,39508,0.0350912485451487,0.00599838675573935,0.0233344105038995,0.0468480865863978,5.01040962054069e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,37183,0.0227791930845695,0.00390140409955615,0.0151324410494394,0.0304259451196995,5.38301470546893e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39288,0.0256077260260171,0.00438643617570978,0.017010311121626,0.0342051409304083,5.39134614816319e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37220,0.0113990732100239,0.00195253636647127,0.00757210193174018,0.0152260444883075,5.40306225199151e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39720,0.0269711761272335,0.00462034624844128,0.0179152974802886,0.0360270547741784,5.40312513048035e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36958,0.0374914308392485,0.00642230267915893,0.024903717588097,0.0500791440904,5.41823819097165e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,39817,0.0129609541248221,0.0022218827689619,0.00860606389765676,0.0173158443519874,5.53865839041907e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39720,0.0233392323088105,0.00400230720615032,0.0154947101847559,0.0311837544328651,5.6018193239465e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,37220,0.0143036623714314,0.00245339685965902,0.00949500452649975,0.0191123202163631,5.66581618249851e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39288,0.0234455281042697,0.0040252855977288,0.0155559683327213,0.0313350878758182,5.84020843984031e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37244,0.0404779829119928,0.00695021374822624,0.0268555639654694,0.0541004018585163,5.87781191836016e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39680,0.0145439228221367,0.00249896752671004,0.00964594646978501,0.0194418991744884,5.99959090217099e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37215,0.0444742046119737,0.00764194537036195,0.0294959916860643,0.0594524175378832,6.02885233694579e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39756,0.0104382964606623,0.00179441255216679,0.00692124785841542,0.0139553450629092,6.10240211420464e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37192,0.0563618182357709,0.00970193555403212,0.037346024549868,0.0753776119216739,6.41522621366522e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39303,0.0194742683834327,0.00335491878908822,0.0128986275568198,0.0260499092100456,6.57497747499955e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37268,0.0329462978318511,0.00567966397477349,0.0218141564412951,0.0440784392224071,6.75095972556252e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,39817,0.0594896097752799,0.0102601743527246,0.0393796680439398,0.0795995515066201,6.83342484034024e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37244,0.0394941618794104,0.00681119402365378,0.026144221593049,0.0528441021657718,6.84536334696117e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,37220,0.0194544865307039,0.00335646403761425,0.01287581701698,0.0260331560444278,6.93966222153933e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39809,0.0308444423519153,0.00532489804564575,0.0204076421824496,0.041281242521381,7.06548398970323e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39720,-0.0251283211082892,0.00433856529797568,-0.0336319090923215,-0.0166247331242568,7.09332249689125e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39668,0.0125243833899432,0.00216469665036534,0.00828157795522717,0.0167671888246593,7.35572764287501e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36877,0.0253479763634244,0.00438165120852746,0.0167599399947106,0.0339360127321382,7.41678081721444e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39594,0.0277943829120563,0.0048085353285832,0.0183696536680332,0.0372191121560794,7.60166016682602e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39348,0.0257494099717564,0.00445921055083791,0.0170093572921141,0.0344894626513987,7.86926578012141e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37220,0.02116489311499,0.00366585186005221,0.0139798234692877,0.0283499627606923,7.93552145319748e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39673,0.0426450770268373,0.00738881907357361,0.028162991642633,0.0571271624110416,8.0007994014937e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,37220,0.0313856930282555,0.00543842324189044,0.0207263834741502,0.0420450025823607,8.05029670624477e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39637,0.0331412644138647,0.005743724443395,0.0218835645048105,0.0443989643229189,8.07603307174532e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,36896,0.0229624182997212,0.0039792739671715,0.015163041324065,0.0307617952753773,8.08320442452806e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39401,0.0162969530478839,0.00282680514747899,0.0107564149588251,0.0218374911369428,8.31340689915676e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36896,0.0221562781596674,0.00384385406321046,0.0146223241957749,0.0296902321235599,8.3964153394095e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,36877,0.0215714419294405,0.00374623799555783,0.0142288154581472,0.0289140684007339,8.69557583420622e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39673,0.0431111183084734,0.00748870267079519,0.0284332610737148,0.0577889755432319,8.7302340038076e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,39401,0.0242271780416614,0.00421307502982692,0.0159695509832006,0.0324848051001222,9.06657971955268e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,39865,0.0482579810338254,0.00840647852261113,0.0317812831295076,0.0647346789381432,9.60678050043913e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,39288,0.0207868233381403,0.00362250969166978,0.0136867043424675,0.027886942333813,9.74622758884487e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39614,0.0136281364173894,0.00237661453532051,0.00896997192816117,0.0182863009066176,9.97315211629143e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37220,0.0461683636517118,0.00805075941874596,0.0303888751909697,0.0619478521124539,9.98238460926777e-09
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36880,0.0290730438785293,0.0050704929428748,0.0191348777104946,0.0390112100465639,1.00403326248738e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36896,0.0405006662084815,0.00706580066318401,0.0266516969086408,0.0543496355083221,1.01494507629427e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39673,0.0361169562982391,0.0063046613612953,0.0237598200301003,0.0484740925663779,1.03097792940871e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,39557,0.0185251281127334,0.00324018506666393,0.0121743653820721,0.0248758908433947,1.10194427336175e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39673,0.0280683823856973,0.00490969968525535,0.0184453710025968,0.0376913937687978,1.10426638625993e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37267,0.0311978118453571,0.00545778983653485,0.0205005437657488,0.0418950799249654,1.11253774720525e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39288,0.022426239423639,0.0039251720470367,0.0147329022114471,0.030119576635831,1.12757404780241e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,37267,0.0563327078474142,0.00987725237468833,0.0369732931930251,0.0756921225018033,1.20007052036487e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39594,0.06983407950433,0.0122463551668329,0.0458312233773376,0.0938369356313225,1.20226803045169e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39716,0.0361387613736136,0.00634368351588133,0.0237051416824861,0.048572381064741,1.2423626893324e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37005,0.0574554037421788,0.0100868213590405,0.0376852338784595,0.0772255736058982,1.25216246862114e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39673,0.0207273159743551,0.00363966977075489,0.0135935632236755,0.0278610687250347,1.25686737692672e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,37220,0.0383518877011248,0.0067348411444938,0.0251515990579169,0.0515521763443326,1.26303227302357e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,39668,0.0265077024510055,0.0046567223062912,0.0173805267306747,0.0356348781713362,1.27525164235164e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,36958,0.0376204059191172,0.00661134660413828,0.0246621665750062,0.0505786452632283,1.2954925918972e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36711,0.0271260919932078,0.00476748259180096,0.0177818261132779,0.0364703578731377,1.29953943887838e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39288,0.0322319147194343,0.0056724168504815,0.0211139776924906,0.0433498517463781,1.35359868015268e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37268,0.0456053769485724,0.0080515910477038,0.029824258495073,0.0613864954020719,1.50796048711188e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39680,0.0154273182948385,0.00272624243778389,0.010083883116782,0.0207707534728949,1.55057627461204e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37268,0.0383895276305312,0.00678441369547414,0.0250920767874019,0.0516869784736605,1.55837729715537e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,39721,0.0285432908485251,0.0050460140186855,0.0186531033719015,0.0384334783251487,1.57064240815588e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39594,0.0352058418106474,0.00622424213712748,0.0230063272218775,0.0474053563994172,1.57411285081907e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39594,-0.0274113549616482,0.00485093262169543,-0.0369191829001712,-0.0179035270231251,1.62527630373229e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,39653,-0.0226353469869844,0.00401083700731471,-0.0304965875213213,-0.0147741064526476,1.69443400048514e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39675,0.0188219705525875,0.00333537712117627,0.012284631395082,0.025359309710093,1.69848450583213e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39671,0.047423681644957,0.00840527513318574,0.030949342383913,0.0638980209060011,1.70834908945384e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39817,0.0134895537526658,0.00239586829536953,0.00879365189374151,0.0181854556115901,1.82883858413193e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36880,0.0272745473608846,0.00484581933639145,0.0177767414615574,0.0367723532602118,1.85569779939955e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,39288,0.0282749249154158,0.00502541460252144,0.0184251122944738,0.0381247375363578,1.87221667906566e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39401,0.0351787608705438,0.00625448629632387,0.022919967729749,0.0474375540113386,1.89180787076944e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39324,0.039334904388091,0.00700438272272641,0.0256063142515473,0.0530634945246348,1.99072545903768e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39636,0.044087060573201,0.00785218274645382,0.0286967823901515,0.0594773387562505,2.00308987045407e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,39401,-0.0214633301827715,0.0038230724271863,-0.0289565521400567,-0.0139701082254864,2.00900854984884e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEP,Leptin,39680,0.0336595350825615,0.00600296693898227,0.0218937198821562,0.0454253502829668,2.09124329361953e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39673,0.0217785331361057,0.00388429044231011,0.0141653238691779,0.0293917424030335,2.09518911421461e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,39594,0.014490595304118,0.00258659032382448,0.009420878269422,0.019560312338814,2.15194256035485e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,39668,0.0191093889650738,0.00341373363522315,0.0124184710400365,0.0258003068901112,2.20700922354953e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,39526,0.0224990802228169,0.004021003872357,0.0146179126329972,0.0303802478126366,2.23814059532698e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39707,0.0154956122031899,0.00277098752617699,0.010064476651883,0.0209267477544968,2.28057396286006e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37267,0.0107831865393917,0.00192832859848353,0.00700366248636396,0.0145627105924194,2.28874256816413e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39594,0.03053770765733,0.0054631807394007,0.0198298734081046,0.0412455419065554,2.31199200720613e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,39820,0.0222691561855608,0.00398765500515723,0.0144533523754527,0.030084959995669,2.3816305528669e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37198,0.0406659807443496,0.00728191984813507,0.0263934178420049,0.0549385436466944,2.38935161280092e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FURIN,Furin,39721,0.0167737241486732,0.0030044973235064,0.0108849093946006,0.0226625389027457,2.40457325712732e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36880,0.036735996453975,0.0066023553079588,0.0237953800503758,0.0496766128575743,2.68749573232682e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37215,0.0379292298471232,0.00681885342864227,0.0245642771269843,0.051294182567262,2.71194010748854e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,37203,0.021555804113562,0.00387548076133691,0.0139598618213417,0.0291517464057824,2.7167629951579e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36958,0.034318524610752,0.00617382562945784,0.0222178263770147,0.0464192228444894,2.77083376708341e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,39680,0.037947819851004,0.0068310116340044,0.0245590370483554,0.0513366026536526,2.81720900253214e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,36958,0.0215787838609105,0.00388527996952686,0.0139636351206378,0.0291939326011831,2.84670435476113e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,39302,0.018460039471579,0.00333011716033953,0.0119330098373135,0.0249870691058445,3.01581868813355e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39715,0.0141552882170852,0.00255540921933003,0.00914668614719836,0.0191638902869721,3.08437714397821e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36880,0.030344155805793,0.00548035163939073,0.0196026665925872,0.0410856450189988,3.138349449215e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39653,0.0478373027758777,0.00865716226706836,0.0308692647324237,0.0648053408193316,3.33272655750206e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,36896,0.0167969311151726,0.00304076843446569,0.0108370249836198,0.0227568372467253,3.37890695604777e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,36922,0.0150921294857835,0.00273426171570753,0.00973297652299678,0.0204512824485703,3.46179624755895e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37268,0.0349875703307587,0.00634789847260322,0.0225456893244564,0.0474294513370611,3.61992935492019e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39860,0.0123759414518763,0.00224588523413237,0.00797400639297687,0.0167778765107758,3.63349888139707e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,39288,0.0216536671336319,0.00393123711230848,0.0139484423935073,0.0293588918737565,3.68517453816952e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37215,0.0232052117062517,0.00421633369228192,0.0149411976693791,0.0314692257431242,3.78872427863726e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37261,0.023540757164319,0.00427921085625816,0.015153503886053,0.031928010442585,3.8415197917645e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36880,0.0176275386159502,0.00320458555369179,0.0113465509307143,0.0239085263011861,3.85375002931126e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39182,0.0178172686341127,0.00324278844275146,0.0114614032863198,0.0241731339819055,3.98229279686954e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39288,0.0415581286666766,0.00756739456576396,0.0267260353177792,0.0563902220155739,4.04294671407694e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36896,0.0138128213476621,0.00251499602968894,0.00888342912947181,0.0187422135658524,4.04431253856637e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,37005,0.0627944938347799,0.0114373823975827,0.0403772243355179,0.085211763334042,4.08730392061645e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37268,0.0524710293018087,0.009563961151558,0.033725665444755,0.0712163931588624,4.1781706549532e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39817,0.0281293478688586,0.00512845571705454,0.0180775746634317,0.0381811210742855,4.19864051395775e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39804,0.01469646277503,0.0026817828932032,0.00944016830435172,0.0199527572457083,4.31510347524868e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,39817,0.0140079830598653,0.00255627778398446,0.00899767860325577,0.0190182875164749,4.32170280971365e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,37267,0.0110936447674466,0.00202739767971469,0.00711994531520583,0.0150673442196874,4.53320436315126e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,39820,0.0141774913699109,0.00259438147091489,0.00909250368691768,0.019262479052904,4.70664460704049e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36896,0.0268370362638424,0.00491110560151237,0.0172112692848782,0.0364628032428067,4.72578567316533e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36958,0.0188797036966592,0.00345991871545305,0.0120982630143712,0.0256611443789472,4.93911291091979e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37215,0.0500880085724354,0.00918088410036018,0.0320934757357295,0.0680825414091414,4.96535871989429e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36827,0.0229298186502505,0.00420721677462528,0.014683673771985,0.0311759635285161,5.12571300794853e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39688,0.0237577538102799,0.00436766007496269,0.015197140063353,0.0323183675572067,5.42325279123894e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39302,0.018506461150712,0.00340248823489088,0.0118375842103259,0.0251753380910982,5.43660174000042e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36880,0.022734011754096,0.00418080724548427,0.0145396295529469,0.0309283939552452,5.4943877913025e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37244,0.0366139209490205,0.00673774319179309,0.023407944293106,0.0498198976049349,5.60213107588576e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39557,0.0456439228006238,0.00840277377031331,0.0291744862108097,0.0621133593904379,5.65533178535393e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39288,0.0144744999295997,0.00266573094822539,0.00924966727107796,0.0196993325881215,5.72567088636804e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39594,0.0185561631430658,0.00341793097118395,0.0118570184395453,0.0252553078465863,5.74901201844576e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37215,-0.0467017123170973,0.00861013374912263,-0.0635775744653777,-0.029825850168817,5.92814229611033e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39594,0.0262920838780162,0.00484969929761559,0.0167866732546896,0.0357974945013428,6.00107912364771e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39617,0.0547649396239781,0.0101091367584343,0.0349510315774468,0.0745788476705094,6.13693633810964e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37158,0.0294068614893267,0.00544206378827251,0.0187404164643126,0.0400733065143409,6.64336186709523e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,37208,0.0361731740500849,0.00670001014787396,0.0230411541602519,0.0493051939399179,6.8170305215443e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,39743,0.0171954478542919,0.00318582505588799,0.0109512307447514,0.0234396649638323,6.85506343518076e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36896,0.0437023794235062,0.00809614711045895,0.0278339310870067,0.0595708277600058,6.85972515562282e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,36958,0.0321375156201551,0.00596557873461,0.0204449813003195,0.0438300499399907,7.28182224381727e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,37172,0.0225784273783729,0.00419186537304756,0.0143623712471997,0.0307944835095461,7.31666711160374e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,39401,0.0141842653673485,0.00263379447642135,0.00902202819356266,0.0193465025411343,7.32993041130507e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36880,0.0367332867657762,0.00682261440821535,0.0233609625256741,0.0501056110058783,7.40929494669554e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,39293,0.0334155859118686,0.0062105752389442,0.021242858443538,0.0455883133801993,7.53907772749103e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37215,0.0184022052857347,0.00342986131297823,0.0116796771122974,0.025124733459172,8.21674739810981e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39594,0.0210529012572663,0.00392509009571876,0.0133597246696576,0.0287460778448751,8.26989349656268e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39288,0.0304755735242299,0.0056827360549712,0.0193374108564863,0.0416137361919734,8.31064026725279e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39673,0.0219105969292396,0.00408631216343143,0.013901425088914,0.0299197687695652,8.34852365042041e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39594,0.0270040357608252,0.00503677788745465,0.0171319511014141,0.0368761204202363,8.37580842496773e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,37220,0.0345293139546366,0.00644196464405238,0.0219030632522939,0.0471555646569793,8.45772138143833e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39721,0.0434399202602079,0.00810951826794437,0.0275452644550369,0.0593345760653788,8.59576895559047e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39668,0.0245390905315443,0.00458316096039187,0.0155560950491762,0.0335220860139124,8.71437576347935e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39721,0.0345766469443652,0.00646066934267661,0.021913735032719,0.0472395588560113,8.82611774217201e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39865,0.0172332543801345,0.00322104561309447,0.0109200049784693,0.0235465037817997,8.90633999089521e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,39713,0.0183422763609556,0.00342888801556854,0.0116216558504412,0.0250628968714699,8.95026940440974e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39817,0.0302880902348218,0.00566422340334151,0.0191862123642725,0.0413899681053712,9.05240308335248e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36896,0.0244998394226106,0.00458247053794058,0.0155181971682471,0.0334814816769741,9.12210887272922e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39865,0.0171109858763262,0.00320253592916138,0.0108340154551699,0.0233879562974825,9.26980741476113e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,39668,0.036671661004786,0.00686405412997722,0.0232181149100306,0.0501252070995413,9.29096246793179e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39743,0.0503800879634538,0.00943310610379328,0.031891200000019,0.0688689759268886,9.38249743703546e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39680,0.0322636386574733,0.00604710981558459,0.0204113034189275,0.0441159738960191,9.66567563916445e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39521,0.0111433456126057,0.00208968434569941,0.00704756429503485,0.0152391269301765,9.818768581018e-08
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37116,0.0149930752284266,0.00281325685228975,0.00947909179793867,0.0205070586589145,1.00131477190072e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37244,0.0234037293517458,0.00439236502064572,0.0147946939112802,0.0320127647922114,1.00757003056719e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39401,0.0431192085419621,0.00809392765785407,0.0272551103325681,0.0589833067513561,1.01043370564289e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,37285,0.014286155963612,0.00268887125739782,0.00901596829911223,0.0195563436281117,1.0951736927157e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,37244,0.0497792488274504,0.0093741920906568,0.031405832329763,0.0681526653251377,1.11229741801654e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39302,0.0350600926513411,0.00660296432207678,0.0221182825800706,0.0480019027226116,1.11295563816119e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39564,0.0113506776528848,0.00213920428523822,0.00715783725381792,0.0155435180519518,1.13561087032409e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37244,0.0227417564070546,0.00428679137739023,0.0143396453073697,0.0311438675067394,1.14420518361336e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,39401,0.0247689760081558,0.004677031562061,0.0156019941465163,0.0339359578697954,1.20060812713556e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39557,0.0369515169868612,0.00697940989946397,0.0232718735839118,0.0506311603898106,1.21041708165186e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36880,0.0364997042735614,0.00689619063529786,0.0229831706283776,0.0500162379187452,1.22457470001538e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,37082,0.0147196880246444,0.00278530322218361,0.00926049370916457,0.0201788823401243,1.27862859300114e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,39673,0.0215442754430189,0.00407982453591571,0.0135478193526241,0.0295407315334137,1.3040389693073e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39401,0.0197284874982717,0.00373891937376944,0.0124002055256836,0.0270567694708598,1.33426985497947e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,39129,0.0119021935755247,0.00225644920748524,0.00747955312885359,0.0163248340221957,1.34755531878865e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,37277,0.0121019116593414,0.00229450331218096,0.00760468516746673,0.0165991381512161,1.3533056776616e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,39473,0.0176193763751575,0.00334174427408018,0.0110695575979603,0.0241691951523546,1.36364451803119e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,37215,0.0156967127717899,0.0029790332718443,0.00985780755897502,0.0215356179846047,1.39254780911742e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36855,0.0171253261484049,0.00325218003277122,0.0107510532841733,0.0234995990126365,1.41806954054636e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37215,0.0273101938797907,0.0051866323210584,0.0171443945305162,0.0374759932290651,1.41979715267399e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39401,0.0278370875198338,0.00528859193293486,0.0174714473312815,0.0382027277083861,1.43132166124047e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,39564,0.0241196565797695,0.00458292807902385,0.0151371175448828,0.0331021956146563,1.43637891086125e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39594,0.0256358817236576,0.00487256205926558,0.0160856600874971,0.0351861033598182,1.44936909292725e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,37268,0.017179380488916,0.00326632268255378,0.0107773880311105,0.0235813729467214,1.46631326649476e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39673,0.0260994018736525,0.00496566511918627,0.0163666982400474,0.0358321055072576,1.49157388171091e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39817,0.0220015083383521,0.00418904701489104,0.0137909761891656,0.0302120404875385,1.52263422843845e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36880,0.0326250512987062,0.0062235757247108,0.020426842878273,0.0448232597191394,1.6117983288627e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36896,0.0210755318167201,0.00402171191292256,0.0131929764673919,0.0289580871660483,1.62695118932104e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39675,0.0114412260356492,0.0021846076599564,0.00715939502213466,0.0157230570491637,1.65120604413803e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37215,0.0531174843090376,0.0101509020124716,0.0332217163645933,0.0730132522534819,1.69503142351911e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39594,0.0530379099815187,0.0101401685434204,0.0331631796364146,0.0729126403266227,1.71240876176787e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39594,0.0544555331908645,0.0104118398106003,0.034048327162088,0.0748627392196411,1.71538387613648e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C5,Complement C5,37285,0.0070586710630037,0.00134962289793121,0.00441341018305853,0.00970393194294886,1.71958986260362e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,36708,0.0375358335686875,0.00718639364431668,0.0234505020258268,0.0516211651115482,1.78624152939466e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37215,0.0115694790185609,0.00221748409700549,0.00722321018843015,0.0159157478486917,1.84177977160459e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,39658,0.0172979294676267,0.00331592350145719,0.0107987194047707,0.0237971395304828,1.84514546359953e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,37189,0.0147234548291839,0.00282622843576943,0.00918404709507582,0.020262862563292,1.9209342711973e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37244,0.0361517664715774,0.00694040156522123,0.0225485794037438,0.049754953539411,1.92796107550076e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39721,0.0137662201518194,0.00264569031677092,0.00858066713094837,0.0189517731726904,1.98259898663836e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,39706,0.0138196052916425,0.00265618085371392,0.00861349081836317,0.0190257197649217,1.9874409645134e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,39760,0.0182086752581503,0.00349986828844662,0.011348933412795,0.0250684171035057,1.98880971539609e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39288,0.0271628627785782,0.00522553386903384,0.0169208163952719,0.0374049091618846,2.03901691222269e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36958,0.0117328261189709,0.00225698072931526,0.00730914388951302,0.0161565083484288,2.03969165064633e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37195,0.0186871555264575,0.00360197126537232,0.0116272918463278,0.0257470192065873,2.15640285630582e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39604,0.0158561329850409,0.00305848764992789,0.00986149719118223,0.0218507687788996,2.1950478698099e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REN,Renin,39680,-0.0303547604951711,0.00585578907931765,-0.0418321070906337,-0.0188774138997086,2.20182753778006e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,39700,0.0172873375254596,0.00333707124616228,0.0107466778829816,0.0238279971679377,2.24135195035538e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,37215,0.0363685813122183,0.00702233689892891,0.0226048009903176,0.0501323616341189,2.26340156584523e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,39697,0.0146298962077708,0.00282558913250771,0.00909174150805568,0.0201680509074859,2.2745516344207e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,39668,0.02343779482123,0.0045273832619877,0.0145641236277341,0.0323114660147259,2.28372153448263e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39544,0.0180461898880257,0.00348664953590145,0.0112123567976589,0.0248800229783926,2.29741271747915e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39557,-0.0239195523057552,0.00462143581596432,-0.0329775665050452,-0.0148615381064651,2.29755130863835e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36958,0.0381400586366479,0.0073691294225893,0.0236965649683728,0.0525835523049229,2.30474551028227e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39668,0.024131363718698,0.00466330014955725,0.0149912954255658,0.0332714320118302,2.31021660878324e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,39434,0.0319576145615437,0.00618562028219499,0.0198337988084415,0.0440814303146458,2.41544255872527e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,36877,0.0195635676124158,0.00379036430569279,0.012134453573258,0.0269926816515737,2.48725954249772e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39865,0.0316835504577008,0.00614658929359649,0.0196362354422517,0.0437308654731499,2.5712216174035e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,37268,0.0304516507913369,0.00591396598937991,0.0188602774521522,0.0420430241305215,2.65434613827039e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37268,0.0338802847874506,0.00658297603974538,0.0209776517495497,0.0467829178253515,2.68925670240729e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,39401,0.0386846596502654,0.00752115993403704,0.0239431861795528,0.053426133120978,2.7302743817349e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39668,0.0153569289323602,0.00298669668817244,0.00950300342354218,0.0212108544411782,2.75400061818846e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39673,0.035544530007765,0.00692303532699053,0.0219753807668636,0.0491136792486664,2.86646235636792e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36958,0.0266807847703832,0.00519618559570534,0.0164962610028007,0.0368653085379656,2.86667904877339e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39680,-0.0149579079307071,0.00291393519866621,-0.0206692209200929,-0.00924659494132134,2.88182077845467e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39743,0.0153098505632409,0.0029845150531849,0.00946020105899852,0.0211595000674833,2.93524490748577e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37220,0.0401802013186717,0.00783528246815366,0.0248230476810906,0.0555373549562529,2.96757558993477e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,39401,0.01732034329272,0.00337787632370299,0.0106997056982622,0.0239409808871779,2.97010019614792e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36877,0.0279901203769247,0.00546142134933782,0.0172857345322226,0.0386945062216268,3.01702167360496e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39836,0.0150456760140475,0.00293769206599549,0.00928779956469635,0.0208035524633987,3.06481799668497e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39288,0.021482422740515,0.00419604472693155,0.0132581750757291,0.0297066704053008,3.09729401581622e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39680,0.0303127141552134,0.00592194397048609,0.0187057039730606,0.0419197243373661,3.11237986898353e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36880,0.0287671515606089,0.00562249709313072,0.0177470572580727,0.0397872458631451,3.15792257758154e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,37220,0.0251162337087503,0.00491244520424595,0.0154878411084282,0.0347446263090724,3.21847842467514e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39755,-0.0115651195844288,0.00226231305821907,-0.0159992531785382,-0.00713098599031943,3.22333220069801e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39721,0.0251871108006983,0.00493301670445897,0.0155183980599588,0.0348558235414379,3.33170265799109e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39288,0.0322001228762894,0.00630673790514611,0.019838916582203,0.0445613291703757,3.33547258107062e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAT,Catalase,37086,0.023888959340064,0.00468003244663231,0.0147160957446647,0.0330618229354633,3.36375229801618e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,36958,0.0224017652672955,0.00439261419981211,0.0137922414356638,0.0310112890989273,3.44632859852457e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36958,0.0101938531835182,0.00199982798937563,0.00627419032434199,0.0141135160426945,3.4921556545523e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,37215,0.0306467604578031,0.00601500548487483,0.0188573497074485,0.0424361712081578,3.53405410552032e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,39738,0.025963217206315,0.00509823863450668,0.0159706694826819,0.0359557649299481,3.57256386187637e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37005,0.0481265307728345,0.00945438417657295,0.0295959377867515,0.0666571237589174,3.62259630288892e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36958,0.0374727873336872,0.00736175932863874,0.0230437390495553,0.0519018356178192,3.62655971176284e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39302,0.0280600340733289,0.00552453410730314,0.0172319472230148,0.0388881209236431,3.83509723317554e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39594,0.0407020253030619,0.00801441571998365,0.024993770491894,0.0564102801142299,3.84568919190283e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37203,0.0378564213693289,0.00745644773623244,0.0232417838063134,0.0524710589323445,3.88597105352762e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36880,0.0412009499788206,0.00812032179307665,0.0252851192643904,0.0571167806932508,3.9530498009102e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36900,0.0152678274903076,0.00301153484302615,0.00936521919797633,0.0211704357826388,4.03731052270594e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,39715,0.0119725603561033,0.00236291030550075,0.00734125615732179,0.0166038645548847,4.08955443487567e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39476,0.017145905010084,0.00338403032423509,0.0105132055745833,0.0237786044455848,4.09366501072225e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36896,0.0246614783183828,0.00486812169313472,0.0151199597998388,0.0342029968369269,4.12007113231458e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37203,0.0229115416121124,0.00453849052920139,0.0140161001748776,0.0318069830493471,4.51696270010623e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39721,-0.0154800074053884,0.00306696473262763,-0.0214912582813385,-0.00946875652943821,4.52967991173028e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39716,0.0226605658567009,0.00449669289592943,0.0138470477806792,0.0314740839327226,4.72170766739846e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37215,0.0226313592814496,0.00449179974104713,0.0138274317889972,0.031435286773902,4.75642977378583e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39680,0.0284055009920803,0.00563882551642771,0.017353402979882,0.0394575990042786,4.76883284546802e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39680,0.0361297429167057,0.00717563023022526,0.0220655076654642,0.0501939781679473,4.82946277679941e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,37021,0.0111626360563422,0.00221784957250755,0.00681565089422742,0.015509621218457,4.89011349764853e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39288,0.0209959865368399,0.00417420074456547,0.0128145530774915,0.0291774199961882,4.96139038125488e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,39727,0.0261143352887216,0.00520271574717757,0.0159170124242536,0.0363116581531896,5.24037035532116e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37244,0.0313608379679577,0.00624956503103381,0.0191116905071315,0.043609985428784,5.28594913682376e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,37285,0.00859885078632577,0.00171598459573304,0.00523552097868901,0.0119621805939625,5.48284636425152e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36896,0.0148462095551573,0.0029695760528318,0.00902584049160694,0.0206665786187076,5.82448678221472e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39594,0.0288870745745019,0.0057826838004608,0.0175530143255987,0.040221134823405,5.93298413901175e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,39836,0.0146874997950046,0.00294045547898386,0.00892420705619624,0.020450792533813,5.9464651112278e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39790,0.032082617715234,0.00642678891453328,0.0194861114427488,0.0446791239877193,6.03840949230188e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,39302,0.0227877541773517,0.00456908698279622,0.0138323436910711,0.0317431646636323,6.18694211850537e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,39344,0.0261773897172622,0.00525242501668373,0.0158826366845621,0.0364721427499623,6.29987977262903e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37268,0.0250843935349031,0.00504016943102121,0.0152056614501015,0.0349631256197046,6.54142649375156e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39680,0.036859416587778,0.00741425433090268,0.0223274780992088,0.0513913550763473,6.71578250908898e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,36958,-0.0413939133209906,0.00832713986366342,-0.0577151074537709,-0.0250727191882103,6.7463360031535e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,39850,0.0142835744501578,0.0028742755772095,0.00864999431882717,0.0199171545814884,6.78365305601182e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36958,0.03447294338319,0.00693692530061353,0.0208765697939875,0.0480693169723926,6.79791551222476e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPART,Spartin,36958,0.0344981985911932,0.00694789821637599,0.0208803180870962,0.0481160790952901,6.94689746413935e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39557,0.035092798633175,0.00707182738708158,0.0212320169544951,0.0489535803118549,7.03791028036869e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36546,0.0484209048099756,0.00975904873282512,0.0292931692936383,0.0675486403263128,7.08060748010371e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,37203,0.0143343742025922,0.00288933839185022,0.00867127095456574,0.0199974774506186,7.09487942848305e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37215,0.0477043729889283,0.00961879237395294,0.0288515399359806,0.0665572060418761,7.15446636634253e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,37220,0.0202773237589896,0.00409143310842399,0.0122581148664786,0.0282965326515006,7.28244407995147e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,36880,0.0264921529628902,0.00534579684141261,0.0160143911537215,0.0369699147720589,7.29773379875058e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,39302,0.0297797385808778,0.00601341219438399,0.0179934506798852,0.0415660264818704,7.41467562385104e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36801,0.0244859771588901,0.00494585375143613,0.0147921038060753,0.0341798505117049,7.48369450005345e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36896,0.0157827612145974,0.00318978615703864,0.00953078034680164,0.0220347420823931,7.59524888298741e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,39715,0.0147269922865166,0.0029780667329307,0.00888998148997246,0.0205640030830608,7.68629169437367e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,37203,0.0150257570574834,0.00303856314637571,0.00907017329058698,0.0209813408243798,7.70620281023466e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,39559,0.0290014236070429,0.00586862156935858,0.0174989253311001,0.0405039218829857,7.82112068468251e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39557,0.0356508647811259,0.00722171927509475,0.0214962950019402,0.0498054345603116,8.03051809779201e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37244,0.0169109756367714,0.00342658634011573,0.0101948664101445,0.0236270848633982,8.10217512981602e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37268,0.0444013601527845,0.00899829445508297,0.0267647030208219,0.0620380172847471,8.13545708946325e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,36896,0.0215887150866636,0.00437599734760251,0.0130117602853626,0.0301656698879645,8.17913779765328e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,37220,0.00933688569412026,0.00189365061181106,0.00562533049497059,0.0130484408932699,8.29505628818508e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37215,0.021004527534514,0.00426105263036483,0.0126528643789989,0.0293561906900291,8.34633332184576e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36896,0.0178053085233923,0.00361287816156642,0.0107240673267221,0.0248865497200625,8.39722713859761e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37215,0.0448345819584371,0.00910221346040367,0.026994243576046,0.0626749203408283,8.50742534524909e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,39836,0.013509330617904,0.00274954562667458,0.00812022118962182,0.0188984400461862,9.04448774139015e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37267,-0.0215580910988224,0.00439909329057005,-0.0301803139483397,-0.0129358682493051,9.6673176312573e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,39574,0.0157218660752035,0.0032123754054665,0.00942561028048918,0.0220181218699179,9.97076444164822e-07
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39302,0.0218458945599669,0.00447138369496011,0.0130819825178451,0.0306098066020887,1.04088722419409e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36896,0.0341519012527553,0.00699526249048234,0.0204411867714099,0.0478626157341007,1.06180452972782e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36877,0.0347919184218868,0.00712855248553547,0.0208199555502372,0.0487638812935363,1.06994062015967e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39061,0.0127556906108021,0.00261515079053551,0.00762999506135252,0.0178813861602517,1.08464569334622e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39594,0.0169713329491611,0.00348295302770454,0.0101447450148602,0.023797920883462,1.1116369992811e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,39673,0.0397685784130241,0.00816371363408779,0.023767699690212,0.0557694571358362,1.11892182884176e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,36827,0.0238190441847116,0.00488963242431881,0.0142353646330467,0.0334027237363765,1.12155307636535e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39401,0.0291205059752002,0.00597879297817721,0.0174020717379729,0.0408389402124276,1.12336258638745e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37268,0.0385674985142783,0.00792028627156283,0.0230437374220151,0.0540912596065414,1.1318125333892e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36855,0.0291430190171353,0.00598517681818621,0.0174120724534903,0.0408739655807803,1.1336981851938e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39401,0.0229005238727738,0.00470615648392298,0.0136764571642848,0.0321245905812628,1.14951096291618e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39648,0.0191284092599546,0.00393100610488648,0.0114236372943772,0.0268331812255321,1.14959035415659e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39288,0.0256302748058843,0.00526887614780924,0.0153032775561782,0.0359572720555904,1.15897945079763e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39430,0.0126313053896573,0.00259743365195058,0.00754033543183416,0.0177222753474804,1.16752159452348e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37240,0.0208696452717691,0.00429219814448367,0.0124569369085811,0.0292823536349571,1.17390906232672e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,39680,-0.0286204976889824,0.00588912161181377,-0.0401631760481374,-0.0170778193298274,1.18575458470223e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36958,0.0372440878395874,0.00766675174819134,0.0222172544131324,0.0522709212660425,1.20027653799881e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,37244,0.0330722287327021,0.0068115287970939,0.0197216322903981,0.0464228251750062,1.21543510947886e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39302,0.026558953858083,0.00547045043608823,0.01583687100335,0.0372810367128159,1.21573883810211e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,39692,0.025179492561527,0.00518729627663464,0.0150123918593231,0.0353465932637308,1.22107072053839e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,39631,0.0291981915830918,0.00601554013524448,0.0174077329180127,0.040988650248171,1.22280767961512e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37244,0.031328019305243,0.00645503088825757,0.0186761587642581,0.0439798798462278,1.22810863174007e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39810,0.0091018827068218,0.00187729592510261,0.00542238269362068,0.0127813827200229,1.25633460735066e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37268,0.0311390435012375,0.0064247704607806,0.0185464933981076,0.0437315936043675,1.26927250977733e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37203,0.0306560398177811,0.00632668605919221,0.0182557351417644,0.0430563444937978,1.27704924154383e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36855,0.0162248018377185,0.00335079211871441,0.00965724928503825,0.0227923543903987,1.29966912782917e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,39668,0.0101940770700548,0.00210563991271138,0.00606702284114051,0.0143211312989691,1.30198560763887e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39865,0.0318543049430947,0.00658522268037903,0.0189472684895518,0.0447613413966376,1.32879324430202e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,39288,0.0348282983303811,0.00720915738176278,0.0206983498621261,0.0489582467986362,1.37072167326663e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37244,0.04192814977678,0.00870206462037486,0.0248721031208452,0.0589841964327147,1.46459503428795e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,37203,0.016445454609319,0.00341835086805291,0.00974548690793526,0.0231454223107027,1.51871014007402e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37203,0.022372272022707,0.00465556708744804,0.0132473605313088,0.0314971835141051,1.5605555407308e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39697,0.010144858816012,0.00211260610165274,0.00600415085677258,0.0142855667752513,1.58478428614348e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39848,0.0164127692386285,0.00341929179267032,0.00971095732499467,0.0231145811522623,1.60060882927221e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,39826,0.00886852681278701,0.00184815689709921,0.00524613929447256,0.0124909143311015,1.61240483147908e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39288,0.0327984899287579,0.00683752843865306,0.0193969341889979,0.0462000456685179,1.62699678740077e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36896,0.0249503673490738,0.00520278234742282,0.0147529139481251,0.0351478207500226,1.63997291626797e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39557,0.0189036175159562,0.00394280698212006,0.0111757158310009,0.0266315192009115,1.64611870437673e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,39288,0.0290495573451165,0.0060611098676562,0.0171697820045104,0.0409293326857227,1.66019664583422e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36855,0.0266362337636344,0.00556053715627374,0.0157375809373378,0.0375348865899309,1.68433154202887e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36958,0.0290220577369725,0.00606283955825182,0.0171388922027989,0.040905223271146,1.71249291908989e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,39673,0.0179720002441717,0.00375580137922132,0.0106106295408979,0.0253333709474454,1.72419742481176e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,37268,-0.0349933156439442,0.00732365493896284,-0.0493476793243114,-0.0206389519635771,1.78815774961452e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39673,0.0117902460346743,0.00246794835157212,0.00695306726559291,0.0166274248037556,1.79217455449588e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36958,0.0157329001611937,0.00329654130605922,0.00927167920131759,0.0221941211210697,1.83875393031618e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,37215,0.044086124919182,0.00925667663256879,0.0259430387193472,0.0622292111190168,1.93094415879362e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39302,0.0167307873795036,0.00351429807718094,0.00984276314822895,0.0236188116107782,1.94598916164867e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39860,0.0147195833644149,0.00309445892801296,0.00865444386550951,0.0207847228633203,1.98446016351698e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,39790,0.0207596383151438,0.00436890880075243,0.012196577065669,0.0293226995646185,2.03498265148618e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,39557,0.0376206876029381,0.00791777938147624,0.0221018400152446,0.0531395351906315,2.0378280664841e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36958,-0.0134473212174922,0.00283020262693826,-0.0189945183662912,-0.00790012406869323,2.04195287248119e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36958,0.0178183428670556,0.0037503053290659,0.0104677444220865,0.0251689413120248,2.04389128397287e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39266,0.0197907691738445,0.00417019267966567,0.0116171915216998,0.0279643468259892,2.09581860473442e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39865,0.0319056181120539,0.00672560393836564,0.0187234343928573,0.0450878018312506,2.11447956722568e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,39743,0.0391559271505555,0.00826145593796085,0.0229634735121523,0.0553483807889588,2.16005602766904e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39716,-0.0270367464200159,0.00570446284456188,-0.0382174935953572,-0.0158559992446746,2.16023283208704e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39510,0.0116332003716986,0.00245593663397186,0.00681956456911378,0.0164468361742835,2.19060221174723e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39680,0.0205780488363212,0.00434510152363721,0.0120616498499923,0.0290944478226502,2.19956699689699e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36880,0.0239361208842739,0.00505630781163897,0.0140257575734615,0.0338464841950863,2.22551896864453e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,39594,0.0227974624371232,0.00481925451982536,0.0133517235782655,0.0322432012959809,2.25917671035294e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37244,0.0359629740425454,0.00760726076267949,0.0210527429476936,0.0508732051373972,2.29669765254442e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,39594,0.00631878963125561,0.00133827703956169,0.0036957666337147,0.00894181262879651,2.3603088808322e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39401,0.0238090265853969,0.00504344102414847,0.0139238821780659,0.0336941709927279,2.36979881015823e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39860,0.0245798950770821,0.00520684171834611,0.0143744853091238,0.0347853048450405,2.37035277995596e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39288,0.0257583534832559,0.00545696595584443,0.0150627002098008,0.036454006756711,2.37600729149129e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37220,0.0275215457704009,0.00583231995111283,0.0160901986662197,0.038952892874582,2.39646143462145e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,37244,0.022991652834188,0.00487629381909196,0.0134341169487677,0.0325491887196082,2.4416697597721e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39288,0.0229846353531215,0.00487543662802733,0.0134287795621879,0.0325404911440551,2.44573759850646e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39860,0.0128804718103655,0.00273496690032729,0.00751993668572401,0.018241006935007,2.5034490588035e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39288,0.0182320039235161,0.00387169765406437,0.0106434765215499,0.0258205313254822,2.51044791113483e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39401,0.0273541573348285,0.00581634406200047,0.0159541229733076,0.0387541916963494,2.58594424515969e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39622,-0.0273755477918097,0.00582149117418343,-0.0387856704932092,-0.0159654250904102,2.59176138299619e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,39668,0.0109676299134513,0.00233255388115508,0.00639582430638731,0.0155394355205152,2.59822289126466e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36958,0.0279667656138215,0.00594839534461442,0.0163079107383772,0.0396256204892658,2.6080791383809e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39721,0.030382784861596,0.00646443225832552,0.017712497635278,0.043053072087914,2.62357080484889e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39288,0.0187167686916327,0.00398253740508983,0.0109109953776567,0.0265225420056088,2.62782432762499e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37215,0.0199745680262757,0.00426402959472016,0.0116170700206242,0.0283320660319272,2.83501686831897e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39865,0.0282052263436849,0.00602407257247942,0.0163980441016252,0.0400124085857445,2.86300499143421e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,39597,0.0301440102017496,0.0064382603266845,0.017525019961448,0.0427630004420513,2.86444107457193e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37268,0.0194508704738632,0.00415428153647597,0.0113084786623703,0.0275932622853561,2.86697525955433e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,37250,0.0141157112682385,0.00301674307232839,0.00820289484647485,0.0200285276900021,2.90925718928241e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39546,0.0199820072747812,0.00427258927406252,0.0116077322976187,0.0283562822519438,2.93828368972686e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39673,0.0193983506829646,0.0041499670549468,0.0112644152552689,0.0275322861106603,2.97336563900508e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39594,0.0319141639997819,0.00683239928496544,0.0185226614012496,0.0453056665983141,3.02210615351844e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,37203,0.0344348615630729,0.00737985249092804,0.019970350680854,0.0488993724452919,3.10009016246774e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37244,0.0195176505175946,0.00418311625840226,0.0113187426511262,0.027716558384063,3.10372985494896e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39601,0.0185934162039789,0.00398687301785357,0.0107791450889859,0.0264076873189719,3.13188950991189e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39633,0.0105000567568249,0.00225373949451775,0.00608272734757015,0.0149173861660797,3.20424989409914e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39721,0.0105612194986285,0.00226845212624902,0.00611505333118038,0.0150073856660765,3.25507103642167e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36855,0.0276350696239537,0.00594037918404799,0.0159919264232196,0.0392782128246877,3.3185927635877e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39668,0.0155354141378601,0.00334230654871725,0.00898449330237432,0.0220863349733459,3.37693914730673e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,39302,0.0254258400684414,0.00547228347249879,0.0147001644623438,0.036151515674539,3.40741662193309e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39302,0.0232830949317773,0.00501221140782477,0.0134591605724407,0.0331070292911138,3.42428028716249e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39721,0.0342557652507293,0.00738193077166972,0.0197871809382566,0.0487243495632019,3.50367570013208e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,37285,0.013049498139849,0.00281345999759559,0.0075351165445616,0.0185638797351363,3.54708788406114e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39288,0.0194377592746219,0.00419212391344088,0.0112211964042778,0.027654322144966,3.56861970642901e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39302,0.0350187173868016,0.00757452127551545,0.0201726556867913,0.0498647790868119,3.80880329111736e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,39865,0.0263931043593267,0.00570974756831991,0.0152019991254197,0.0375842095932338,3.82170154347734e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39288,0.0350247360671627,0.00758625925577269,0.0201556679258482,0.0498938042084772,3.92722802723268e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39860,0.0127964642707118,0.00277379410413912,0.00735982782659909,0.0182331007148244,3.99315833082329e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,39721,0.012044189944198,0.00261377118101024,0.00692119842941794,0.0171671814589781,4.09777860015419e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39860,-0.0138517025950792,0.00301087486370014,-0.0197530173279315,-0.00795038786222696,4.24594700790865e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,39236,0.0188103125788203,0.0040896501561302,0.0107945982728051,0.0268260268848355,4.26901382222924e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37005,0.020409377444743,0.0044385476845279,0.0117098239830683,0.0291089309064177,4.3010917311595e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39288,0.0151959950480517,0.00330963388239796,0.00870911263855171,0.0216828774575517,4.43668289223656e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39801,0.0231979944713232,0.00505389186272127,0.0132923664203896,0.0331036225222569,4.46362653453854e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,39554,-0.00930044744255015,0.00202880369660256,-0.0132769026878912,-0.00532399219720913,4.59238233504529e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39594,0.0386669633192672,0.00844326960066417,0.0221181549019654,0.055215771736569,4.69393583930117e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,39401,0.0326489244487099,0.0071292180252575,0.0186756571192052,0.0466221917782146,4.69495434288559e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,39680,0.0282140831120105,0.00616229857944397,0.0161359778963003,0.0402921883277207,4.71890062297788e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39860,0.0109289632031393,0.00238908854851399,0.00624634964805191,0.0156115767582268,4.80867375911241e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39288,0.0188702049744018,0.0041309797712302,0.0107734846227907,0.026966925326013,4.96276103215627e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39557,0.0286045258871211,0.00627344975278482,0.0163085643716628,0.0409004874025793,5.16343421800003e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37244,0.015326132171321,0.00336190166467337,0.00873680490856115,0.0219154594340808,5.19103158150915e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,39826,0.0243341198581491,0.00534026421255308,0.0138672020015451,0.0348010377147531,5.23422214056451e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,37215,0.046440924373057,0.0101913595770246,0.0264658596020889,0.0664159891440252,5.23763991396587e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,39720,0.0235834743266229,0.00518698456626483,0.0134169845767438,0.0337499640765019,5.49061708467114e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39288,0.027581330357788,0.00607022209708311,0.0156836950475051,0.039478965668071,5.56919333969168e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39645,0.038825649957587,0.00854549831065608,0.0220764732687011,0.0555748266464729,5.5763349893023e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37195,0.028693692196323,0.00631667544923782,0.0163130083158169,0.0410743760768291,5.60704810802716e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,39651,0.0156836586041791,0.00345569413651303,0.0089104980966136,0.0224568191117447,5.70745684198478e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39743,0.0443859854201976,0.00978023857591522,0.0252167178114038,0.0635552530289914,5.71164012726842e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,39485,0.0134124254496176,0.00295557139176082,0.00761950552176634,0.0192053453774688,5.72096958012643e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,39793,0.02813660753916,0.00620063165133376,0.0159833695025458,0.0402898455757742,5.72866361900404e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,39333,0.0359233576587401,0.0079353521216446,0.0203700675003166,0.0514766478171635,6.02724526460933e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39697,0.0133532560097629,0.00295360352284042,0.00756419310499569,0.0191423189145302,6.19929137759506e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MDK,Midkine,39651,0.0203052816298481,0.00449431190080623,0.0114964303042679,0.0291141329554284,6.28804667991785e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37215,0.0195801089775663,0.00433430258787809,0.0110848759053253,0.0280753420498074,6.31176702347242e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37267,-0.00931070247560227,0.00206237203020327,-0.0133529516548007,-0.00526845329640386,6.39889294989461e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,37213,0.0187446313994663,0.00415299146912738,0.0106047681199766,0.026884494678956,6.43038594218766e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39741,0.0449636507395124,0.00997566011063662,0.0254113569226646,0.0645159445563602,6.61157380363433e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,37267,0.033821137247023,0.00751153206952026,0.0190985343907633,0.0485437401032827,6.77054602217783e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37203,0.022840610579941,0.00507321391018048,0.0128971113159873,0.0327841098438948,6.78242218318697e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,36880,0.0116465148238632,0.00258684873990657,0.00657629129364629,0.0167167383540801,6.78370353056284e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39720,0.0347512049605182,0.00772297873311259,0.0196141666436175,0.0498882432774189,6.85282513607895e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39738,0.0110371481503465,0.00245340165634381,0.0062284809039126,0.0158458153967803,6.88513239194007e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36855,0.0239661277489864,0.00533657343059569,0.0135064438250189,0.034425811672954,7.15269800153846e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39650,0.0331418762508398,0.00738203814268677,0.0186730814911737,0.0476106710105059,7.18859942188238e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,39743,0.0193526598849753,0.00431136133010795,0.0109023916779637,0.0278029280919869,7.21432248173018e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36855,0.027050216890377,0.00602882922396991,0.015233711611396,0.038866722169358,7.29178978437679e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37244,0.0425548847900203,0.00948580470349811,0.023962707571164,0.0611470620088766,7.31207186050776e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39557,0.0403485528398521,0.00900251471694158,0.0227036239946466,0.0579934816850576,7.44977010212491e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36896,0.038836662843141,0.00867059176255786,0.0218423029885276,0.0558310226977544,7.55869529198148e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37005,0.0283703106281467,0.00633515639703886,0.0159534040899505,0.0407872171663428,7.58973101947041e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39721,0.0138498181891598,0.00309312811839419,0.00778728707710721,0.0199123493012124,7.60102014693109e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39384,0.0165651270379397,0.00370482022088142,0.00930367940501215,0.0238265746708673,7.8319898455076e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39716,0.0132263347045664,0.00295833201997425,0.00742800394541686,0.0190246654637159,7.84403677202469e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37268,0.0113074886891425,0.0025311826296891,0.00634637073495186,0.0162686066433331,7.98705063869373e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,39673,0.037863714209368,0.00847869208577248,0.0212454777212539,0.054481950697482,8.03415309532417e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37005,0.029089787452213,0.00652248621723101,0.0163057144664402,0.0418738604379857,8.26690430124809e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39401,0.0372650899320528,0.00836193495719364,0.0208756974159533,0.0536544824481524,8.38851025489418e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36855,0.0160515858616329,0.0036022516515875,0.00899117262452144,0.0231119990987444,8.42064219846587e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,39557,0.0384635269856893,0.00863402831224327,0.0215408314936925,0.0553862224776861,8.45218211124034e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37244,0.0260764818322515,0.00585407048905966,0.0146025036736946,0.0375504599908085,8.48026966226341e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39680,0.0137399936628694,0.00309112196608791,0.00768139460933706,0.0197985927164017,8.8495302996541e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,39594,-0.0518878961940219,0.0116815509556963,-0.0747837360671867,-0.0289920563208571,8.97897641906661e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37220,0.0186053570296776,0.00418841255870251,0.0103960684146207,0.0268146456447345,8.98000374630341e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39203,0.0230485085655003,0.00519220398383476,0.0128717887571842,0.0332252283738165,9.09826382408708e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39673,0.0380456809507581,0.00857305947799457,0.0212424843738887,0.0548488775276275,9.14896398825916e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RETN,Resistin,39599,0.0159683155721128,0.00360496817737695,0.00890257794445395,0.0230340531997716,9.50754862002495e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36855,0.0107886100916576,0.00243905162035364,0.00600806891576446,0.0155691512675507,9.80034903860971e-06
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36880,0.0242274280235223,0.00549446842863608,0.0134582699033956,0.034996586143649,1.04477882985683e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39288,0.030105171626653,0.00682812279791791,0.016722050942734,0.0434882923105721,1.04552498506589e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36832,0.019882725574097,0.00451218932975329,0.0110388344877806,0.0287266166604135,1.05923003051161e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,39684,0.0184998154348592,0.00420124140965334,0.0102653822719387,0.0267342485977798,1.0725813047693e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37268,0.0343783336103642,0.00780685979219091,0.01907688841767,0.0496797788030583,1.07290773287241e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,39860,0.0103998792188372,0.00236360330252635,0.00576721674588554,0.0150325416917888,1.08945607748674e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,36795,0.0221082765552095,0.00502697781001486,0.0122554000475804,0.0319611530628386,1.10163278209227e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36896,0.0147946619649952,0.00336508339054718,0.00819909851952269,0.0213902254104676,1.10870232976092e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36958,0.0467167452421663,0.0106353178814702,0.0258715221944847,0.0675619682898479,1.12880226068975e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,36716,0.0271330354680148,0.00617997121582438,0.015020291884999,0.0392457790510305,1.14004297190138e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36896,0.0186146835751871,0.00424216420759435,0.0103000417283022,0.0269293254220721,1.1528836575503e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36880,0.0236578966853511,0.00539578484948116,0.0130821583803681,0.0342336349903342,1.17156574726263e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39594,0.0103388758685681,0.0023593703621901,0.00571450995867549,0.0149632417784607,1.18329606074891e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36958,0.0441063531225041,0.0100660305194872,0.0243769333043093,0.0638357729406989,1.18671310556427e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39673,0.03193134768182,0.007289586065151,0.017643758994124,0.0462189363695159,1.19220221704446e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39721,0.0368258746535033,0.00841801611859882,0.0203265630610496,0.053325186245957,1.22403453100075e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37846,-0.0119283603612576,0.00272830769348569,-0.0172758434404896,-0.00658087728202565,1.23961151321007e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,39784,0.00988131876102734,0.0022605025840415,0.00545073369630601,0.0143119038257487,1.24295623193337e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36877,0.0239457055545972,0.00547899184657055,0.0132068815353189,0.0346845295738755,1.24946885308625e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37267,0.0208327713108169,0.00476734330058747,0.0114887784416655,0.0301767641799684,1.25243286114155e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,36896,0.0113107222246962,0.00259001215343582,0.00623429840396202,0.0163871460454304,1.2690539397918e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37203,0.0141346373641897,0.00324261689504424,0.00777910824990301,0.0204901664784764,1.316229814685e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37244,0.0162034104024803,0.00372105046034219,0.00891015150020955,0.023496669304751,1.34346356283384e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,39865,0.0235327824101614,0.00540704119241125,0.0129349816730354,0.0341305831472875,1.35584328698948e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39288,0.0313148903089672,0.00719573369948694,0.0172112522579728,0.0454185283599616,1.35849857644341e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37200,0.0326522694464122,0.00750539897950015,0.0179416874465919,0.0473628514462325,1.36834108914462e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36877,0.0266519033161658,0.00612795204238366,0.0146411173130938,0.0386626893192378,1.37652459838213e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36855,0.0250778234309867,0.00577512722123845,0.0137585740773594,0.0363970727846141,1.4201202309652e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,37203,0.00826004451050535,0.00190395060436423,0.00452830132595146,0.0119917876950592,1.44597551495412e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,39738,0.0388759509952483,0.00896910495398728,0.0212965052854332,0.0564553967050634,1.47037839331679e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,39680,0.0472231780971224,0.0109002361674386,0.0258587152089428,0.0685876409853021,1.48463876689732e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36880,0.0392568332902973,0.00906767340729898,0.0214841934119913,0.0570294731686033,1.50690149288343e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37203,0.0241585908872123,0.00558426422149923,0.0132134330130738,0.0351037487613508,1.52813324618918e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37268,0.0248079031928456,0.00573589846661912,0.0135655421982722,0.0360502641874191,1.53617117549183e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37215,0.0250134141565774,0.00578860682291405,0.0136677447836658,0.0363590835294889,1.56343642391001e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37267,0.0161595305131099,0.0037410260509702,0.00882711945320827,0.0234919415730115,1.57475972145499e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36958,0.0339183740472664,0.0078558640248153,0.0185208805586284,0.0493158675359044,1.58904079775466e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36922,0.0332142403990312,0.00769452680621191,0.0181329678588558,0.0482955129392065,1.59613621011902e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,36880,0.0270865955812487,0.00628146820729904,0.0147749178949425,0.0393982732675548,1.62868997021103e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,39673,0.0328804676640434,0.00763962648068558,0.0179067997618997,0.0478541355661872,1.68798664466046e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,37076,0.00890410760529848,0.00207207621988356,0.0048428382143267,0.0129653769962703,1.74213628405903e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,36896,0.0200043977496272,0.00465619233256745,0.010878260777795,0.0291305347214594,1.74931541263523e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,39668,0.0245503288478785,0.00571561481173658,0.0133477238168748,0.0357529338788822,1.75491877874082e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,39679,0.0103979103416822,0.00242186232544751,0.00565106018380505,0.0151447604995593,1.77042665034717e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39817,0.0179380757867021,0.00417866443838857,0.00974789348746054,0.0261282580859438,1.77493023511884e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,36877,0.0260572476708848,0.00607179131571631,0.0141565366920808,0.0379579586496888,1.78732361663195e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39621,0.0223201252820707,0.00521029281537592,0.0121079513639339,0.0325322992002075,1.84773345706393e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39770,0.0159260240522443,0.00371788952216468,0.00863896058880155,0.0232130875156871,1.84956493991091e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39636,-0.00854541662376134,0.00199512530206221,-0.0124558622158033,-0.00463497103171942,1.85357913750715e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39754,0.00913583053402979,0.0021338487762776,0.00495348693252569,0.0133181741355339,1.86821810757804e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,37277,-0.00846201059931608,0.00198166867530451,-0.0123460812029129,-0.00457793999571924,1.96690662630729e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,37203,0.0377937398453808,0.00886498101776674,0.0204183770505579,0.0551691026402036,2.0284883390253e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39668,0.0095858770736666,0.00225147411610503,0.00517298780610075,0.0139987663412325,2.07825443196722e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,39778,0.0227089662730956,0.00534414135257086,0.0122344492220567,0.0331834833241344,2.15640352944406e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36958,0.008178178331107,0.00192450136959624,0.00440615564669836,0.0119502010155156,2.15725525051975e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39680,0.0484990061083964,0.0114166025124242,0.0261224651840449,0.0708755470327479,2.16812333310535e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,37180,0.033374804026695,0.00785839075549921,0.0179723581459166,0.0487772499074735,2.18095413165196e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36855,0.0135519652754303,0.00319395959141416,0.00729180447625859,0.0198121260746021,2.2208203057586e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39738,0.0124342155023401,0.00293385483411389,0.00668386002747692,0.0181845709772034,2.26607814502006e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37203,0.0356894244360972,0.00842685129008552,0.0191727959075296,0.0522060529646648,2.2987632138775e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,39721,0.0237473474735954,0.00560799224683545,0.0127556826697979,0.0347390122773929,2.30295744869756e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39594,0.0166819913183698,0.00394186016056503,0.00895594540366238,0.0244080372330773,2.32924675848458e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39401,0.019562152580215,0.00462387285009478,0.0104993617940292,0.0286249433664008,2.34315128713187e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37005,0.027893889721514,0.00659379504653297,0.0149700514303093,0.0408177280127186,2.34935973577848e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36880,0.0162989227637857,0.00385336556365513,0.00874632625902168,0.0238515192685498,2.35510046802307e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36896,0.00757295187464258,0.00179124751759903,0.00406210674014849,0.0110837970091367,2.37645708318947e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37215,0.0159082822762703,0.00376487645249252,0.00852912442938497,0.0232874401231557,2.40051216664365e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,37277,0.0258523082971355,0.00611944285645398,0.0138582002984857,0.0378464162957853,2.40926978594573e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,36896,0.0120296964933606,0.00284868076073145,0.00644628220232696,0.0176131107843942,2.42814655789494e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39668,0.0130654220764627,0.00309565000626468,0.0069979480641839,0.0191328960887415,2.45040586662232e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,39646,0.0343226965052419,0.00814794754586514,0.0183527193153462,0.0502926736951376,2.540347029e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,39050,0.0115193707466394,0.00273503619795573,0.00615869979864616,0.0168800416946326,2.54826609336548e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39401,0.0218459036610057,0.00518821901089913,0.0116769943996434,0.032014812922368,2.56041775212526e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39673,0.0346030048488819,0.00822181361881239,0.0184882501560096,0.0507177595417542,2.58281867265728e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39658,0.0118190856662294,0.00280881171083316,0.00631381471299638,0.0173243566194624,2.5922436823825e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37268,0.0149229535397084,0.00355340056944889,0.00795828842358855,0.0218876186558282,2.69083336811581e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,37267,0.0159637251229682,0.00380281338855964,0.00851021088139129,0.0234172393645451,2.71172381384847e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39820,0.0349332934201354,0.00833479373018867,0.0185970977089656,0.0512694891313052,2.78902255277476e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,39658,-0.0670671502466977,0.0160088225352828,-0.098444442415852,-0.0356898580775433,2.81228086276987e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37277,0.0176821079876168,0.0042225112568556,0.00940598592417983,0.0259582300510538,2.83743732752477e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37203,0.0257249081788708,0.00614427870450207,0.0136821219180467,0.0377676944396948,2.84721631105823e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36795,0.0184476797191298,0.00440886421903009,0.00980630584983077,0.0270890535884287,2.8803025786653e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,39288,0.0363442743860457,0.0086888129376497,0.0193142010282523,0.0533743477438391,2.89428612032591e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,37277,0.00841753308091275,0.00201252087898573,0.00447299215810071,0.0123620740037248,2.90049386896783e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36896,0.0116370579809261,0.00278518009348933,0.00617810499768702,0.0170960109641652,2.95731344315679e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36896,0.0338013604347565,0.00809272820706498,0.0179396131489091,0.0496631077206039,2.97618808639966e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,36880,0.0191763495031641,0.0045939430004938,0.0101722212221963,0.028180477784132,3.00889137458404e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36877,0.0196116903526636,0.00469953850063651,0.010400594891416,0.0288227858139112,3.02421816996487e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36972,0.0241449828960203,0.00578952009024126,0.0127975235191475,0.0354924422728932,3.05936139190925e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,39680,0.0250979018797379,0.00602812713590364,0.0132827726933668,0.0369130310661091,3.15112826839681e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,39594,0.0329712010443019,0.00792029287425541,0.0174474270107613,0.0484949750778425,3.15935867260862e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39200,0.00712802319303282,0.00171361684363303,0.00376933417951207,0.0104867122065536,3.2048936783268e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,39251,0.0160672408615593,0.00386378899197685,0.00849421443728471,0.023640267285834,3.22198902709991e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37244,0.0244759932578695,0.00588598388849326,0.0129394648364227,0.0360125216793163,3.22549613363268e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37215,0.0393117188821168,0.00945947000812938,0.0207711576661832,0.0578522800980504,3.26163243996857e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39673,0.0451030083577358,0.010882788355392,0.0237727431811676,0.0664332735343041,3.42426276764132e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37168,0.0178151609412744,0.00430206348079048,0.00938311651892511,0.0262472053636238,3.47816985260081e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37244,0.0366742694907437,0.00886163988100854,0.019305455323967,0.0540430836575205,3.51658967400314e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37215,0.023922377395384,0.00578215665276681,0.012589350355961,0.0352554044348069,3.53606606685519e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,36896,0.016785812068019,0.00406004098833535,0.00882813173088167,0.0247434924051562,3.58119274543551e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,39604,0.0293597968258851,0.00710372453978266,0.0154364967279111,0.0432830969238591,3.59888831051101e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39836,0.0219824683118671,0.00531917287998906,0.0115568894670886,0.0324080471566457,3.60377153483627e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HLA_DRA,,39606,0.0130193778481927,0.00315255073507179,0.00684037840745196,0.0191983772889334,3.64965183420334e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36880,0.019061205337488,0.00462769948515583,0.00999091434658261,0.0281314963283935,3.82975146712612e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36855,0.0228043281118001,0.00553810143856449,0.0119496492922137,0.0336590069313865,3.8501238338178e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37268,0.0117305952533171,0.00284918863384391,0.00614618553098308,0.0173150049756512,3.85849946796392e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39529,0.0120703136946818,0.00293340950668876,0.00632083106157183,0.0178197963277918,3.89542478705132e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39594,0.0218709921753646,0.00532098075650303,0.0114418698926187,0.0323001144581106,3.97095792351464e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37244,0.0173826324438424,0.00423007359580441,0.00909168819606575,0.0256735766916191,3.99228168670028e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37220,0.01621324629373,0.00394757002659052,0.0084760090416126,0.0239504835458474,4.02964043823624e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36896,0.0220769878418865,0.00537701075552348,0.0115380467610605,0.0326159289227125,4.05355977839512e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39721,0.0109603675697336,0.00267037441134782,0.00572643372349186,0.0161943014159753,4.0733884926825e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37005,0.0130558337821956,0.00318094996927296,0.00682117184242057,0.0192904957219706,4.07845076496015e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37215,0.00931472196995216,0.00226973899660245,0.00486603353661135,0.013763410403293,4.08703015506746e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,39668,0.0167498005442931,0.00408231490448984,0.008748463331493,0.0247511377570932,4.09844546090839e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37244,0.0134902668700536,0.00328788087589916,0.00704602035329125,0.0199345133868159,4.10193326964954e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39673,0.0440028342638822,0.010734143353018,0.0229639132919669,0.0650417552357975,4.16410833103028e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,37244,-0.0185958001318891,0.00453643724681863,-0.0274872171356536,-0.00970438312812454,4.17012975031344e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,36655,0.0142422461045203,0.00347493968305555,0.00743136432573145,0.0210531278833092,4.18295129897392e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39817,0.0102344795655945,0.00249767058362347,0.00533904522169245,0.0151299139094965,4.1950076371385e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,39302,0.0260164157426368,0.00635166137997116,0.0135671594378933,0.0384656720473803,4.22490097202345e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,37203,0.0395386562600479,0.00965372201623552,0.0206173611082263,0.0584599514118695,4.23395913528466e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36896,0.0193668644045343,0.00473425207279638,0.0100877303418534,0.0286459984672152,4.32478019582707e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,39697,0.011784886633425,0.00288221027444328,0.0061357544955162,0.0174340187713338,4.35683232234311e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,37285,0.0198439302489863,0.00485997874771077,0.0103183719034732,0.0293694885944994,4.46905045428577e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37268,0.0119651318858624,0.00293094771956038,0.00622047435552407,0.0177097894162008,4.48426371268223e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37005,0.0304298351355279,0.00746327628360532,0.0158018136196615,0.0450578566513943,4.58347499343827e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36896,0.0139226386336729,0.00341480237808406,0.00722962597262817,0.0206156512947177,4.58630664448518e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36863,0.0287628469549413,0.00707308515086543,0.0148996000592451,0.0426260938506376,4.80014754938815e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,39770,0.0120354497137765,0.00296182434541741,0.00623027399675839,0.0178406254307946,4.85690393197738e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39401,0.0115346683438838,0.00283996603205095,0.00596833492106395,0.0171010017667037,4.89868220205828e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,36958,0.0130466024734688,0.00321355680287662,0.00674803113983058,0.0193451738071069,4.93868530226036e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,39293,0.0399546079327213,0.00984796973336435,0.0206525872553272,0.0592566286101155,4.99213818854139e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,36880,0.0169107768718326,0.00417159354091875,0.00873445353163185,0.0250871002120334,5.06868788468765e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37203,0.0262404691474685,0.0064746778815316,0.0135501004996666,0.0389308377952704,5.08987189005795e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,37257,0.0134137537347336,0.00331314852904755,0.00691998261780042,0.0199075248516668,5.18053275343636e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,39288,0.0225087757736541,0.00556006868252846,0.0116110411558983,0.0334065103914098,5.18448188499925e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39401,0.0143200523516261,0.00353915983552891,0.00738329907398946,0.0212568056292628,5.23135731453958e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39680,0.0279712630743894,0.00691724899595024,0.014413455042327,0.0415290711064519,5.2864145456473e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37220,0.0226687606043387,0.00560654453510146,0.0116799333155398,0.0336575878931375,5.30071732202295e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,39693,0.0384210697306988,0.00950993546289428,0.019781596223426,0.0570605432379716,5.36810735847759e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,39669,0.0078123110487785,0.00193414456376858,0.00402138770379209,0.0116032343937649,5.38972886594592e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39401,0.0402318828486358,0.00997731857642322,0.0206763384388463,0.0597874272584253,5.54891968442493e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37220,0.0192961515793271,0.00478662675022565,0.00991436314888481,0.0286779400097694,5.57857391696147e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,36880,-0.025966233893434,0.00644323877300678,-0.0385949818885273,-0.0133374858983407,5.60947425997987e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36855,0.0142503701584249,0.00354223526314423,0.00730758904266225,0.0211931512741876,5.77896917472729e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,39302,0.0160186905158265,0.00398432151799292,0.00820942034056033,0.0238279606910926,5.8367683401073e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39564,0.026746800542263,0.00665959151579176,0.0136940011713111,0.0397995999132148,5.9398486411371e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39637,0.0243086747947511,0.00605264691341474,0.0124454868444582,0.036171862745044,5.94165392125001e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,39836,0.0103395103565806,0.00257517254655182,0.00529217216533905,0.0153868485478222,5.96984319146628e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39668,0.0148009561450535,0.00369325120988029,0.00756218377368812,0.0220397285164189,6.16283819404069e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,39288,0.0207439411362251,0.00517962846294971,0.0105918693488436,0.0308960129236065,6.23320372176828e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37244,0.0426399341304661,0.0106519121048881,0.0217621864048854,0.0635176818560469,6.28733653874615e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,36880,0.0143637569934032,0.00358834681104005,0.00733059724376473,0.0213969167430417,6.29203052407239e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,37203,0.0228256494971421,0.00570437821555609,0.0116450681946521,0.034006230799632,6.33018629494877e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39673,0.0368908164998228,0.00922827835767235,0.018803390918785,0.0549782420808606,6.42828343288862e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39668,0.0165300972347852,0.00413889914506758,0.00841785491045278,0.0246423395591177,6.5306172201472e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37203,0.0148288388872246,0.00371543218155227,0.00754659181138219,0.0221110859630671,6.6106004520128e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,39668,0.00834132190518134,0.00209122292630826,0.00424252496961714,0.0124401188407455,6.67273426928613e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,39362,0.025565709942973,0.00641635408753499,0.0129896559314044,0.0381417639545415,6.79429095086729e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39594,0.00991553552195428,0.00248954741808455,0.00503602258250856,0.0147950484614,6.83952944861063e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37277,0.0507285918612507,0.012736281773912,0.0257654795843833,0.0756917041381182,6.84103640988388e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39865,0.0129770273506988,0.00325870907196625,0.00658995756964495,0.0193640971317527,6.85647403350182e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39288,0.0229563575067103,0.00576977923586648,0.011647590204412,0.0342651248090086,6.9602870647007e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37203,0.0172211923037399,0.00432838973589799,0.00873754842137984,0.0257048361861,6.96710106319209e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39557,0.0217027789194911,0.00545523182981455,0.0110105245330545,0.0323950333059276,6.97090743664207e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39630,0.0388465886269665,0.00976822227268214,0.0197008729725095,0.0579923042814235,7.01508828369857e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39401,0.0312967650571023,0.00787030731469989,0.0158709627202906,0.0467225673939141,7.02353585031495e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37244,0.0196249651384835,0.00493533743640702,0.00995170376312574,0.0292982265138413,7.03289500860548e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36958,0.0316804169671589,0.00797540310258139,0.0160486268860993,0.0473122070482184,7.15733933066271e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,37203,0.00978337931057831,0.00246574999231147,0.00495050932564784,0.0146162492955088,7.29463388525778e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,37220,0.0252939433358734,0.00637580756516823,0.0127973605081437,0.0377905261636031,7.3109394740547e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,39288,0.03472677469756,0.00876191816258524,0.0175534150988929,0.051900134296227,7.42301451195797e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39673,0.0212998922251899,0.00538028146262001,0.0107545405584547,0.0318452438919251,7.56313246131513e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,37213,0.0111102784355022,0.00280831744543998,0.00560597624243984,0.0166145806285646,7.65436139812917e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,39630,0.0140678976642428,0.00356597105699395,0.0070785943925347,0.021057200935951,8.01321723463033e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,39817,-0.041663835908748,0.0105720271797599,-0.0623850091810774,-0.0209426626364186,8.15052683474092e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,39680,0.0221266128758864,0.00562373739962712,0.0111040875726173,0.0331491381791556,8.37251347344204e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36896,0.0200673243233055,0.00510167820680246,0.0100680350379727,0.0300666136086383,8.41603188736285e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37244,0.02038883514859,0.00518368899611726,0.0102288047162002,0.0305488655809799,8.42217056219543e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,37257,0.00981784096281978,0.00249655333922564,0.00492459641793753,0.014711085507702,8.44700118345829e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39743,0.0298667134840858,0.00759924942635953,0.0149721846084211,0.0447612423597504,8.52282341478436e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39836,0.00879644757429603,0.00224025296210005,0.00440555176857993,0.0131873433800121,8.6537602842301e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36880,0.0243232837480524,0.00619581144545738,0.012179493314956,0.0364670741811489,8.6900638352377e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39668,0.0270875343341084,0.00690425781581878,0.0135551890151036,0.0406198796531132,8.77105743535182e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,37215,0.0213931463472452,0.00545570307227895,0.0106999683255785,0.032086324368912,8.85330676067108e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,39680,0.0400923590138866,0.0102295873342074,0.0200423678388401,0.0601423501889332,8.91971310819088e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,39860,0.0180642804262786,0.00461118469941871,0.00902635841541795,0.0271022024371393,8.98467278821329e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39673,0.0352882681045859,0.00901692401868411,0.0176150970279651,0.0529614391812068,9.13264517755318e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39836,0.0447910140909371,0.0114545573370271,0.022340081710364,0.0672419464715102,9.25538997540442e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39557,0.0329519743515554,0.00842996301038273,0.0164292468512052,0.0494747018519055,9.31026201946514e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39622,0.0310813450281158,0.00795295066739697,0.0154935617200177,0.0466691283362138,9.33933487319989e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,39738,0.0104334504025112,0.00267088238281926,0.00519852093218544,0.0156683798728369,9.4081796699038e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37203,0.0100529131648665,0.00257531937542242,0.00500528718903856,0.0151005391406945,9.52542592242831e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,36880,0.0223679616099307,0.00573855880185724,0.0111203863582905,0.0336155368615709,9.75425166959052e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39521,0.0334134028944255,0.00857726828291508,0.016601957059912,0.0502248487289391,9.83727126234033e-05
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37285,0.0087648082295014,0.00225508088085889,0.00434484970301798,0.0131847667559848,0.000102107529794799
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,39266,0.015525436249767,0.00399573982181428,0.007693786199011,0.023357086300523,0.000102547923289012
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37215,0.0289279058659441,0.007453488241293,0.0143190689130099,0.0435367428188784,0.000104475007484823
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36855,0.0417777722498738,0.0107705282849277,0.0206675368114155,0.0628880076883322,0.000105448386736217
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39673,0.0255359327245858,0.00658644893427662,0.0126264928134036,0.038445372635768,0.000106162009806715
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,39521,0.0162942491185015,0.00420393038581635,0.00805454556230141,0.0245339526747015,0.00010663998464514
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39632,0.0162755862403903,0.00420016843830468,0.00804325610131318,0.0245079163794675,0.000107062985723905
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,37203,0.0141157614693364,0.00364294873628364,0.0069755819462205,0.0212559409924524,0.000107214923149902
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39288,0.0250518065530298,0.00647217472214503,0.0123663440976256,0.0377372690084341,0.00010897299020634
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37244,0.0266966941281122,0.00690914027247278,0.0131547791940656,0.0402386090621589,0.000112086282958201
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39288,0.0183214027190643,0.00474534652925457,0.00902052352172534,0.0276222819164032,0.000113421737480715
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36896,0.0145584998730342,0.0037711361282563,0.0071670730616519,0.0219499266844166,0.000113697882414323
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,39680,-0.0192921401027245,0.00500220662982182,-0.0290964650971753,-0.00948781510827376,0.000115371137573134
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,36922,0.0356183381911624,0.00924208338165669,0.0175038547631153,0.0537328216192095,0.000116793419964199
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,39288,0.0136450980157232,0.00354161093966232,0.00670354057398508,0.0205866554574614,0.000117250130972405
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36880,0.0315688739449342,0.00819547992996193,0.0155057332822088,0.0476320146076596,0.000117725262287363
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39680,-0.0143047036793567,0.00371696040895857,-0.0215899460809155,-0.00701946127779793,0.000119312752488386
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37244,0.00917663618132231,0.00238591383508413,0.00450024506455742,0.0138530272980872,0.000120533488855056
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,39673,-0.0146000830166087,0.00380035724302239,-0.0220487832129326,-0.00715138282028484,0.000122629383329487
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,39401,0.0256699841533321,0.00669134222223777,0.0125549533977461,0.0387850149089182,0.000125396456853256
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,39673,0.0278098838139639,0.00725229890854722,0.0135953779532114,0.0420243896747165,0.000126241110561203
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37244,0.0178640849805259,0.00465855279957381,0.0087333214933612,0.0269948484676905,0.00012630132356317
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36827,0.0340155976483822,0.00887251946507763,0.0166254594968301,0.0514057357999344,0.000126767518467843
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37203,0.0389976497310722,0.0101747006904146,0.0190552363778595,0.0589400630842849,0.0001272714802626
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,37244,0.00735688868907714,0.00192131327754668,0.00359111466508565,0.0111226627130686,0.000129202290192065
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37203,-0.0133471174301641,0.00348753535754756,-0.0201826867309574,-0.00651154812937093,0.000130257974067869
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36877,0.0179707928612036,0.00469575293015782,0.00876711711809425,0.0271744686043129,0.000130304775351893
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,39680,0.0174284715955511,0.00455620645980439,0.00849830693433446,0.0263586362567677,0.000131159581925108
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36855,0.0191252485877086,0.0050006967807197,0.00932388289749795,0.0289266142779192,0.000131641264639098
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37277,-0.0210006735588793,0.00549152273261318,-0.0317640581148011,-0.0102372890029574,0.000131791842769625
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37221,0.0371680077656963,0.00972784322781244,0.0181014350391839,0.0562345804922087,0.000133629495486504
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37244,0.0159814744297761,0.00418412232403359,0.00778059467467028,0.024182354184882,0.000134297786853953
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37277,-0.00867651199058846,0.00227193612951767,-0.0131295068044431,-0.00422351717673382,0.000134599921189977
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39401,0.016243183146074,0.00425422711364142,0.00790489800333678,0.0245814682888112,0.000134990317690747
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,37203,0.0273776373294742,0.00717052488872011,0.0133234085475828,0.0414318661113656,0.000135102664286655
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,37268,0.0312174446561114,0.00817717784691589,0.0151901760761562,0.0472447132360665,0.000135345649281467
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39401,0.0146240616913773,0.00383699125295949,0.00710355883557675,0.0221445645471779,0.000138750978972244
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,37268,0.0243990834613675,0.00640195645180013,0.0118512488158392,0.0369469181068958,0.000138916712653435
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,39618,0.00927035149006488,0.00243485771474639,0.00449803036916195,0.0140426726109678,0.00014099697631656
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39521,0.0378568385369167,0.00995042981921162,0.0183539960912619,0.0573596809825715,0.000142606262056768
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,39288,0.019557404085083,0.00514472267124074,0.00947374764945118,0.0296410605207149,0.000144405397917367
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39302,0.0125546401128794,0.00330384860453104,0.00607909684799858,0.0190301833777603,0.000145248709926749
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36880,0.0143613454680079,0.00378169101373941,0.00694923108107867,0.0217734598549371,0.000146768166852695
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,39288,0.0299186182823412,0.00788055554706276,0.0144727294100982,0.0453645071545842,0.000147308456709589
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,36896,0.00927438181527106,0.00244742174436342,0.00447743519631876,0.0140713284342234,0.000151660757608961
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37268,0.0332226783911394,0.00877608048714604,0.0160215606363332,0.0504237961459457,0.000154010115301685
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37220,0.0129427943080114,0.00342217287800018,0.00623533546713104,0.0196502531488917,0.000156226397174832
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,39337,0.0157083651231287,0.00415582333189234,0.00756295139261973,0.0238537788536377,0.000157515465185086
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37220,0.032918338704957,0.00871225635192259,0.0158423162551887,0.0499943611547253,0.000158528365990125
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37220,0.02332204716601,0.00617414565434501,0.0112207216834938,0.0354233726485262,0.000159179267179082
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39594,0.0328183068700159,0.00868881768304903,0.0157882242112398,0.049848389528792,0.000159265867770576
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37203,0.0147132134467212,0.00390346455988606,0.00706242290934458,0.0223640039840979,0.000164430901336004
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37203,0.0120143759734506,0.00319109330959568,0.00575983308664312,0.0182689188602582,0.000167282586714436
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36855,0.0205865351515156,0.00548210971572006,0.00984160010870427,0.0313314701943269,0.00017394393579882
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,39401,-0.0421454755547711,0.0112373520715853,-0.0641706856150782,-0.020120265494464,0.000177136298345616
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39557,0.0129519137551023,0.00345713304844195,0.00617593298015605,0.0197278945300485,0.000180009579159049
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,36855,-0.030758682364917,0.00821035922035811,-0.0468509864368189,-0.0146663782930151,0.000180219231186883
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39302,0.0146017974128359,0.00390142344622415,0.00695500745823655,0.0222485873674352,0.000182724591229416
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,37253,0.0154139376153672,0.00412537244505205,0.00732820762306522,0.0234996676076693,0.000187467736432174
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39860,0.0141866547975929,0.00379949220829156,0.00673965006934146,0.0216336595258444,0.000189244266865956
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,39668,0.0405062073011306,0.010856233043506,0.0192279905358588,0.0617844240664023,0.000191276595041405
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39557,0.0178852873130972,0.00480451563323533,0.00846843667195594,0.0273021379542384,0.000197871163839454
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,39668,0.0107897641621299,0.00289968028311971,0.00510639080721523,0.0164731375170445,0.000199108175757286
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,36855,0.0129921602681861,0.00349183042211768,0.00614817264083548,0.0198361478955368,0.000199484297392369
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36877,0.0144306719711284,0.00388935309081469,0.00680753991313164,0.0220538040291252,0.000207874349529095
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,39288,0.0171369550980063,0.00462286763988721,0.00807613452382741,0.0261977756721853,0.000210465599667574
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,36877,0.0435684828831606,0.0117629152802466,0.0205131689338773,0.0666237968324439,0.000213200749357638
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39288,0.0323653528267685,0.0087502014088448,0.0152149580654327,0.0495157475881043,0.000217362415171967
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36896,0.0104838198208156,0.00284505477726667,0.00490751245737295,0.0160601271842583,0.000229694594993628
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36880,0.00959406036398112,0.00260528584876588,0.0044877001004,0.0147004206275622,0.000231858954294004
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37220,0.0348617325859939,0.00948022638792851,0.016280488865654,0.0534429763063337,0.000236630705280765
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37215,0.0323373537144926,0.00880022949309746,0.0150889039080216,0.0495858035209636,0.000239151035433973
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37268,0.0110846126419683,0.00301748562917013,0.00517034080879484,0.0169988844751418,0.000240219504715541
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39288,0.0214154804177541,0.00583817164515139,0.00997266399325738,0.0328582968422508,0.000245102255579085
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36855,0.0226701351194933,0.00618521428037867,0.0105471151299511,0.0347931551090355,0.000248115782671933
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37244,0.0413790122016605,0.0113108442846905,0.0192097574036672,0.0635482669996538,0.00025482009569727
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,39721,0.0126246534801348,0.00345402734002225,0.00585475989369122,0.0193945470665784,0.000257958721510422
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39288,0.0166654786219219,0.00456123496447236,0.00772545809155606,0.0256054991522877,0.000259324017796866
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,39401,0.0187486737441827,0.00513204593000796,0.00868986372136714,0.0288074837669983,0.000259788098487305
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36877,0.0252933136552345,0.00692618336331999,0.0117179942631273,0.0388686330473416,0.000261389020679643
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39668,0.00866805793200696,0.00237583393176303,0.00401142342575142,0.0133246924382625,0.000264699069285005
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39401,0.0116741377312992,0.00320155876172008,0.00539908255832787,0.0179491929042706,0.000266816756638711
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,39470,0.0342184367399957,0.00938444905811375,0.0158249165860927,0.0526119568938987,0.000266916984736927
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,39673,0.0128917365988731,0.00354204775340331,0.00594932300220256,0.0198341501955435,0.000273902173778101
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37189,0.0116966966958062,0.00321424996215911,0.00539676676997434,0.017996626621638,0.000274719492567895
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39302,0.0125438240887534,0.00344810888603726,0.00578553067212035,0.0193021175053864,0.000275781426352782
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36855,0.0242171647450802,0.00666012728642011,0.0111633152636968,0.0372710142264637,0.000277822035262776
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,39521,0.0104158162395415,0.0028653823671123,0.00479966680000142,0.0160319656790816,0.000278813783932608
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,37215,0.0334716602750923,0.00920906500199321,0.0154218928711856,0.051521427678999,0.00027941141293764
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,36877,0.0159436987769301,0.00439282982403105,0.00733375232182921,0.0245536452320309,0.000285078246671157
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,36880,0.0289725109433917,0.00799148763474666,0.0133091951792882,0.0446358267074951,0.000289591117943157
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37215,-0.00949208782048906,0.00262056986395854,-0.0146284047538478,-0.00435577088713033,0.000293251567389981
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39817,-0.0414169660598249,0.0114427130532854,-0.0638446836442642,-0.0189892484753855,0.000296079183616655
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,36896,0.00838479673209918,0.0023172660296553,0.00384295531397479,0.0129266381502236,0.000297550629195367
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,39125,-0.0129885290480995,0.00359329976572425,-0.0200313965889191,-0.00594566150727999,0.000301718624720612
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36958,0.0120504192914472,0.00333698254946859,0.00550993349448872,0.0185909050884056,0.000305954920671541
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36896,0.0125632372064848,0.00348249947236245,0.0057375382406544,0.0193889361723152,0.000310276558792968
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36795,0.0133550434520312,0.00370741903445674,0.006088502144496,0.0206215847595664,0.000316659629351352
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39673,0.0339103829135546,0.00943870495723353,0.0154105211973769,0.0524102446297323,0.000328269713163337
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,37220,0.0269263394313242,0.00750073832533939,0.012224892313659,0.0416277865489894,0.000332085320359639
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,37277,-0.0163934261423679,0.00456917338536901,-0.0253490059776912,-0.00743784630704469,0.000334626188898324
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37220,0.00914420736159223,0.00255033218751725,0.00414555627405843,0.014142858449126,0.000337637338080801
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,39817,0.00938933701832072,0.00262102614457365,0.00425212577495636,0.0145265482616851,0.000341578308996703
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39557,0.00927612814969353,0.00259074589984269,0.00419826618600186,0.0143539901133852,0.000343991827494474
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,39401,0.0102936478167239,0.00287652785631499,0.00465565321834649,0.0159316424151013,0.000346626803131694
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39288,0.0164285485242879,0.00459251233124867,0.00742722435504055,0.0254298726935353,0.000348295799098404
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,39220,0.0270437915368544,0.00756144487184312,0.0122233595880419,0.041864223485667,0.000349245197997667
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39288,0.0294362284479995,0.00823240547321653,0.0133007137204951,0.0455717431755039,0.000350422056311478
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39836,0.0171613883304775,0.00480064828499554,0.00775211769188627,0.0265706589690688,0.000351520654855155
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,39401,0.0123885784501474,0.00348059448345971,0.0055666132625664,0.0192105436377285,0.000372913485244356
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,39401,0.0187284037528304,0.00526387789438387,0.00841120307983799,0.0290456044258228,0.000374930666071006
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39535,0.0185417279554574,0.0052135441217104,0.00832318147690504,0.0287602744340098,0.00037700300124418
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,39721,-0.0120211389923519,0.00338111171145812,-0.0186481179468099,-0.00539416003789404,0.0003785307705421
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39673,0.0309345648014379,0.00871548454591975,0.0138522150914352,0.0480169145114406,0.000387259814880028
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39673,0.0263147513183341,0.00741477826046043,0.0117817859278317,0.0408477167088366,0.000387877252576155
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39673,0.0329737361548669,0.00931157709490275,0.0147230450488575,0.0512244272608763,0.000399525369798447
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,36896,0.00821622908143692,0.00232164316686487,0.00366580847438177,0.0127666496884921,0.000403087438676585
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,39651,0.0106007306558398,0.0029989030191487,0.00472288073830838,0.0164785805733713,0.000409143764174625
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37005,0.0119951580993681,0.00339422769103459,0.00534247182494029,0.0186478443737959,0.000410746150561243
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,39401,0.0163101715431811,0.00461925512654208,0.00725643149515858,0.0253639115912035,0.000415332253342327
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39401,-0.00959442541917992,0.00271731237681117,-0.0149203576777298,-0.00426849316063003,0.000415423782986447
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39288,0.0123535211262221,0.00350129798585416,0.00549097707394796,0.0192160651784963,0.00041950309823615
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37244,0.0188233634961522,0.00533918446041663,0.00835856195373556,0.0292881650385688,0.000424076372126326
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39401,0.0112275227995302,0.00318713070838118,0.00498074661110308,0.0174742989879573,0.00042829021140268
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37220,0.0241071571108272,0.0068524746066697,0.0106763068817546,0.0375380073398998,0.000436220447390791
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,39668,0.01665819785167,0.00473974791543102,0.00736829193742523,0.0259481037659148,0.000441690730168861
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36896,0.00677338319631989,0.00192800432980435,0.00299449470990336,0.0105522716827364,0.000444314449366525
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39668,-0.0162571402797813,0.00462894627762047,-0.0253298749839174,-0.00718440557564513,0.000445886699032256
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39860,0.0121917836984101,0.00347187311543105,0.00538691239216527,0.018996655004655,0.000446666955913747
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37215,0.0219646052291687,0.00625987005473948,0.0096952599218793,0.0342339505364581,0.000451621802005075
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37244,0.0150245001421,0.00428269401533275,0.00663041987204778,0.0234185804121522,0.000452648856940716
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37203,0.0166930415921048,0.00475958283060227,0.00736425924412437,0.0260218239400853,0.000454254274582266
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,39292,0.0173949446732295,0.00496017343548466,0.00767300473967959,0.0271168846067795,0.000454609092942401
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,37215,0.0222138277975735,0.00633544100948966,0.00979636341897377,0.0346312921761732,0.000455908904664043
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37215,0.0156740098831449,0.00447384957328229,0.00690526471951157,0.0244427550467781,0.000460736382784238
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,39673,0.0212911917410888,0.00607768074108499,0.00937893748856221,0.0332034459936154,0.000461013653539214
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39636,0.0154932926328824,0.00442440401643596,0.00682146076066791,0.0241651245050969,0.000463437502503741
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,36624,-0.0133931349375541,0.00382534988956804,-0.0208908207211074,-0.00589544915400071,0.000464832102831988
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36958,0.00876172584788825,0.00250528295205797,0.00385137126185463,0.0136720804339219,0.000471550924765961
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36958,0.0298232853627242,0.00852838573358561,0.0131076493248964,0.046538921400552,0.000472180300997011
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37203,0.0117221449472181,0.00335290131279873,0.00515045837413258,0.0182938315203036,0.000473610561099653
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37244,0.0250035745061847,0.00715313391642998,0.0109834320299819,0.0390237169823874,0.000474757254959857
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,39401,0.0151754871608892,0.00434536597602262,0.00665856984788491,0.0236924044738936,0.00048014201747072
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39673,-0.0154022342598039,0.00442014308700206,-0.0240657147103279,-0.00673875380927987,0.000494289884627485
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39401,0.0219239583752834,0.00629350817313493,0.00958868235593895,0.0342592343946279,0.000496111324812465
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39743,0.00622509723807503,0.00179031433773025,0.00271608113612373,0.00973411334002633,0.000508229316674815
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39743,0.0372519787194351,0.0107145406525389,0.0162514790404589,0.0582524783984113,0.000508852331140761
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37220,0.0100874918248407,0.00290205584890447,0.00439946236098797,0.0157755212886935,0.000510604411008272
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,39594,0.0129754851443214,0.00373587299205959,0.00565317407988458,0.0202977962087582,0.000515648366326917
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36896,0.0103756239671388,0.00298755317266546,0.00452001974871448,0.0162312281855631,0.000516440702608888
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,39521,0.0187525316723112,0.00540753112397287,0.00815377066932441,0.0293512926752981,0.000526039983963361
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,39860,0.00935767292895565,0.00270568796684994,0.00405452451392977,0.0146608213439815,0.000544567645000531
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39269,0.0216150371272418,0.00625328705424012,0.0093585945009312,0.0338714797535525,0.000548535700575193
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,37215,0.0208878609712058,0.00604369209268336,0.0090422244695464,0.0327334974728652,0.000549669886800999
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36827,-0.0201163468993802,0.00582616698103866,-0.0315356341822159,-0.0086970596165444,0.000556656799726962
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36855,-0.0125217795053542,0.00363376361083065,-0.0196439561825823,-0.00539960282812612,0.000570847846959405
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37080,0.00246799205248897,0.000717362348075619,0.00106196185026076,0.00387402225471718,0.000582713389100344
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,39539,0.00875599207877702,0.00254532996122356,0.00376714535477883,0.0137448388027752,0.000583180174850478
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37005,0.0204843053270639,0.00595539351260143,0.00881173404236509,0.0321568766117627,0.000584334345437824
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36880,0.0234482412208211,0.00682031362889038,0.0100804265081959,0.0368160559334462,0.000587860063501868
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39288,0.0122327910930494,0.0035598354731717,0.00525551356563286,0.0192100686204659,0.000591192688110424
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',36855,0.0130805214153108,0.00380687054216512,0.00561905515266716,0.0205419876779544,0.000592151887971195
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,36896,0.0147081445230434,0.00428875507187128,0.0063021845821757,0.0231141044639111,0.000606639893713304
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,36896,0.019252992920358,0.00563039375803638,0.00821742115460667,0.0302885646861093,0.00062934140400055
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37220,0.0211256657347726,0.00617835909646733,0.00901608190569667,0.0332352495638486,0.000629699289461363
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PI3,Elafin,39407,0.0160360975108067,0.00469866476407194,0.00682671457322575,0.0252454804483877,0.00064438126084607
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37244,0.0189301326858928,0.0055474429880599,0.00805714442929539,0.0298031209424902,0.000645825010623068
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36896,0.0131299438486719,0.00385110013073077,0.00558178759243957,0.0206781001049042,0.000653029471878933
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39490,0.0110060820458041,0.0032297032652516,0.00467586364591097,0.0173363004456972,0.00065661496391688
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,39521,0.0241300692817668,0.00708565313924098,0.0102421891288545,0.0380179494346791,0.000662129739011442
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39288,0.0175258659191719,0.00515012322967883,0.00743162438900143,0.0276201074493424,0.000668198047378495
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,39269,0.0108113324693682,0.00317764746415047,0.00458314343963327,0.0170395214991031,0.000669893839918492
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39557,0.0174168639396619,0.00512043717702465,0.00738080707269355,0.0274529208066302,0.000671987688302615
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,37268,0.0160726722919286,0.00473531157799374,0.00679146159906091,0.0253538829847964,0.000690246146349658
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37268,-0.0177318482045764,0.00522678826832012,-0.0279763532104838,-0.00748734319866894,0.000694596449744398
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39557,0.00847799556144666,0.00250107071296102,0.00357589696404305,0.0133800941588503,0.000701294951272199
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,39668,0.0170109247635686,0.00502462325192847,0.00716266318978884,0.0268591863373484,0.000712183209125728
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39671,0.0151491000928003,0.00448033904796438,0.00636763555879011,0.0239305646268105,0.000723342740218508
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36896,0.00954607146503437,0.00282410986909071,0.00401081612161658,0.0150813268084522,0.000726441533593156
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39817,0.0196097364916735,0.00580638394661159,0.00822922395631476,0.0309902490270322,0.000733835347823164
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,36880,0.0222965470831953,0.00660724847491636,0.00934634007235923,0.0352467540940314,0.000741499842257114
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37267,0.0185138301064115,0.00548647217890505,0.00776034463575761,0.0292673155770654,0.000741727822937053
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37220,0.0118035484486031,0.00349819663376174,0.00494708304643005,0.0186600138507761,0.000742461950426421
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,36855,0.0213245957426092,0.00632071495490186,0.00893599443100155,0.0337131970542169,0.000743647727399254
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,39673,-0.00973035662093357,0.00288513544646836,-0.0153852220960116,-0.00407549114585558,0.000746453922794861
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37268,-0.0238271040098571,0.0070685157591178,-0.037681394897728,-0.0099728131219862,0.00075140560140896
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,39693,0.0116053846043118,0.00344970401006545,0.00484396474458354,0.0183668044640401,0.000769568882120762
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37268,0.00843020188833863,0.00250796727505105,0.00351458602923858,0.0133458177474387,0.000777739634835127
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39288,0.0141168510281481,0.00420695247339675,0.00587122418029051,0.0223624778760058,0.000793839435470601
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39743,0.00782702469222902,0.00233263729902244,0.00325505558614504,0.012398993798313,0.000794244310051642
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,36958,0.0151274064225616,0.00451025696797916,0.00628730276532244,0.0239675100798008,0.00079877998128829
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,37220,0.0210520617025008,0.00627867162277287,0.00874586532186598,0.0333582580831356,0.000801777004060185
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,39557,0.015600504274578,0.00465546197579011,0.00647579880202941,0.0247252097471266,0.00080707013988431
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39401,0.0135792660761453,0.00405308598813007,0.00563521753941039,0.0215233146128803,0.000809009638404881
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37267,-0.00942944841016404,0.00281949276045207,-0.0149556542206501,-0.00390324259967799,0.000826935039198235
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37005,0.0200036254549795,0.00598876448195547,0.00826564707034682,0.0317416038396123,0.000839533946975816
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,39836,-0.0174981557431403,0.00524317196999871,-0.0277747728043378,-0.00722153868194284,0.00084782808912388
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36880,0.0228025210611279,0.00684296244014716,0.00939031467843948,0.0362147274438163,0.000863840841793103
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37005,0.0108960570647263,0.0032763419856997,0.00447442677275493,0.0173176873566977,0.000884454606408658
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,39401,0.0132831612382182,0.00399858696681668,0.00544593078325752,0.0211203916931789,0.000895924618690532
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,39836,0.00773516618533914,0.00233848266222856,0.00315174016737116,0.0123185922033071,0.000942492080391664
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37005,0.0103266484742903,0.00312361854569877,0.00420435612472067,0.0164489408238598,0.000948953650203695
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39557,0.0168636239259018,0.00510726334856205,0.00685338776272022,0.0268738600890834,0.000962500223905013
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,36877,0.0238342838712747,0.00722555442606448,0.00967219719618831,0.0379963705463611,0.000974256161874812
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37132,0.00810369636421625,0.00245718120019999,0.00328762121182426,0.0129197715166082,0.00097644544171311
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39401,0.0140680508692726,0.00427603926458267,0.00568701391069051,0.0224490878278546,0.001004202111337
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36880,0.0147299000697504,0.00447856810427542,0.00595190658537059,0.0235078935541302,0.00100819661529588
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39557,0.0298879031742865,0.00909203060726685,0.0120675231840435,0.0477082831645296,0.00101388227766122
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,37244,0.0202581637924614,0.00616769262281552,0.00816948625174303,0.0323468413331798,0.0010240367749331
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,39673,0.0188151276769002,0.00573250406271872,0.00757941971397155,0.0300508356398289,0.001032300278755
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36880,0.0146407577248949,0.00446178694182711,0.00589565531891378,0.023385860130876,0.00103577247306818
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36877,0.00909838100193893,0.00277426403906136,0.00366082348537866,0.0145359385184992,0.0010424006526912
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39266,0.0138502980555359,0.00422445884495495,0.0055703587194242,0.0221302373916476,0.00104555720494089
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,39673,0.0189850662233704,0.00579165332244889,0.00763342571137062,0.0303367067353703,0.00104769273782609
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39065,0.0136659813489023,0.00417252038398281,0.00548784139629598,0.0218441213015086,0.00105810601294391
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36959,0.0153321213133321,0.00468156023257311,0.00615626325748877,0.0245079793691753,0.00105935385740268
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36862,0.011314192860395,0.00345703292736594,0.00453840832275771,0.0180899773980322,0.00106763960240097
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39646,0.024697202891542,0.00754666698959009,0.00990573559194538,0.0394886701911385,0.00106793074732486
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39721,0.0118638110660671,0.00363048020822564,0.00474806985794483,0.0189795522741893,0.00108603916922782
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39266,0.0191930217834299,0.00587557751782307,0.00767688984849665,0.0307091537183631,0.00109094502352451
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39521,0.0212854945136517,0.00651628718882756,0.00851357162354973,0.0340574174037538,0.00109117468058251
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39860,0.00873150850254078,0.00267489844721763,0.00348870754599422,0.0139743094590873,0.00109988887560904
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,36896,0.00857452452009906,0.00263153960487878,0.00341670689453666,0.0137323421456615,0.00112341868811963
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,36855,0.0114069981330342,0.00350206718028633,0.00454294645967302,0.0182710498063954,0.00112798361867409
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36855,0.0145230322137101,0.00446150328613055,0.00577848577289425,0.023267578654526,0.00113607291486819
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,37268,0.00851267338315949,0.00261746051515336,0.0033824507734589,0.0136428959928601,0.00114772522024142
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,39162,0.0220815535880761,0.00679212198851077,0.00876899449059499,0.0353941126855572,0.00115226799691356
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39288,0.013987809015395,0.0043044884913949,0.00555101157226102,0.022424606458529,0.00115820306037261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39302,0.00783897242154371,0.00241570164623476,0.00310419719492358,0.0125737476481638,0.0011769709744502
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36855,0.0162393401014586,0.00500814552931464,0.00642337486400188,0.0260553053389153,0.00118749206986821
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37215,0.0254502037402592,0.00785161438184424,0.0100610395518445,0.0408393679286739,0.00119236739784112
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39594,0.00988993552588119,0.00305456993005581,0.00390297846297181,0.0158768925887906,0.00120725691394273
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39302,0.0110407228713147,0.00341303589953691,0.00435117250822239,0.0177302732344071,0.00121954756913483
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37005,0.0206485012871904,0.00639424514482844,0.0081157808033267,0.0331812217710542,0.00124427999543903
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,37244,0.0191608507822968,0.00593868251383589,0.00752103305517843,0.0308006685094151,0.00125638348757821
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36880,-0.0170895083224489,0.00530498547342028,-0.0274872798503527,-0.00669173679454516,0.00127877109584915
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,39668,0.0117853273459585,0.00366417773245015,0.00460353899035625,0.0189671157015608,0.00130087537969768
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,39680,0.00999134087372774,0.00310677908569887,0.00390205386575795,0.0160806278816975,0.00130260952804848
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36855,-0.0216573789838105,0.0067341625871229,-0.0348563376545714,-0.00845842031304961,0.00130287906490254
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,39634,0.0286285019788311,0.00890253775155551,0.0111795279857823,0.0460774759718799,0.00130357822469091
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37215,0.0144993663063261,0.00451126817892996,0.00565728067562336,0.0233414519370288,0.00131195422343257
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37196,0.0161038269980248,0.00501082320178247,0.00628261352253118,0.0259250404735184,0.0013129848028344
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36896,0.0194506498206385,0.00606908654536725,0.00755524019171872,0.0313460594495583,0.00135447652565844
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37215,0.0123095754761674,0.00384313947212147,0.0047770221108093,0.0198421288415255,0.00136323045938094
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36896,0.00930600021889151,0.0029061845515154,0.00360987849792134,0.0150021219398617,0.00136739747172039
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37005,0.00954065314108989,0.00298704489070487,0.00368604515530834,0.0153952611268714,0.00140641900060116
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39860,0.0113714719187989,0.00356579538992094,0.00438251295455386,0.0183604308830439,0.00143020042867321
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,39865,0.0141204740646527,0.00443234830114017,0.005433071394418,0.0228078767348875,0.00144642724159898
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37203,0.0137166880750347,0.00430608041126803,0.00527677046894934,0.02215660568112,0.00144875058252508
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,38653,0.0136018141229074,0.00427071324018383,0.00523121617214711,0.0219724120736677,0.00145102043382234
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,36896,0.0116119265551301,0.00364844751562568,0.0044609694245038,0.0187628836857565,0.00146249482868138
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36795,0.0158135464610426,0.0049730463260684,0.00606637566194851,0.0255607172601366,0.00147698248194621
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,37203,0.0137592195502348,0.0043304135883764,0.00527160891701705,0.0222468301834525,0.00148968697549932
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,39680,0.0211169795345538,0.00666363254007374,0.00805625975600924,0.0341776993130983,0.00153261284992776
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,36855,0.0169749022408189,0.00536034964140773,0.00646861694365974,0.027481187537978,0.00154507656878479
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,39673,0.0227813982659673,0.00720869243191151,0.00865236109942077,0.0369104354325139,0.00157921377690116
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,37083,0.0170246382825787,0.00539500457765912,0.0064504293103668,0.0275988472547906,0.00160511043524108
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,36827,0.0121851747895074,0.00386313768149381,0.00461342493377957,0.0197569246452353,0.00161296771269223
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,39817,0.0171378184191143,0.00543540017843162,0.00648443406938831,0.0277912027688403,0.00161901005519347
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,39401,0.0319209382363722,0.0101371510260458,0.0120521222253224,0.0517897542474219,0.00164192997413559
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,39860,0.0248616201791211,0.00790409734493108,0.00936958938305618,0.040353650975186,0.0016615840818639
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,39777,0.0318738607278529,0.0101364966048289,0.0120063273823882,0.0517413940733176,0.00166696653479029
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,39288,0.0206687634343756,0.00658142993630487,0.00776916075921808,0.0335683661095332,0.00168997215247821
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,37220,0.0268443970080347,0.00856759466513231,0.0100519114643753,0.043636882551694,0.00173257247162629
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39302,0.0113066909931773,0.00360988014798326,0.00423132590313013,0.0183820560832245,0.00173854577121087
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,37203,0.0117834050874351,0.0037633297208832,0.00440727883450398,0.0191595313403661,0.00174522095593291
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,39673,0.0147718960083744,0.00471982906304396,0.00552103104480822,0.0240227609719405,0.00175272016076109
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,37220,0.0242018853313136,0.00773467151649183,0.0090419291589896,0.0393618415036376,0.00175772101904458
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,39656,0.0142180701368893,0.00455087862212215,0.00529834803752992,0.0231377922362487,0.00178583126404137
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36896,0.0222902326755655,0.00713987429978365,0.00829607904798951,0.0362843863031414,0.00180058704173954
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36896,0.0179322881783834,0.00574869157529686,0.00666485269080154,0.0291997236659652,0.0018163419086406
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36896,0.0128030399005047,0.00411956769276018,0.00472868722269472,0.0208773925783146,0.00188852583998426
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,37072,0.00944337212455206,0.00303919123673323,0.00348655730055494,0.0154001869485492,0.00189269668448743
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39594,-0.0232298435360719,0.00748615316520363,-0.037902703739871,-0.00855698333227278,0.00191882164018253
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39401,0.00788654935163004,0.00254556333302631,0.00289724521889848,0.0128758534843616,0.00195076927456268
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36682,0.00902640115976457,0.00291704400498811,0.00330899490998786,0.0147438074095413,0.00197658607876206
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37277,0.00680712089361529,0.0022010723203669,0.00249301914569616,0.0111212226415344,0.00198792824105715
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,39781,-0.0147467810626518,0.00476880259448401,-0.0240936341478404,-0.00539992797746314,0.00198925470003996
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36896,0.023693071143557,0.00766850451003114,0.00866280230389598,0.038723339983218,0.00200807579610018
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,39590,0.00799216238674121,0.00258690699295088,0.00292182468055748,0.0130625000929249,0.00200866013500339
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,39836,0.00561605288589442,0.00182030681193592,0.00204825153450001,0.00918385423728882,0.00203746896044246
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,36880,0.00832201988812362,0.00269881708307438,0.00303233840529785,0.0136117013709494,0.0020495366224681
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37005,-0.00840792042889913,0.00273078979166418,-0.0137602684205609,-0.00305557243723733,0.00208171136840803
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39557,0.0191870047540795,0.00623409222791847,0.00696818398735926,0.0314058255207997,0.00208926163172708
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,39641,-0.0072199851586717,0.00234618007024344,-0.0118184980963488,-0.00262147222099456,0.00209217341048196
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39302,0.0184764542503302,0.00601080871866284,0.00669526916175098,0.0302576393389093,0.00211668796602247
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39401,0.00977136304187185,0.00318050629221795,0.00353757070912467,0.016005155374619,0.00212807312675257
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39302,0.0231556417606087,0.00753866386718501,0.0083798605809261,0.0379314229402913,0.00213296283543299
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36958,0.0205002217362535,0.00667433053893966,0.00741853387993173,0.0335819095925752,0.00213421157179226
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39668,0.00638234774381345,0.00208211846675327,0.00230139554897704,0.0104632999386499,0.00217807887916626
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36277,0.0140216255199455,0.00458545818139018,0.00503412748442077,0.0230091235554703,0.00223408339559751
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37244,0.0184345814896221,0.0060396504290783,0.00659686664862861,0.0302722963306156,0.00227570830162618
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,37220,0.0292778028374575,0.00960098594965229,0.010459870376139,0.048095735298776,0.00229703514516535
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39288,0.0110128026313834,0.00361149694602359,0.00393426861717719,0.0180913366455897,0.00229707950493371
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36880,0.0111726648876586,0.00366637724675512,0.00398656548401854,0.0183587642912986,0.00231345943882771
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,39775,-0.0110670911871482,0.00363418553283174,-0.0181900948314984,-0.00394408754279798,0.00232848385785524
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,39207,0.0175131879077305,0.00575617602373887,0.00623108290120232,0.0287952929142587,0.00235015254577108
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39288,0.0138228576549664,0.00454682011904923,0.00491109022162988,0.0227346250883029,0.00236883935717053
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37215,0.0134165550527155,0.00441830332716537,0.00475668053147139,0.0220764295739596,0.00239735749483997
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37203,0.0111723126674677,0.0036846361118732,0.00395042588819619,0.0183941994467391,0.00243297036212634
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,36958,0.0186063895714293,0.00614059275735087,0.00657082776702159,0.030641951375837,0.00244978796519248
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,36827,0.011465448150941,0.00378572106205694,0.00404543486930944,0.0188854614325726,0.00246170129231986
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39721,0.0165748523823341,0.00547600849029663,0.00584187574135265,0.0273078290233155,0.00247543519131917
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,39302,0.0174382096573001,0.00576649535787847,0.00613587875585834,0.0287405405587419,0.00249819234953036
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39282,0.0158357051080487,0.00523857419089682,0.0055680996938909,0.0261033105222064,0.00250773104943903
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,37005,0.0145099615683732,0.0048052763816209,0.0050916198603962,0.0239283032763501,0.00253603381232379
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39594,0.0114893738606078,0.00380960433710775,0.00402254935987661,0.018956198361339,0.00256629339005701
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39743,0.0109164949655853,0.00364178658035452,0.00377859326809048,0.0180543966630802,0.00272565915916749
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36877,-0.0162007905848087,0.00540731547673936,-0.0267991289192178,-0.00560245225039952,0.0027398300291226
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,36855,0.0112739928873231,0.00377395375070104,0.00387704353594907,0.0186709422386971,0.00281963895189304
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39594,0.0152754151620869,0.00512375469031632,0.00523285596906694,0.0253179743551069,0.00287473052519055
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39673,0.0266351766850942,0.00895001507247195,0.00909314714304922,0.0441772062271393,0.00292483912750045
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39668,0.0116440584197647,0.00391382347061779,0.00397296441735379,0.0193151524221755,0.00293325484249698
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,37215,0.0291599124985529,0.00981160827128936,0.00992916028682577,0.04839066471028,0.00296412511248921
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37215,0.0202835618605255,0.00682702892422508,0.00690258516904437,0.0336645385520067,0.0029729522636073
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37244,0.0165813666631954,0.00558115681596084,0.00564229930391211,0.0275204340224786,0.00297402504797096
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36855,0.0122873508272686,0.00413690263754884,0.00417902165767288,0.0203956799968643,0.00298168082838144
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,36896,0.0070950457350162,0.00239260150360862,0.00240554678794331,0.0117845446820891,0.0030282682458399
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36855,0.0112710042971231,0.00380082569640257,0.00382138593217402,0.0187206226620721,0.00302829669351421
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,36877,0.00713492130796671,0.00240780475795758,0.00241562398236985,0.0118542186335636,0.00304962533880589
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36855,0.0116555033983956,0.00393391307845115,0.00394503376463137,0.0193659730321599,0.00305380150662961
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39302,0.00918612732083233,0.00310353693049153,0.00310319493706893,0.0152690597045957,0.00308216511184082
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39302,0.0079532791028515,0.00268856919011187,0.00268368349023223,0.0132228747154708,0.00309927583848454
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36896,0.00591952300644911,0.00200149277316976,0.00199659717103638,0.00984244884186184,0.00310646736543306
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36896,0.0109669481070283,0.0037136860931754,0.00368812336440456,0.0182457728496521,0.00315144411516893
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39770,0.00777383816615171,0.00263476600312933,0.00260969680001823,0.0129379795322852,0.00317737528489882
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39845,0.0136701751577616,0.00463982116730003,0.00457612566985358,0.0227642246456697,0.00322093477498898
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,36941,0.00946941721200366,0.00321945890171042,0.00315927776465123,0.0157795566593561,0.00327403112188764
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,39269,-0.0162136058817452,0.00551833989178076,-0.0270295520696355,-0.00539765969385495,0.0033068665425041
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39288,0.0154755665208037,0.00526814074957119,0.00515001065164414,0.0258011223899632,0.00331277732786213
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,36907,0.0114217976881203,0.00389930133269238,0.0037791670760432,0.0190644283001973,0.00340433914262903
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36855,0.0176692455817391,0.00603724740957891,0.00583624065896449,0.0295022505045138,0.00343166490404395
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37203,0.0136982051835092,0.00468094204282981,0.00452355877956276,0.0228728515874556,0.00343512476893122
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,39836,-0.00988420151445563,0.0033786190191163,-0.0165062947919236,-0.00326210823698769,0.00344370122567966
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36775,0.00657348162886117,0.00224920713168295,0.0021650356507626,0.0109819276069597,0.0034774948978576
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37244,0.0234412990455971,0.00802644104503721,0.00770947459732418,0.03917312349387,0.00350042574967497
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36896,0.00769600750310072,0.00264433573966666,0.00251310945335407,0.0128789055528474,0.00361606679366208
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36880,0.0155751235021333,0.00535511053113484,0.00507910686110899,0.0260711401431575,0.00363827806125493
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37267,0.00667041622754664,0.00229541215610832,0.00217140840157434,0.0111694240535189,0.00366706750584666
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,37137,0.02423784698095,0.00835819639155039,0.00785578205351119,0.0406199119083887,0.0037390620020286
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,36855,-0.0132757913537468,0.00458052445928336,-0.0222536192939422,-0.00429796341355147,0.00375803864250853
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39783,0.026500800924852,0.00916713185106587,0.00853322249676291,0.0444683793529411,0.00384721096540182
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,39817,0.00888959376370796,0.00307544344665814,0.002861724608258,0.0149174629191579,0.00385138378839819
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39817,0.024706428556188,0.00854752523821933,0.00795327908927813,0.0414595780230979,0.00385175802662759
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37215,0.037457929104377,0.0129702234151776,0.0120362912106288,0.0628795669981251,0.00388329778629872
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36795,0.00673477103873499,0.00233210688558651,0.00216384154298542,0.0113057005344846,0.00388529903852568
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,37244,0.0115144374351463,0.00398774976888251,0.00369844788813654,0.019330426982156,0.00388997399207488
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39653,0.0157389858852839,0.00546520851797648,0.00502717719005004,0.0264507945805178,0.00398398030215505
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36780,0.0158956143133873,0.0055234396461924,0.00506967260685015,0.0267215560199244,0.00401055542028715
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37203,0.00865533456402554,0.00301028807422043,0.0027551699385535,0.0145554991894976,0.00404344725401451
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37220,0.0255779798998462,0.00890427946069639,0.00812559215688132,0.0430303676428112,0.00407815909686003
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37277,0.0134927269014561,0.00471069317120171,0.00425976828590076,0.0227256855170114,0.00418611707512538
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37098,0.0140598388861376,0.00491385353623427,0.00442868595511844,0.0236909918171568,0.00422614718555148
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36896,0.00705059283369372,0.00246836816252409,0.0022125912351465,0.0118885944322409,0.00429181931113027
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37268,0.0267471858379519,0.00936499518160536,0.0083917952820054,0.0451025763938984,0.00429564571770533
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,39302,0.0186059158647015,0.00652882349587815,0.00580942181278032,0.0314024099166227,0.00438030515667913
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,39228,0.00765004649207421,0.00268685709367852,0.00238380658846432,0.0129162863956841,0.00441627115053697
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,37268,0.00661634298984221,0.00232624882820992,0.00205689528655077,0.0111757906931336,0.00445889094728027
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39721,0.0249768861499684,0.008808584496486,0.00771206053685587,0.042241711763081,0.00458095491139923
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39029,0.00950405118694413,0.00335198220381791,0.00293416606746104,0.0160739363064272,0.00458356934469945
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,37147,0.0181958118453965,0.00641953935872679,0.00561351470229195,0.030778108988501,0.00459750382483395
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36855,0.0127381867652476,0.00450630056517602,0.00390583765750256,0.0215705358729926,0.00470947849852888
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39680,0.0218116216185481,0.00772374591884974,0.00667307961760263,0.0369501636194936,0.00474922132668163
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,36983,-0.00804462366299887,0.00284878617482945,-0.0136282445656646,-0.00246100276033315,0.00475179822383769
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36855,-0.0111439101660901,0.00394739399245594,-0.0188808023913037,-0.00340701794087644,0.00476331993310583
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,39302,0.0139864071451174,0.00495772653491499,0.00426926313668402,0.0237035511535508,0.00479153813308212
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39721,0.0196558501980185,0.00697878011618803,0.00597744117028993,0.033334259225747,0.00486074821381157
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39673,0.0229520470943017,0.00818215490846225,0.00691502347371569,0.0389890707148877,0.00503569419317132
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39302,0.0160877237348543,0.00573677254893632,0.00484364953893909,0.0273317979307695,0.00504864031742445
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,39836,0.0113988004822026,0.00407116458801007,0.00341931788970284,0.0193782830747023,0.00511818590550577
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37285,0.00424005369117492,0.00151584829670813,0.00126899102962698,0.00721111635272287,0.00516291076404905
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36880,0.0181950666038596,0.00651207282282978,0.00543140387111327,0.030958729336606,0.00521282724506203
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,36958,0.00924306643117838,0.00330980754463022,0.00275584364370314,0.0157302892186536,0.00523573428963319
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39836,0.00880518914314097,0.00315636934807281,0.00261870522091827,0.0149916730653637,0.00528263299438245
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,39817,0.0163779333880145,0.00587639069992911,0.0048602076161534,0.0278956591598755,0.00532492522095422
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37005,0.0130925958031209,0.00470480985754797,0.00387116848232687,0.0223140231239149,0.00539671071736514
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37220,0.0147728025895879,0.00531392189433817,0.00435751567668504,0.0251880895024907,0.00544317865059408
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39680,0.0140346511574836,0.00504919663982835,0.00413822574342006,0.0239310765715472,0.00544933272437884
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,36958,-0.0101424201093947,0.00366814340254684,-0.0173319811783865,-0.0029528590404029,0.00570022676383216
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,37267,0.0124394144170776,0.00450085258660991,0.00361774334732219,0.021261085486833,0.00572121514393715
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39685,0.014007235819047,0.00507438759731701,0.00406143612830568,0.0239530355097884,0.00578006944407761
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,36855,0.0196218441382326,0.00711133221138215,0.00568363300392363,0.0335600552725416,0.00580177635785587
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39673,-0.00949273212842501,0.00344675808373149,-0.0162483779725387,-0.0027370862843113,0.00589202035568774
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36880,0.0076295439797259,0.00278238019070649,0.00217607880594117,0.0130830091535106,0.00611325325520785
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,39792,0.00573947962817963,0.00209540065361172,0.00163249434710066,0.00984646490925859,0.00616790236855347
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,39401,0.0108969032067043,0.00397893155788053,0.00309819735325846,0.0186956090601501,0.00617621826088072
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36840,0.0097297548097907,0.0035568955094475,0.0027582396112736,0.0167012700083078,0.00623772707885542
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37202,0.00892099179322661,0.00327011377933114,0.00251156878573756,0.0153304148007156,0.00637958135934692
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36855,0.0170807115467514,0.00626188702084776,0.00480741298588978,0.029354010107613,0.0063858220062064
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36880,0.00953817409974855,0.00350736700617455,0.00266373476764644,0.0164126134318507,0.00654736215905129
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39743,0.00676246276939835,0.00248695776789863,0.00188802554431704,0.0116368999944797,0.00655169217275158
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39721,0.00572890410154253,0.00211794251677425,0.001577736768665,0.00988007143442006,0.00683899905046783
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39675,0.0123959511471648,0.00458958494626068,0.00340036465249388,0.0213915376418357,0.00692284439655889
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,39373,0.0101476366779129,0.00376386080148057,0.00277046950701101,0.0175248038488149,0.00702383636593531
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,39743,0.00936095527958636,0.0034792013720632,0.00254172059034249,0.0161801899688302,0.00714095726066034
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,37217,0.0230320934911994,0.0085643927139497,0.00624588377185795,0.0398183032105408,0.00716941571593027
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39743,0.0248507114581529,0.00924309647660005,0.00673424236401679,0.042967180552289,0.00718336599832122
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39288,0.00810313500896585,0.0030196225251893,0.00218467485959483,0.0140215951583369,0.00729352868701903
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,37277,0.0172746124142671,0.00643751009956814,0.00465709261911355,0.0298921322094207,0.00729604529327222
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,37220,0.0120982289559972,0.00451023884290445,0.00325816082390447,0.0209382970880899,0.00731876511909131
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39721,0.0199677763107674,0.00744564618498492,0.00537430978819699,0.0345612428333379,0.00733017890323742
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36855,0.00618048261919739,0.00230640508671851,0.00165992864922911,0.0107010365891657,0.00737801750928489
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37268,0.0174588858702356,0.00651844194106861,0.00468273966574117,0.0302350320747301,0.00740687042974982
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,39860,0.00556423409042462,0.00207791418501719,0.00149152228779093,0.00963694589305831,0.00741835856783957
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39269,0.0121491617497592,0.00454209488861248,0.00324665576807872,0.0210516677314396,0.00748544380191229
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,36880,0.00664915253918188,0.00248695134949187,0.0017747278941778,0.0115235771841859,0.00751319661782397
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,37267,0.021402475348536,0.00800605220265704,0.00571061303132821,0.0370943376657438,0.00752029155378917
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36855,0.0120098987868433,0.00450068867349311,0.00318854898679682,0.0208312485868898,0.00762948894295419
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37268,0.0194427507204864,0.00728678422474172,0.00516065363999267,0.0337248478009802,0.00763457907478742
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39179,-0.0237082034948538,0.00888708969667578,-0.0411268993003383,-0.00628950768936926,0.00764498287489412
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39680,0.0155996020099488,0.00585614055793393,0.00412156651639831,0.0270776375034993,0.00773411911571776
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,36855,0.0158785442321516,0.00598042633567292,0.00415690861423264,0.0276001798500705,0.0079384940175551
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,36877,0.00996203958815014,0.0037532528420347,0.00260566401776212,0.0173184151585382,0.00795835457065117
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,39594,0.0439320903965525,0.0165643387409512,0.0114659864642881,0.0763981943288168,0.00800472052131905
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37005,0.0174810566998718,0.00659240833613579,0.00455993636104562,0.0304021770386979,0.00801849256831287
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36896,0.0151863250384295,0.00573484171300978,0.00394603528093032,0.0264266147959287,0.00810476019893085
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39780,-0.00539057252615531,0.0020363726497651,-0.00938186291969491,-0.00139928213261571,0.0081254596176014
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,39836,0.00388569724531037,0.00147067714840609,0.00100317003443443,0.00676822445618631,0.00824705130318362
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,37215,0.00715318737894601,0.00271032955666512,0.00184094144788237,0.0124654333100096,0.00831906865508105
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36827,0.0178440792690976,0.00676170461034071,0.00459113823282984,0.0310970203053654,0.00832525458479319
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37268,0.0177440829074277,0.00673159622674737,0.00455015430300281,0.0309380115118525,0.0084001213321793
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39673,0.00866369333895367,0.00329299322804177,0.0022094266119918,0.0151179600659155,0.0085229680369923
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36958,0.00493943752348884,0.00187854772760011,0.00125748397739262,0.00862139106958506,0.0085637747050182
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39721,0.00630783549943689,0.00239994214250863,0.00160394890011997,0.0110117220987538,0.00858883607591587
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,37005,0.00668362809552678,0.00254292346102586,0.00169949811191608,0.0116677580791375,0.00859063609089397
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,37174,0.0224983639762685,0.00856525426468598,0.00571046561748402,0.0392862623350531,0.00863157304918795
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37244,0.0101219997627874,0.00385581784474683,0.00256459678708362,0.0176794027384912,0.0086715893012256
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,36877,0.0175113677847303,0.00668619285960158,0.00440642977991125,0.0306163057895494,0.00882813212038277
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37244,0.00648562562598483,0.00247764824993554,0.00162943505611118,0.0113418161958585,0.00886361788561732
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39743,0.0205071182175543,0.00783792929373855,0.00514477680182674,0.0358694596332819,0.00889478321947374
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39557,0.00675817620665545,0.00258346534470457,0.0016945841310345,0.0118217682822764,0.00890687905087838
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,39594,0.00438434763104614,0.00167811473791732,0.0010952427447282,0.00767345251736408,0.00899253516487499
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39599,0.00620118749438042,0.00237608057325773,0.00154406957079528,0.0108583054179656,0.00906706309386103
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39302,0.0261137534719236,0.0100103190652737,0.00649352810398716,0.0457339788398601,0.00909788497114074
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,37005,-0.00783703822560836,0.00300694039062275,-0.013730641391229,-0.00194343505998776,0.00916251104545954
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37244,0.0155759715617621,0.00598354669209427,0.00384822004525732,0.0273037230782669,0.00924778509313245
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36855,0.0151879837745499,0.00583759912864359,0.00374628948240847,0.0266296780666913,0.0092854146253348
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39482,0.0136384061367012,0.00524392882215992,0.00336030564526781,0.0239165066281347,0.00930944844730178
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39302,0.0326746427259443,0.0125633451402642,0.00805048625102653,0.0572987992008621,0.00930975757282359
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36877,0.0135725663037414,0.00522081351982516,0.00333977180488408,0.0238053608025987,0.00934097233763913
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36958,0.0241816505119697,0.00931786008483593,0.0059186447456913,0.0424446562782482,0.0094643079666206
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36896,0.0252590740737972,0.00974797960003105,0.00615303405773633,0.044365114089858,0.00957453417080422
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37277,0.0140548235111143,0.00543159609911043,0.00340889515685787,0.0247007518653708,0.00967499392609921
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,39288,0.0281573023072693,0.0108887516096047,0.00681534915244405,0.0494992554620946,0.00972138231915971
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37005,0.0106377998912392,0.00411605539171918,0.00257033132346957,0.0187052684590087,0.00976370664166132
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,39721,0.0161404864210407,0.00627075359062771,0.00384980938341041,0.028431163458671,0.0100640271080492
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,36896,0.0093102252609347,0.00362625423252112,0.00220276696519331,0.0164176835566761,0.0102560139102739
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37244,0.00813984271747938,0.00317142307313256,0.00192385349413956,0.0143558319408192,0.0102802375197072
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,39673,0.0070936624732593,0.00276794783087595,0.00166848472474244,0.0125188402217762,0.0103927252517593
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,39401,0.0136691909846584,0.00534558124266016,0.00319185174904448,0.0241465302202723,0.0105642689096848
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36855,0.00850245470048182,0.00332855410345332,0.00197848865771331,0.0150264207432503,0.010648434661803
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCN,Decorin,39401,0.00492605766723034,0.00192961225146858,0.00114401765435192,0.00870809768010876,0.0106932729291327
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37203,0.00992705398029664,0.00388928207146555,0.00230406112022416,0.0175500468403691,0.0107090019935581
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36795,0.0197084674784566,0.00772852485397085,0.00456055876467376,0.0348563761922395,0.0107808032322357
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36827,0.0136746148553161,0.00536693778566771,0.00315541679540736,0.0241938129152248,0.0108476639989272
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,37204,0.0190923368265126,0.00753980567363677,0.00431431770618457,0.0338703559468407,0.0113461263220421
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36880,0.0105075955751957,0.00415029124615632,0.00237302473272935,0.0186421664176621,0.0113604016919561
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,36896,0.0264332432434475,0.010441203714425,0.00596848396317448,0.0468980025237204,0.0113650867219021
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39860,0.00508064360309717,0.00201127908354799,0.00113853659934311,0.00902275060685123,0.0115440229436991
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36880,-0.00583013935487509,0.00230905949965414,-0.0103558959741972,-0.00130438273555298,0.0115849694221799
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,37083,0.0246225234522979,0.00979587155989824,0.00542261519489737,0.0438224317096985,0.01196368755038
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,35499,0.0225470321032357,0.00897365651178232,0.00495866534014237,0.0401353988663291,0.0119985938685174
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36855,0.0150153546353912,0.00598038692278153,0.00329379626673938,0.026736913004043,0.0120589792309911
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36795,0.0142904891165786,0.00569601889116559,0.00312629208989406,0.0254546861432632,0.0121244272507062
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39743,-0.00627709842717659,0.00250513525863873,-0.0111871635341085,-0.00136703332024467,0.0122311107100343
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,37215,0.0127424339634764,0.00508760024336712,0.00277073748647689,0.022714130440476,0.0122706069547511
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36855,0.00812771640206751,0.00324860507248635,0.00176045045999428,0.0144949823441408,0.0123647375067807
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,37277,0.0204016933976626,0.00815519529307324,0.0044175106232391,0.0363858761720862,0.0123723536838225
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39557,-0.0245248705192607,0.00980710486805821,-0.0437467960606548,-0.00530294497786664,0.0124040550806335
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,39756,-0.00614715210812083,0.00246054121965959,-0.0109698128986536,-0.00132449131758804,0.012489330212938
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36880,0.00723053952229897,0.0029047250432327,0.00153727843756287,0.0129238006070351,0.0128142661238898
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36827,0.016981979582957,0.00684503397983428,0.00356571298248179,0.0303982461834322,0.0131169730237606
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37005,0.016936028253766,0.00683665278407238,0.00353618879698415,0.0303358677105479,0.0132527681939548
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36896,0.00976908393986065,0.00394806648597397,0.00203087362735168,0.0175072942523696,0.013358759298236
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36896,0.0100222563084364,0.00405060511735928,0.00208307027841221,0.0179614423384606,0.0133638255349185
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37005,0.0167394635926978,0.00676857562720945,0.00347305536336724,0.0300058718220283,0.0134066637778545
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,39288,0.0184058047947099,0.0074596816567086,0.00378482874756101,0.0330267808418587,0.013621686998982
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39673,0.00964331252531305,0.00390839796604909,0.00198285251185683,0.0173037725387693,0.0136229488462604
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36896,0.00776635122594529,0.00314830507948412,0.00159567327015642,0.0139370291817342,0.0136440520733513
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,39726,0.00854142255813266,0.00346422783476607,0.00175153600199117,0.0153313091142742,0.0136886544661213
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37005,0.00751390296071819,0.00304848271372535,0.00153887684181651,0.0134889290796199,0.0137216310278172
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,37244,-0.00771083995977364,0.00312850388729616,-0.0138427075788741,-0.00157897234067316,0.0137250660147111
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,39672,0.00678610380880025,0.00275977240133405,0.00137694990218552,0.012195257715415,0.0139455787233478
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36827,0.0163902490265719,0.00667383088379452,0.0033095404943346,0.0294709575588091,0.0140663188865393
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37005,0.0153164164478079,0.00623674830282074,0.0030923897742792,0.0275404431213365,0.0140686661073578
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36827,-0.0101371591030612,0.00413891567671531,-0.0182494338294232,-0.00202488437669914,0.0143293130278156
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39826,0.026624242495069,0.0109103498351411,0.00523995681819247,0.0480085281719455,0.0146869264887356
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39401,0.010511641991731,0.00431193724048113,0.00206024500038799,0.018963038983074,0.0147880645678091
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39673,0.0114418177622557,0.00469744328214971,0.00223482892924228,0.0206488065952691,0.0148717428094273
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37244,0.00594530014091015,0.00244102624233162,0.00116088870594018,0.0107297115758801,0.0148811444143563
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36877,0.021742516436995,0.00893916801246063,0.00422174713257214,0.0392632857414178,0.0150176898268023
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,37090,0.0231446440345647,0.00954247924868752,0.00444138470713717,0.0418479033619923,0.0153034277656761
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39668,0.00517938981148829,0.00213756975779382,0.000989753086212408,0.00936902653676417,0.0154029285058666
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,36958,-0.00704724676148134,0.00291353756204229,-0.0127577803830842,-0.00133671313987845,0.0155856025788334
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37268,0.00644201866496022,0.00266387673518332,0.00122082026400091,0.0116632170659195,0.0156070051440041
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39790,0.0150856926431929,0.00626457506721946,0.00280712551144279,0.0273642597749431,0.0160472901998151
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36815,0.00738326598188208,0.00306756776692462,0.00137083315870982,0.0133956988050543,0.0161033796039074
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37268,0.00571295837150039,0.00237414193659618,0.00105964017577188,0.0103662765672289,0.0161273403809448
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,39673,0.0136793255927447,0.00569622783144889,0.00251471904310492,0.0248439321423846,0.0163407742705541
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39302,0.0157199799168035,0.00655097656592623,0.00288006584758807,0.0285598939860189,0.0164230116085391
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37220,0.0103029731901598,0.00429594525659696,0.00188292048722974,0.0187230258930898,0.0164849173232528
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37277,0.00547878547640615,0.00228500174436417,0.00100018205745238,0.00995738889535993,0.0165112274257162
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,39673,0.0126016621706328,0.00525805575213946,0.00229587289643944,0.0229074514448261,0.0165577492937865
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39860,0.0152638355714732,0.00637234699998405,0.00277403545150446,0.0277536356914419,0.016617108261506
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37268,0.0104239771309525,0.0043561238155269,0.00188597445251973,0.0189619798093852,0.0167272889751285
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39302,0.0136260270533805,0.00569617763547234,0.00246151888785467,0.0247905352189062,0.0167625541297945
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36877,0.0116066023931402,0.00485401273477413,0.00209273743298288,0.0211204673532975,0.0168104661734734
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,37277,0.00507405269372791,0.00212282909618419,0.000913307665206898,0.00923479772224893,0.0168514721384884
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36880,-0.0092349871288211,0.00386444834832519,-0.0168093058915385,-0.00166066836610373,0.0168749124749106
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39266,0.00882378936721391,0.00371717438915859,0.00153812756446309,0.0161094511699647,0.0176187744857156
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,37005,0.00890909589701046,0.00375340069753465,0.00155243052984255,0.0162657612641784,0.0176296046584885
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36795,0.00901694304883206,0.00380149223468826,0.00156601826884307,0.016467867828821,0.0177091155519152
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39517,0.0058286133064742,0.00245817235533234,0.00101059549002281,0.0106466311229256,0.0177464666373046
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,36896,0.00881581184893571,0.00372317216044623,0.0015183944144611,0.0161132292834103,0.0179076144804806
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,37215,0.0175465688748357,0.00741096785269178,0.00302107188355981,0.0320720658661116,0.0179156879377388
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,37268,0.0112482284981659,0.00476339853257478,0.00191196737431933,0.0205844896220125,0.0182209268988687
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36896,0.0126183973270926,0.00534668553970712,0.00213889366926667,0.0230979009849186,0.0182875618799932
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,36704,0.00910655765357492,0.00387255255922311,0.00151635463749762,0.0166967606696522,0.0187096624557709
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36827,0.0155864901538323,0.00665111967772315,0.00255029558549497,0.0286226847221697,0.0191219346720566
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,37244,0.00625263554722796,0.00267482442559912,0.00100997967305368,0.0114952914214022,0.0194233265968329
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,39668,0.00819003344609886,0.00350833873588731,0.00131368952375974,0.015066377368438,0.0195847456678928
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39865,0.0071145781029194,0.0030505921870554,0.00113541741629082,0.013093738789548,0.0197027319687188
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39817,0.00440388150632211,0.00189058691070119,0.000698331161347778,0.00810943185129644,0.0198517449402179
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,37267,0.0119979686767794,0.00515410821950191,0.00189591656655561,0.0221000207870031,0.0199351002024997
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36896,0.00574671741544125,0.00246894578577184,0.000907583675328437,0.0105858511555541,0.0199485982675717
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,39817,0.00636820886532058,0.00273683196948081,0.0010040182051382,0.011732399525503,0.0199854792364709
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,36795,0.0122546624609617,0.00527020579530551,0.00192505910216288,0.0225842658197605,0.0200728040134052
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37215,0.00559234813394095,0.00240612240469067,0.000876348220747241,0.0103083480471347,0.0201288443345136
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39860,0.00604721656988084,0.00260696454459212,0.000937566062480294,0.0111568670772814,0.0203729377327729
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,39594,0.0195530908720601,0.00844891352288142,0.00299322036721247,0.0361129613769076,0.0206655753859492
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36795,0.00674538337134792,0.00292150748643766,0.0010192286979301,0.0124715380447657,0.0209664343510846
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,37244,0.00785651011166334,0.00340503032867656,0.00118265066745729,0.0145303695558694,0.0210519173146779
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37267,0.0168930081022651,0.00732417654072439,0.00253762208244528,0.0312483941220849,0.0210994458223298
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36827,0.0126637478425686,0.00549586631240441,0.0018918498702559,0.0234356458148812,0.0212253841544544
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37203,0.0113966941809146,0.00494673979575695,0.00170108418123098,0.0210923041805982,0.0212446793816374
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,39288,0.00624870266417549,0.002719235640453,0.000919000808887608,0.0115784045194634,0.0215772130058124
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,39156,-0.0121759005649731,0.00530317268060066,-0.0225701190189504,-0.00178168211099578,0.0216913227422428
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37244,0.0140331251578533,0.00611269326603385,0.00205224635642697,0.0260140039592796,0.0217064112066675
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37220,0.0120564344604954,0.00525198882994344,0.00176253635380629,0.0223503325671846,0.0217145169938645
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,39763,0.00700012866835746,0.00305903750080573,0.00100441516677823,0.0129958421699367,0.0221305794111696
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37215,-0.0345672914556909,0.0151215272352098,-0.0642054848367021,-0.00492909807467972,0.0222718580752533
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36795,0.0115174164908232,0.00504532060873138,0.00162858809770967,0.0214062448839367,0.0224587869946755
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,39302,0.0140317082753906,0.00615527225158612,0.00196737466228175,0.0260960418884994,0.0226435563447578
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39673,-0.0109658220399653,0.00482103547996783,-0.0204150515807023,-0.00151659249922836,0.0229445790801046
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37267,0.0271857814324698,0.0119597084199116,0.00374475292944311,0.0506268099354965,0.0230350569993789
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,36922,0.00764392761559137,0.00336676165142293,0.00104507477880243,0.0142427804523803,0.0231989629365243
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,39236,0.0138424977479339,0.00609713324851532,0.00189211658084392,0.025792878915024,0.0232014103890254
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39865,0.00671839752529028,0.00296305492891444,0.000910809864617984,0.0125259851859626,0.0233797616697976
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,37220,0.0276485721223718,0.0121999173524999,0.00373673411147203,0.0515604101332716,0.0234494493050548
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36795,0.0106535769301325,0.00470305460627016,0.00143558990184302,0.0198715639584221,0.0235140362445358
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36795,0.0119633653584329,0.00530033985528594,0.00157469924207249,0.0223520314747934,0.0240188116975047
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),37021,0.0352359765732201,0.0156169820543671,0.00462669174666057,0.0658452613997797,0.0240706744560757
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,39860,0.00574439545418026,0.0025513411700423,0.000743766760897351,0.0107450241474632,0.0243661358282903
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36880,0.0192598506190008,0.00855929825092567,0.00248362604718647,0.0360360751908151,0.0244549700682435
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,39223,0.0134521229936423,0.00598818642457053,0.00171527760148407,0.0251889683858005,0.0246897541157728
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36855,0.0124488280759069,0.00554457841750111,0.00158145437760472,0.0233162017742091,0.0247704132108316
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,39680,0.00703657622165217,0.00313590299915513,0.000890206343308116,0.0131829460999962,0.024854180199742
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,39836,0.00851434829725216,0.00380533952749005,0.00105588282337166,0.0159728137711327,0.0252691071857551
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36880,0.0115909076453373,0.00519339835964532,0.00141184686043245,0.0217699684302421,0.0256415522938685
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37203,0.00969900024412189,0.00434794882180616,0.00117702055338182,0.018220979934862,0.0257170951365862
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,39302,0.0101025395094846,0.00453498257479582,0.00121397366288478,0.0189911053560844,0.0259154839136423
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39673,0.0170853102051515,0.00767249280132281,0.0020472243145588,0.0321233960957442,0.0259728991599137
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,37203,0.0103812838377582,0.00467475687860841,0.0012187603556857,0.0195438073198307,0.0263872728466952
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,36795,0.00590270803658541,0.00266488099373261,0.000679541288869487,0.0111258747843013,0.0267775076814615
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37215,0.0155674623546304,0.00703368447907377,0.00178144077564577,0.029353483933615,0.0268956855152077
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37285,0.00365577052337512,0.00165548544451545,0.000411019052124846,0.0069005219946254,0.0272418024263529
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,39557,0.00651035238320216,0.0029489819696647,0.000730347722659341,0.012290357043745,0.0272823242694853
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39302,0.0113673397445977,0.00515532576667483,0.001262901241915,0.0214717782472803,0.0274708708516699
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,36855,0.0161061577903185,0.00734669538353664,0.00170663483858667,0.0305056807420503,0.028375548092936
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,39668,-0.00371244380537121,0.00169998851109429,-0.00704442128711602,-0.000380466323626395,0.0289912106547892
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39860,0.0135202752895181,0.00619430487436421,0.00137943773576429,0.025661112843272,0.0290728014168619
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,36896,0.00908050272246091,0.00417264293271292,0.000902122574343583,0.0172588828705782,0.0295582528179705
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36877,0.0140912967954501,0.0064824367376257,0.00138572078970373,0.0267968728011965,0.0297407181000201
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39401,0.0070721897493147,0.00325478706423118,0.000692807103421584,0.0134515723952078,0.0298060716493969
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39721,0.00875989622292954,0.00403253504245226,0.000856127539723105,0.016663664906136,0.0298474225103179
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39675,0.0180563399806703,0.00831396400237016,0.00176097053602484,0.0343517094253159,0.0298849002858458
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,37203,-0.0125824758588572,0.00582152270190597,-0.0239926603545929,-0.00117229136312154,0.0306843479777246
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39288,0.00585874134927938,0.00271416222135082,0.000538983395431775,0.011178499303127,0.0308979936040647
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,39557,0.00639494753045187,0.00296446397795527,0.000584598133659547,0.0122052969272442,0.0310050597473448
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36877,0.0106401669198091,0.0049413303643818,0.000955159405620777,0.0203251744339974,0.0313134146190506
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,39245,-0.0173117513404587,0.00804374150913571,-0.0330774846983647,-0.00154601798255268,0.0313970064519596
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39288,0.0104734598220439,0.00487089472255249,0.000926506165841027,0.0200204134782468,0.0315538842253692
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39680,0.00842373324784722,0.00392061283387421,0.000739332093453777,0.0161081344022407,0.0316831851710154
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,37203,-0.0153896538991018,0.00716952479308866,-0.0294419224935555,-0.00133738530464799,0.0318480932359054
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37220,-0.00484156329720853,0.00225576516716228,-0.0092628630248466,-0.000420263569570466,0.0318664931547462
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,39401,0.00930630770555568,0.00433747273641869,0.000804861142175057,0.0178077542689363,0.0319235505130799
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,37220,0.00711604376907594,0.00331782327730742,0.000613110145553391,0.0136189773925985,0.0319873896574287
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,37277,0.0115937555754155,0.00542225843462105,0.0009661290435582,0.0222213821072727,0.0325202820613118
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,36880,0.022275236420496,0.0104213993424653,0.00184929370926396,0.042701179131728,0.0325798528769578
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36827,0.0138356131895878,0.00647731871349497,0.00114006851113763,0.0265311578680379,0.0326973260632848
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39594,0.00628846836395047,0.00294527864939849,0.000515722211129438,0.0120612145167715,0.0327681351026701
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39302,0.00915480156919682,0.0042901009416485,0.000746203723565764,0.0175633994148279,0.0328637150277221
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37203,0.00737424865055722,0.00347462238473311,0.000563988776480315,0.0141845085246341,0.0338295319136444
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39594,0.00872737178939457,0.00411815884115339,0.000655780460733935,0.0167989631180552,0.0340857093050312
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37244,0.0111920219242067,0.00528527958685372,0.00083287393397344,0.02155116991444,0.0342287280444478
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37203,0.00687350278447026,0.00325468278538979,0.000494324525106277,0.0132526810438343,0.0347151928102546
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,37203,-0.00704155124954285,0.00335559647804093,-0.0136185203465031,-0.000464582152582625,0.0358841677966681
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37203,-0.00703567512315446,0.00335452094794752,-0.0136105361811316,-0.000460814065177313,0.0359795095350318
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37277,0.00872650602665289,0.00416186222133096,0.000569256072844209,0.0168837559804616,0.0360318016611832
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39401,0.0120558869437871,0.00577611170280904,0.000734708006281424,0.0233770658812929,0.0368865200639197
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,37215,0.011193007798541,0.00536390760464125,0.00067974889344412,0.0217062667036378,0.0369317886497673
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,37244,-0.00947427396427875,0.00455350177618442,-0.0183991374456002,-0.000549410482957282,0.0374843123986567
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,36877,0.0121883070791077,0.00587216042124678,0.000678872653464035,0.0236977415047514,0.0379497463798224
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,36896,0.0140959332588427,0.00679253053011068,0.00078257341982578,0.0274092930978597,0.0379865598909378
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36896,0.00546754066768328,0.00263558574991327,0.000301792597853266,0.0106332887375133,0.0380518404453292
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,36765,0.00747820343107703,0.00360739676143408,0.000407705778666231,0.0145487010834878,0.0381902740243528
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,39668,-0.00579494618258504,0.00279821590498948,-0.0112794493563644,-0.000310443008805655,0.0383802949376448
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39836,0.010307416537721,0.00498303440517519,0.000540669103577592,0.0200741639718643,0.0386088956324948
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,39368,0.00995639071182475,0.00481853618903696,0.000512059781312305,0.0194007216423372,0.0388196761854952
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36896,0.00478868844635698,0.00231859762310078,0.000244237105079454,0.0093331397876345,0.0389107242271664
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LXN,Latexin,39491,0.0122520943952905,0.00593542768791315,0.000618656126980708,0.0238855326636002,0.039012271992937
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36877,0.0153488189627222,0.00746430696914856,0.000718777303191028,0.0299788606222534,0.039773957308165
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39668,0.0051530575822684,0.00250639082277437,0.000240531569630635,0.0100655835949062,0.0398020513892702
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,39288,0.00853324854852966,0.00415188805606157,0.000395547958648986,0.0166709491384103,0.0398697856872673
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,37268,0.0117582635268674,0.00573144474721701,0.000524631822322033,0.0229918952314127,0.0402341895511645
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37203,0.0197167709810732,0.00961604840591466,0.000869316105480505,0.038564225856666,0.040344651012003
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36877,0.00716544457421425,0.00349842646834832,0.000308528696251546,0.0140223604521769,0.0405613339633674
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,37203,0.00918703576716113,0.00449676622375774,0.000373373968595965,0.0180006975657263,0.041068909510068
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,37203,0.00814055672519047,0.00398539804390471,0.000329176559137235,0.0159519368912437,0.0411120936594491
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39817,0.00806622334374588,0.0039519932781708,0.000320316518531102,0.0158121301689607,0.0412620882387797
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,39640,0.0120638975362551,0.00591204031795301,0.000476298513067188,0.023651496559443,0.0413107772118148
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,39302,0.0121156057914185,0.00594279487007398,0.000467727846073527,0.0237634837367635,0.0414964717629153
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39680,0.0157917950918478,0.00775244825950338,0.000596996503221136,0.0309865936804744,0.0416659039025797
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39648,0.00314707720183453,0.00154694316352471,0.000115068601326095,0.00617908580234296,0.0419295209460214
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36775,0.0085966538922048,0.00422674908902441,0.000312225677716963,0.0168810821066926,0.0419852026721925
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,39715,0.00328725584052793,0.00161762999240206,0.000116701055419886,0.00645781062563598,0.0421557933419777
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,37005,0.00596680267853894,0.00293730091988481,0.000209692875564717,0.0117239124815132,0.0422355603264451
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37005,0.00942348570872971,0.00464091275648392,0.000327296706021213,0.0185196747114382,0.0423233722930678
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39302,0.0151439548650486,0.00747882165058494,0.000485464429902108,0.0298024453001951,0.0428935850452302
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39302,0.00782492052041293,0.00387098330280179,0.000237793246921424,0.0154120477939044,0.0432525216566138
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,39653,0.0119374234690136,0.00592223384176463,0.000329845139154921,0.0235450017988723,0.0438486710213282
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37203,0.00922064280616324,0.00458605244272842,0.000231980018415526,0.0182093055939109,0.0443895169383849
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,37203,0.019620384427046,0.00977449786726057,0.000462368607215283,0.0387784002468767,0.0447374783852285
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39288,-0.00936892335835658,0.00467180263839785,-0.0185256565296164,-0.000212190187096792,0.044935667610202
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39680,0.012943063658384,0.00646123794594749,0.000279037284326888,0.0256070900324411,0.0451743167452546
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39860,0.00439689392736006,0.00219715845188276,9.04633616698554e-05,0.00870332449305027,0.0453906203213406
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,36877,0.00881776876340451,0.00440780378910852,0.000178473336751809,0.0174570641900572,0.0454680776266526
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39557,0.0107059648467474,0.00535647212474789,0.000207279482241562,0.0212046502112533,0.0456583602318969
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37277,0.00397080617758853,0.00198740789745709,7.54866985726217e-05,0.00786612565660443,0.045738708040798
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,37285,0.012714528409955,0.00641471972797993,0.000141677743114361,0.0252873790767957,0.0474899349353433
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,36998,0.0172207952363094,0.00869901130132765,0.000170733085707163,0.0342708573869116,0.0477663249234417
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36896,0.0158074064463509,0.00799622958686939,0.000134796456086907,0.0314800164366149,0.0480787786419109
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,39523,0.0127660952582335,0.00646295607376858,9.87013536470939e-05,0.0254334891628199,0.0482548335625968
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,39814,0.0101849558137949,0.00516902125132368,5.36741612005062e-05,0.0203162374663893,0.0488116634705977
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37203,0.0104400254508513,0.00529880669379648,5.43643310102447e-05,0.0208256865706924,0.048829255584103
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39171,-0.0148938658311944,0.00756286237953403,-0.0297170760950811,-7.06555673077331e-05,0.0489317827944151
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,39401,0.00706963583575535,0.00359025846869959,3.27292371041484e-05,0.0141065424344065,0.0489574957496145
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNST,Consortin,39680,0.0188853816918197,0.00959931601185149,7.0722308590801e-05,0.0377000410750486,0.0491583111546486
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36855,0.0172454898879948,0.00876927536230232,5.77101778822149e-05,0.0344332695981073,0.0492527896201105
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,36795,0.00721590589961991,0.0036757448189794,1.14460544202721e-05,0.0144203657448195,0.0496543308399435
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36827,0.0125553568269021,0.00641370749088364,-1.55098552298231e-05,0.025126223509034,0.0503005266967276
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36880,0.0103719376649664,0.00530382840786424,-2.35660144474997e-05,0.0207674413443803,0.0505387451729579
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37267,0.00689461009858747,0.00352755022314276,-1.93883387723404e-05,0.0138086085359473,0.050662428569056
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39288,0.0220162369442399,0.0112905674512083,-0.000113275260128391,0.0441457491486083,0.0511981086560148
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37268,0.00852735537681876,0.00438630638083095,-6.98051296099001e-05,0.0171245158832474,0.051906010252956
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37005,0.00796871846931963,0.00410499366725698,-7.70691185040459e-05,0.0160145060571433,0.0522522734451072
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39288,0.0151500778345126,0.00782750801953915,-0.000191837883784117,0.0304919935528094,0.0529482194834458
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39673,0.0113477152241678,0.00587014216878911,-0.000157763426658812,0.0228531938749945,0.0532387019069645
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36896,0.00969342420550265,0.00502917496494238,-0.000163758725784408,0.0195506071367897,0.0539467385382195
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39288,0.00846725580663661,0.00440560271179367,-0.00016772550847898,0.0171022371217522,0.0546330834557589
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37005,0.00869844715065988,0.00452727047321767,-0.000175002976846745,0.0175718972781665,0.0547098639623416
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,36896,0.00986581621587927,0.00513797678261965,-0.000204618278055244,0.0199362507098138,0.0548575525232273
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HLA_A,,37244,0.00551523606077686,0.00287266725621064,-0.000115191761396006,0.0111456638829497,0.0548916667344296
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37277,0.00594902600329096,0.00310108427715322,-0.000129099179929349,0.0120271511865113,0.0550853526760283
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,37005,0.0149945053378205,0.00782265294864895,-0.000337894441531388,0.0303269051171725,0.0552842834695288
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,39597,0.0149533627501234,0.0078125385642373,-0.00035921283578169,0.0302659383360285,0.0556355925278675
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,37005,0.00492961270156003,0.00257731373566758,-0.000121922220348438,0.00998114762346849,0.0558089356601185
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39288,0.0126706668932387,0.00663637594473478,-0.000336629958441486,0.0256779637449189,0.0562451520956886
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,36827,0.0160317364837262,0.00840953875214614,-0.000450959470480215,0.0325144324379327,0.0566236218658858
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,39302,0.00795201206327205,0.00420940969956656,-0.000298430947878417,0.0162024550744225,0.0588966344893676
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36877,0.0130640636115627,0.00693073141111884,-0.000520169954230187,0.0266482971773557,0.0594592062357797
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39649,0.0105540050036373,0.00563990101222164,-0.000500200980317157,0.0216082109875917,0.0613205581399193
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36896,0.0100025822218464,0.00534926859894167,-0.0004819842320793,0.0204871486757721,0.0615204950752647
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,39259,-0.0197909780703519,0.010600153861629,-0.0405672796391448,0.000985323498440927,0.0619141088282186
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37285,0.00499750987273479,0.00267823506597181,-0.000251830856569967,0.0102468506020395,0.0620671656451939
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,36877,0.00575602454334964,0.00308579913883794,-0.000292141768772712,0.011804190855472,0.0621580589251961
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39302,0.00540202803544879,0.00290019027379385,-0.000282344901187156,0.0110864009720847,0.0625310522589741
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36880,0.00460254379023058,0.00247268036458251,-0.000243909724351141,0.0094489973048123,0.0627161332414687
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36958,0.00686600487912966,0.00368925374415136,-0.000364932459407013,0.0140969422176663,0.0627549421200819
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37220,-0.0143808763851714,0.0077414144670469,-0.0295540487405834,0.000792295970240477,0.0632400250901855
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37151,0.00464429687600221,0.00251538937772863,-0.000285866304345898,0.00957446005635033,0.0648631771064156
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,36855,0.00853661414153376,0.00462745010392237,-0.000533188062154095,0.0176064163452216,0.0650927068087181
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,36896,0.00667539983853077,0.00362334700913783,-0.000426360299379387,0.0137771599764409,0.065449632754477
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36855,-0.00919590506022393,0.0049916661944176,-0.0189795708012824,0.000587760680834562,0.0654611235008362
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36896,0.014745123761164,0.00800643799689792,-0.000947494712755939,0.0304377422350839,0.065547836385644
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37005,0.0119493507310042,0.00650414132121264,-0.000798766258572552,0.024697467720581,0.0662042456600748
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,39302,0.00798174688823347,0.00434744192271298,-0.000539239280283965,0.0165027330567509,0.0663821956640133
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,39646,0.0143969644360754,0.0078829849903657,-0.00105368614504141,0.0298476150171921,0.0678188262621892
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37267,0.00531431427536797,0.00291024158687715,-0.000389759234911245,0.0110183877856472,0.0678614602589174
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,39288,0.0164670438096825,0.00902275275029711,-0.00121755158089984,0.0341516392002648,0.0680116580858371
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36880,0.00601281855838723,0.00329573216565107,-0.00044681648628886,0.0124724536030633,0.0681106417460421
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36795,0.00544763636291189,0.0029867274012964,-0.000406349343629051,0.0113016220694528,0.06818295062165
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36958,-0.00641874310719741,0.00352084703899841,-0.0133196033036343,0.000482117089239476,0.0683158958386294
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36855,0.0067702895711289,0.00372181149368818,-0.000524460956499936,0.0140650400987577,0.0689215438481935
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36827,0.00548687838989814,0.0030181173107116,-0.000428631539096605,0.0114023883188929,0.0690901783525135
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,36877,0.00806488845296521,0.00443752066685329,-0.000632652054067241,0.0167624289599977,0.069174096466315
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,39288,0.0152086312838144,0.008371412375509,-0.00119933697218324,0.031616599539812,0.0692772150650148
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36855,0.00713529290320063,0.00392975803722506,-0.000567032849760476,0.0148376186561617,0.0694382202231369
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36896,0.0110123757422714,0.00606886487732547,-0.000882599417286481,0.0229073509018294,0.0696131023087649
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37005,0.0104527727242962,0.00576918039259693,-0.000854820845193754,0.0217603662937862,0.0700353152884444
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,39663,0.0128003344926935,0.00706735133677788,-0.00105167412739117,0.0266523431127781,0.0701300206465668
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36836,0.0134262946959598,0.00741888589867262,-0.00111472166543855,0.0279673110573581,0.0703584041056777
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36827,0.0079248433185776,0.00437973848273736,-0.00065944410758763,0.0165091307447428,0.0704069070772962
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,36795,0.00579344713656778,0.00321171195553034,-0.000501508296271685,0.0120884025694072,0.0712780552542674
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37005,0.00848327302449774,0.0047043773592642,-0.000737306599660096,0.0177038526486556,0.07136836216365
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,39860,-0.00654596529019892,0.00363460115997507,-0.0136697835637501,0.000577852983352226,0.0717195945404799
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37267,0.00538735035452624,0.00299277989751917,-0.000478498244611331,0.0112531989536638,0.0718648270954357
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,39680,0.00607615902390244,0.00337923952955698,-0.000547150454029236,0.0126994685018341,0.0721826387562461
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,37244,-0.00986657419445914,0.00550527279664295,-0.0206569088758793,0.000923760486961037,0.0731228067682749
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36855,0.00761320049071825,0.00425002884225403,-0.000716856040099643,0.0159432570215361,0.0732637555897741
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,39302,0.00796936150094376,0.00446201514824002,-0.00077618818960668,0.0167149111914942,0.0741115273069608
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,36855,0.00639948572266569,0.00358662253976555,-0.00063029445527479,0.0134292659006062,0.0744039090377129
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,39401,0.0185357287776614,0.0103969819609995,-0.00184235586589766,0.0389138134212205,0.074638546389653
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,36995,0.00357734543700145,0.00200912519603575,-0.000360539947228619,0.00751523082123152,0.0750092990949254
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39401,0.0123297344572461,0.00693681023699573,-0.00126641360726558,0.0259258825217577,0.0755161261032869
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37005,0.0107330864964102,0.00604695300247581,-0.00111894138844237,0.0225851143812628,0.0759279887793595
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,39302,0.00958358774918827,0.00540158467776634,-0.00100351821923374,0.0201706937176103,0.0760468287820531
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37158,0.00423411980657023,0.00238697115536141,-0.000444343657938119,0.00891258327107859,0.0761114662933456
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39667,-0.012329656896732,0.00696355828546017,-0.025978231136234,0.00131891734276992,0.0766469750928559
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39401,0.00473899733123553,0.0026779347075292,-0.000509754695521693,0.00998774935799276,0.0768056812705273
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,39594,0.0108351168846119,0.00612599734800617,-0.0011718379174802,0.022842071686704,0.0769615419971789
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,39557,0.00553626264954526,0.00313028416155255,-0.000599094307097743,0.0116716196061883,0.07697782363337
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,39860,0.00896934050219083,0.00509628165330772,-0.0010193715382923,0.018958052542674,0.0784307456615233
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36795,0.014504341672226,0.00825008078699819,-0.00166581667029042,0.0306745000147425,0.0787567289436518
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37215,0.00725221045324936,0.0041442194770027,-0.000870459721675924,0.0153748806281746,0.0801485082565029
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39401,0.00332349828700773,0.00190552099273881,-0.000411322858760334,0.0070583194327758,0.0811541854065382
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37203,0.00563978974334037,0.00323787680310033,-0.000706448790736283,0.011986028277417,0.0815634667689375
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39398,0.00613161217853797,0.00352080767972975,-0.000769170873732348,0.0130323952308083,0.0816095154983057
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36855,0.0185449325172859,0.0106552478054912,-0.00233935318147691,0.0394292182160486,0.0818035962217376
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,39738,0.00727286607365457,0.00418599839888624,-0.000931690788162463,0.0154774229354716,0.0823312428462847
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36855,0.00610933947907412,0.00353066620689349,-0.000810766286437123,0.0130294452445854,0.0835889122753934
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,39594,0.00549908607159759,0.00318636934670562,-0.000746197847945432,0.0117443699911406,0.0844002172310267
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39557,-0.00486078435560024,0.00281749573160102,-0.0103830759895382,0.000661507278337758,0.0845085147279151
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,37220,-0.0178178420756479,0.0103354021931731,-0.0380752303742672,0.00243954622297144,0.0847378118595259
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,36877,0.00666641056295031,0.00388169524830829,-0.00094171212373394,0.0142745332496346,0.0859305018411439
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,39836,-0.00660058362181722,0.00384596482488337,-0.0141386746785886,0.000937507434954189,0.0861382267258481
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37005,0.0079088259374828,0.00462655527177777,-0.00115922239520164,0.0169768742701672,0.0873927874572273
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,37203,0.00527674852885497,0.00308735647580504,-0.00077447016372291,0.0113279672214329,0.0874468291008173
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39302,0.00793531633542742,0.00464993541750645,-0.00117855708288522,0.0170491897537401,0.0879270696222042
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,37203,0.00601640967626527,0.0035276710012439,-0.000897825486172773,0.0129306448387033,0.0881262419906026
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,39594,-0.0048299168997797,0.00283320358171971,-0.0103829959199503,0.000723162120390935,0.08825993968663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,36877,0.00913591955996091,0.00536051248789222,-0.00137068491630785,0.0196425240362297,0.0883489851960619
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,36855,0.00977577328495122,0.00574216462801655,-0.00147886938596122,0.0210304159558636,0.0886941407112243
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37244,0.00982462590553459,0.00578256688668603,-0.00150920519237003,0.0211584570034392,0.0893409651075308
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,39401,-0.00997508383913914,0.00589405516738548,-0.0215274319672147,0.0015772642889364,0.0905902664284515
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37267,0.00403164482464482,0.00238547300996595,-0.000643882274888443,0.00870717192417807,0.0910355294138373
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39060,0.00925019174769058,0.00547542861192693,-0.0014816483316862,0.0199820318270674,0.0911632167771694
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,36880,0.00763102625917159,0.00452415047857064,-0.00123630867882688,0.01649836119717,0.0916789852124625
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39693,0.00953729747494573,0.00566961763955825,-0.00157515309858844,0.0206497480484799,0.0925543415780872
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,36827,-0.00790925300336981,0.00470412129632079,-0.0171293307441585,0.00131082473741894,0.0927199135564119
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37203,0.00424986091020024,0.00253000204034962,-0.000708943088885019,0.0092086649092855,0.0930224550440621
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,39738,0.00765172659564429,0.00455647570966154,-0.00127896579529233,0.0165824189865809,0.0931116868895903
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,36896,0.00887834558207211,0.00529223660901513,-0.00149443817159755,0.0192511293357418,0.0934458836723491
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37220,0.0355778946546573,0.0212435578932996,-0.00605947881620999,0.0772152681255245,0.0940044236093291
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,36877,0.0104968972324349,0.00626979754983465,-0.00179190596524098,0.0227857004301109,0.0941152552115729
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36855,0.00499734601498227,0.0029908048906306,-0.000864631570653702,0.0108593236006182,0.0947648427456454
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,36896,0.013037432362891,0.00780347349909129,-0.00225737569532791,0.02833224042111,0.0948006693266429
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,39649,-0.0071540964259571,0.00428964075936308,-0.0155617923143087,0.00125359946239453,0.0953829712528123
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36795,0.0109630722556492,0.00657846335116686,-0.00193071591263784,0.0238568604239363,0.0956361714329848
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37005,0.00922353009506708,0.0055447984407736,-0.00164427484884918,0.0200913350389833,0.096244962287813
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,36827,0.0124559724042069,0.0075164011463533,-0.00227617384264558,0.0271881186510593,0.0975088198070561
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,37215,-0.0143867128135666,0.00870001026405578,-0.0314387329311159,0.00266530730398273,0.0982235322483371
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36795,0.009981076430383,0.00603883561303732,-0.00185504137117015,0.0218171942319361,0.098392845020498
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36519,0.00716896452143379,0.0043384751116184,-0.00133444669733828,0.0156723757402059,0.0984746305859819
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,37215,0.0372271830588251,0.0225384933141414,-0.00694826383689212,0.0814026299545423,0.0986160323126586
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,36896,0.0093492410555998,0.00567447533564713,-0.00177273060226857,0.0204712127134682,0.0994597680264554
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37005,0.0100252209722097,0.00612587658556611,-0.00198149713549984,0.0220319390799193,0.10175128046595
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,37142,0.0036510477047369,0.00223135457852953,-0.000722407269180966,0.00802450267865477,0.1018115525591
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36877,0.0112087539494972,0.00685296329109188,-0.00222305410104286,0.0246405620000373,0.101946065802153
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37268,-0.00567125742169738,0.00347960468310876,-0.0124912826005906,0.0011487677571958,0.10315525164984
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,37267,0.00536333907652583,0.00329961112307324,-0.00110389872469772,0.0118305768777494,0.104091105743948
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37005,0.00855501753862726,0.00527832305347761,-0.00179049564618885,0.0189005307234434,0.105088119702011
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37220,0.00515783265919309,0.0031836294508233,-0.00108208106442058,0.0113977463828068,0.105232065405892
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36795,0.00601259396627923,0.00371484326684979,-0.00126849883674636,0.0132936867693048,0.105572303852073
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39680,0.00403217601648562,0.00249561655527984,-0.000859232431862865,0.0089235844648341,0.106178407939609
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36827,0.00837545093763434,0.00518916180458421,-0.00179530619935072,0.0185462080746194,0.106545748117124
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36877,-0.00694779292122809,0.0043139546635398,-0.0154031440617661,0.00150755821930992,0.107304450112625
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,36896,0.00835893111261789,0.00519122431079134,-0.00181586853653313,0.0185337307617689,0.10737749998115
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37005,0.0103109694862303,0.00642784002898177,-0.00228759697057391,0.0229095359430346,0.10871359148764
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39288,0.00447066922494507,0.00279002758474461,-0.000997784841154364,0.0099391232910445,0.109093278800675
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37088,0.00363362602577309,0.00226931837938467,-0.000814237997820857,0.00808149004936703,0.109357148146981
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,39266,0.00486298063732467,0.00304246922503085,-0.0011002590437358,0.0108262203183851,0.109981961284219
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36827,0.00685268896054957,0.00429362898674677,-0.0015628238534741,0.0152682017745732,0.110510193209573
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BSND,Barttin,36795,0.00474553180220942,0.00297694212693713,-0.00108927476658736,0.0105803383710062,0.110938947064748
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37005,0.00588735543206967,0.00369975322116704,-0.00136416088141772,0.0131388717455571,0.111569884801851
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39302,0.00431170260159321,0.00271061338273531,-0.00100109962856801,0.00962450483175442,0.111703400696017
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,39658,0.00397779289556559,0.00250697154598473,-0.000935871334564478,0.00889145712569567,0.112602324246319
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,37224,0.00334861237663007,0.00211218272629599,-0.000791265766910061,0.0074884905201702,0.112903669172923
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36827,0.00791686431306915,0.0049955166645696,-0.00187434834948728,0.0177080769756256,0.113037555274193
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36877,0.00515414978877086,0.00325258173853003,-0.00122091041874799,0.0115292099962897,0.113073934548051
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,39401,0.00756388739778992,0.00477798762667236,-0.00180096835048789,0.0169287431460677,0.113425929085926
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,39607,0.011846793583285,0.00749285214976009,-0.00283919663024474,0.0265327837968148,0.113879986430414
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36896,0.00582354467441957,0.0036836816469837,-0.00139647135366848,0.0130435607025076,0.113924397919586
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37268,-0.00958264234090692,0.00606764362379341,-0.021475223843542,0.00230993916172816,0.1142903688674
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,39594,0.0110482716230131,0.00701288060612929,-0.00269697436500029,0.0247935176110265,0.115178344769497
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,39673,0.00933150752153161,0.00593279166075126,-0.00229676413354086,0.0209597791766041,0.115769026827386
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,39865,-0.00386934215629453,0.00246138338505397,-0.00869365359100031,0.000954969278411251,0.115965845055296
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36855,0.0082343294880514,0.00524233592625251,-0.00204064892740353,0.0185093079035063,0.116268164677126
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,37186,0.0070237465979182,0.00447444536989652,-0.00174616632707897,0.0157936595229154,0.116497755548979
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36827,-0.00604879833612085,0.00385357963884777,-0.0136018144282625,0.00150421775602078,0.116519324770046
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39721,0.00378552009858478,0.00241265439799544,-0.000943282521486288,0.00851432271865586,0.116661575972936
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,36896,0.00479416134954579,0.00306037849061307,-0.00120418049205582,0.0107925031911474,0.117249884980674
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,39668,0.0033142479350593,0.0021193433054706,-0.000839664943663073,0.00746816081378167,0.117882469362244
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,39668,0.0124353042593043,0.00796634854570712,-0.00317873889028163,0.0280493474088903,0.118548680106543
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36896,0.00757081312680269,0.00487359242804286,-0.00198142803216131,0.0171230542857667,0.120343322710239
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39673,0.00492865631740855,0.00317450760059804,-0.0012933785797636,0.0111506912145807,0.120545077513313
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39557,0.00316668983739203,0.00204141378375439,-0.000834481178766568,0.00716786085355062,0.120868198333259
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39743,0.00585835586763339,0.00377901273755831,-0.00154850909798089,0.0132652208332477,0.121105169470583
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,37285,0.00354807197731229,0.00229439095545,-0.000948934295369706,0.00804507824999428,0.122028850823584
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36827,0.0123223497205508,0.00799676671963642,-0.00335131304993661,0.0279960124910382,0.123361512821232
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39401,0.00899417853818426,0.00584821379199064,-0.00246832049411739,0.0204566775704859,0.12408462191712
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36958,0.00721171651518564,0.00469460609645158,-0.00198971143385945,0.0164131444642307,0.124520664980362
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39668,0.00409122497652195,0.00267180872296589,-0.0011455201204912,0.00932797007353511,0.125725975721787
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,36877,0.00827127004809262,0.00540288713923717,-0.00231838874481224,0.0188609288409975,0.125818861343722
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37203,0.00595369049445515,0.00389267412198309,-0.0016759507846317,0.013583331773542,0.12617408127663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,37277,0.00360537537389904,0.00235794598503886,-0.00101619875677713,0.00822694950457521,0.126280031898731
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39641,0.00516235793189163,0.00338453679943012,-0.00147133419499141,0.0117960500587747,0.127209929164285
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,39557,0.0016670536390182,0.00109363633999342,-0.000476473587368905,0.0038105808654053,0.127448507002256
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,36877,0.00898519475970995,0.00589561560525443,-0.00257021182658873,0.0205406013460086,0.127521285819236
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36827,0.00432977738307352,0.00284384828349526,-0.00124416525257719,0.00990372001872424,0.127906612838899
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,36896,0.00735853773409928,0.00483574795959334,-0.00211952826670366,0.0168366037349022,0.1281095558458
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36795,0.00741979993894795,0.00487660051274255,-0.00213833706602745,0.0169779369439234,0.128156168069193
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39715,0.00360553777843402,0.00237129650626353,-0.00104220337384251,0.00825327893071054,0.128407265368238
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,39557,0.00569939547934184,0.00374889500543428,-0.00164843873130935,0.013047229689993,0.1284590591392
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36877,-0.0050742282051742,0.00335082384647721,-0.0116418429442695,0.00149338653392113,0.129968324398363
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,36855,0.00470256317948848,0.00311432931817737,-0.00140152228413915,0.0108066486431161,0.1310738080297
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39401,0.00652611956542302,0.0043431109518214,-0.00198637790014692,0.015038617030993,0.13295297404831
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,36795,0.0122652412237238,0.00820806433977741,-0.00382256488223992,0.0283530473296875,0.135123824563018
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39668,0.00495153126082861,0.00332151818118606,-0.00155864437429608,0.0114617068959533,0.136048833091679
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39668,0.00566712236757468,0.00380818527942736,-0.00179692078010295,0.0131311655152523,0.136733263980702
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36827,0.00380892194698115,0.00256585732334324,-0.0012201584067716,0.0088380023007339,0.137710264772094
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39480,-0.0155523318071066,0.0104898037657057,-0.0361123471878899,0.00500768357367664,0.13819712184255
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36827,-0.00501724818455406,0.00338427768720243,-0.0116504324514708,0.00161593608236271,0.138227165248996
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,39654,0.0164161271683287,0.0110873291282788,-0.00531503792309781,0.0381472922597553,0.138727667803681
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39832,0.00461386897644161,0.00311643466886469,-0.00149434297453319,0.0107220809274164,0.138760659344697
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,36880,0.0113239481151427,0.00766201096799922,-0.00369359338213578,0.0263414896124212,0.139449577907203
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,39756,0.00408264886128418,0.00276375088774883,-0.00133430287870352,0.00949960060127187,0.139638349170224
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,36855,0.0064795585379821,0.00438924443430243,-0.00212336055325067,0.0150824776292149,0.139904907493833
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,36877,0.00412496489100441,0.00279501157400042,-0.00135325779403641,0.00960318757604523,0.140013438612333
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,36896,0.00703728519454895,0.00477165657018861,-0.00231516168302072,0.0163897320721186,0.140287873424805
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,36880,0.00904186441820193,0.00614808044641653,-0.00300837325677446,0.0210921020931783,0.141401602465706
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,37203,-0.00519388471825921,0.0035369736018261,-0.0121263529778384,0.00173858354131994,0.142004386541183
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39401,0.00742195224006571,0.00506707249916464,-0.00250950985829699,0.0173534143384284,0.143011639419212
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39401,0.0079703700044404,0.00544695106387592,-0.00270565408075641,0.0186463940896372,0.143413238848676
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37244,0.0121423567495316,0.00833379520224432,-0.00419188184686729,0.0284765953459304,0.145139272440423
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,36877,-0.0047187308441393,0.00323871561799436,-0.0110666134554082,0.00162915176712963,0.145147133504508
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37267,-0.00603520208775955,0.00414640210375098,-0.0141621502111115,0.00209174603559237,0.145546710127233
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36795,0.00822947639039333,0.00565563021459448,-0.00285555883021185,0.0193145116109985,0.145667369694798
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,39621,0.0133745158200074,0.009206266907176,-0.00466976731805756,0.0314187989580724,0.146309720804628
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36855,0.00600373814159717,0.00413637256860539,-0.00210355209286939,0.0141110283760637,0.146678723361085
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36958,0.0109454467962255,0.00756361799940542,-0.00387924448260909,0.0257701380750601,0.147887844588802
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37203,0.00651984953887584,0.00451199713584025,-0.00232366484737105,0.0153633639251227,0.148480517473731
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,36827,0.00681568184372348,0.00472512373178564,-0.00244556067057637,0.0160769243580233,0.149203968561605
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39401,-0.00551858981965091,0.00382703105345591,-0.0130195706844245,0.00198239104512267,0.149321710609889
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,36492,0.0157749997325877,0.0109505731719199,-0.00568812368437541,0.0372381231495507,0.149732726910241
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36795,0.00384349165212405,0.0026687906927351,-0.00138733810563675,0.00907432140988485,0.149845698171307
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36855,0.00470774154755995,0.00327061844800585,-0.00170267061053152,0.0111181537056514,0.150060155092234
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,36855,-0.00752973889606915,0.005261312948537,-0.0178419122752017,0.00278243448306338,0.152410685150683
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,39821,0.00668488120023678,0.00467480887409261,-0.00247774419298472,0.0158475065934583,0.152742455596372
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36855,0.00504859788837492,0.00353935256924304,-0.00188853314734144,0.0119857289240913,0.153771607671566
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,39836,0.00315018565916206,0.00221078296199709,-0.00118294894635224,0.00748332026467635,0.154200280367293
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,36880,0.00383891213918754,0.00269531707700801,-0.00144390933174817,0.00912173361012325,0.154386616670623
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36877,0.00901366211554784,0.00632999563737136,-0.00339312933370003,0.0214204535647957,0.154481951464142
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37220,-0.00529259990835247,0.00371833408726225,-0.0125805347193865,0.00199533490268154,0.15464957061232
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,39288,0.0207968540747995,0.0146190121577312,-0.00785640975435363,0.0494501179039526,0.15487539010212
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37220,0.0069621776272671,0.00492656165258343,-0.00269388321179642,0.0166182384663306,0.157622568576851
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,37277,-0.00321690810644685,0.00227861712699501,-0.00768299767535706,0.00124918146246336,0.15803767852152
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,36896,0.00479871468451269,0.00340121173415807,-0.00186766031443713,0.0114650896834625,0.158302729762162
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,36795,0.00763945366323583,0.00542477719128752,-0.00299310963168771,0.0182720169581594,0.159080479093073
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39288,0.00582714514470401,0.00414151455193839,-0.00229022337709523,0.0139445136665032,0.159445086379848
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39302,0.00805553501053844,0.00572574686684138,-0.00316692884847067,0.0192779988695475,0.159478114511536
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,36862,0.00835924982210945,0.00595533866747847,-0.00331321396614835,0.0200317136103672,0.160445044755543
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36896,0.00739270314030161,0.00531566035120008,-0.00302599114805056,0.0178113974286538,0.164327927259349
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36827,-0.00777755571879862,0.00560226502998702,-0.0187579951775732,0.00320288373997595,0.165073300377114
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,36827,0.00794566744626741,0.00572384060342777,-0.00327306013645102,0.0191643950289858,0.165108939875747
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39668,0.00372416053377644,0.00268524649385357,-0.00153892259417655,0.00898724366172943,0.165492702171406
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36827,0.00725951003207182,0.00524178125925882,-0.00301438123607548,0.0175334013002191,0.166097120608738
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36827,0.0117933253714864,0.00856972952244867,-0.00500334449251302,0.0285899952354858,0.168795636970791
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36795,0.00663753222760119,0.00483386636618513,-0.00283684585012167,0.0161119103053241,0.169735396847608
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39658,0.00836445147282916,0.00609758200627346,-0.00358680925946682,0.0203157122051251,0.170155989664402
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37183,0.00497960599257142,0.0036373441774303,-0.00214958859519197,0.0121088005803348,0.171015323177355
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,36827,0.00576462237076061,0.00421109086247341,-0.00248911571968728,0.0140183604612085,0.171049786704585
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,39302,0.00430793152264418,0.0031480558040584,-0.00186225785331028,0.0104781208985986,0.171193699340949
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,36855,0.00594236010050366,0.00434618251775168,-0.00257615763428963,0.014460877835297,0.171567574659174
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36877,0.0126055135344079,0.00922421184643759,-0.00547394168460979,0.0306849687534256,0.171784329221854
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39401,0.00384465878971582,0.00282168771495246,-0.00168584913159101,0.00937516671102265,0.173047675013576
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37203,0.00547342016542785,0.00403191810827629,-0.00242913932679368,0.0133759796576494,0.174638159530255
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37005,0.00793340980069872,0.00584776878667368,-0.0035282170211817,0.0193950366225791,0.174913881108991
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,39557,0.0050256919372026,0.00372483572469867,-0.0022749860832068,0.012326369957612,0.177279818179807
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36880,0.00958282961736613,0.00712591195012018,-0.00438395780486943,0.0235496170396017,0.178717642161844
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,37005,0.00499515859387608,0.00372054398958417,-0.00229710762570889,0.012287424813461,0.179428525542604
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,36855,0.00496004640764591,0.00369462496969716,-0.00228141853296053,0.0122015113482523,0.179456295048683
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,36896,-0.00532868701459982,0.00400864887006636,-0.0131856387999299,0.00252826477073025,0.183773093626603
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36896,0.00830231899300321,0.00627293100947233,-0.00399262578556255,0.020597263771569,0.18568734413424
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36877,0.00347126788658945,0.00262685162738177,-0.00167736130307882,0.00861989707625771,0.186372711037876
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,36795,0.00575186360286797,0.00435670370600011,-0.00278727566089224,0.0142910028666282,0.186780629081718
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39401,0.00359641986449951,0.00272536328137845,-0.00174529216700226,0.00893813189600128,0.186984306126947
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39675,0.0034726978215317,0.00263469595231526,-0.00169130624500622,0.00863670188806962,0.187501322899582
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39302,0.00573051394880961,0.00435565265555996,-0.00280656525608792,0.0142675931537071,0.188311111674924
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,37005,-0.00696910035757396,0.00529714794408673,-0.017351510327984,0.00341330961283603,0.18832034185563
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39401,-0.00722848629331069,0.00549661197755485,-0.0180018457693182,0.00354487318269682,0.188502309888832
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,36896,0.00500314451595191,0.0038212322693459,-0.00248647073196606,0.0124927597638699,0.19045537376216
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39668,-0.00649522095609842,0.00496353085999091,-0.0162237414416806,0.00323329952948376,0.190692696756058
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37203,0.00695901001074909,0.00531848884076386,-0.00346522811714807,0.0173832481386463,0.19074113906282
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,37267,0.00460104129476378,0.00351820722106875,-0.00229464485853098,0.0114967274480585,0.190970338709317
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,36855,0.00411919220850164,0.0031536715299404,-0.00206200399018155,0.0103003884071848,0.191522068487448
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36795,0.0167256390006245,0.0128121488888046,-0.00838617282143254,0.0418374508226814,0.191762370245875
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39721,0.00786554087391845,0.00602883417759895,-0.0039509741141755,0.0196820558620124,0.192029719786222
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,39401,0.00917871154133285,0.00703603846210806,-0.00461192384439895,0.0229693469270646,0.192072822805998
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37005,0.00678269225482585,0.00520465014590824,-0.0034184220311543,0.016983806540806,0.192529828619666
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36807,0.0113604794878328,0.00872113426466723,-0.005732943670915,0.0284539026465805,0.192721602680828
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37285,-0.00200815584516152,0.00155391154388969,-0.00505382247118531,0.00103751078086227,0.196267504976025
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,39302,0.00579705737448598,0.00449795144364747,-0.00301892745506306,0.014613042204035,0.197479391452176
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36877,0.00894772060614496,0.00696545098303025,-0.00470456332059433,0.0226000045328842,0.198959863620944
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,39638,0.00900807273565888,0.00702195898555009,-0.00475496687601929,0.0227711123473371,0.199565839924714
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,39207,0.00791260505323292,0.00616972027380627,-0.00418004668342737,0.0200052567898932,0.199690152463259
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,37203,0.00675338830173554,0.0052700665217128,-0.00357594208082156,0.0170827186842926,0.20005381974205
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCT,Secretin,36877,0.00504931188685222,0.00394233901731957,-0.00267767258709414,0.0127762963607986,0.200289944892829
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36855,0.00360940233811081,0.00281870014448797,-0.00191524994508562,0.00913405462130723,0.200385116761601
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,36855,0.00619249086918174,0.00484020651764842,-0.00329431390540915,0.0156792956437726,0.200784119393485
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36877,0.00732403089450437,0.00572970817571038,-0.00390619712988798,0.0185542589188967,0.201182150391019
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36827,0.00638302400049182,0.0050153176136187,-0.00344699852220083,0.0162130465231845,0.203145264492352
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39594,0.00224244095708609,0.00176244629346968,-0.00121195377811449,0.00569683569228667,0.203269121776272
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36827,0.00708723734426173,0.00557108166441235,-0.00383208271798648,0.0180065574065099,0.203343546662322
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,36877,-0.00470856716626358,0.00371086592056157,-0.0119818643705643,0.0025647300380371,0.204513897668078
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,36866,0.00780530681166362,0.00620615146994768,-0.00435875006943383,0.0199693636927611,0.208532756997908
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36896,0.00501297342693129,0.00398877811656247,-0.00280503168153114,0.0128309785353937,0.208859745309582
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,36827,-0.00392754625807973,0.00312875343327293,-0.0100599029872947,0.00220481047113522,0.209389936145957
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36877,-0.00741390284832684,0.00591594357194446,-0.019009152249338,0.00418134655268431,0.210152834239939
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39721,0.00294774825521852,0.00235357819239962,-0.00166526500188473,0.00756076151232177,0.210422972104202
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36855,0.00704057105005502,0.00563278252057979,-0.00399968269028137,0.0180808247903914,0.211348459067776
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,36877,0.00251420962717462,0.00201250168964991,-0.00143029368453919,0.00645871293888844,0.211579418286464
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37203,0.00677335801362532,0.00542486716206535,-0.00385938162402278,0.0174060976512734,0.211842164115973
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,37215,-0.0126223632680904,0.0101121633464203,-0.0324422034270742,0.00719747689089347,0.211966637569597
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,37005,0.00466348438688118,0.00374047845467511,-0.00266785338428204,0.0119948221580444,0.212507190160494
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,36896,0.0116397965196943,0.009343014560521,-0.00667251201892686,0.0299521050583155,0.212849647528653
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,39529,0.0034529845920941,0.00278257695350692,-0.00200086623677946,0.00890683542096766,0.214650005273691
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,36795,0.00806256030052476,0.00651729458310626,-0.00471133708236351,0.020836457683413,0.216071553917565
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39680,0.0084767161429221,0.00691306996728833,-0.00507290099296304,0.0220263332788072,0.22014658403638
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39817,-0.00464126829665555,0.00379430559574915,-0.0120781072643239,0.00279557067101278,0.221264895598759
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,39401,0.00572846931742591,0.00468579464606324,-0.00345568818885804,0.0149126268237099,0.221530258824435
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,39269,0.00992276128611243,0.00814355249597109,-0.00603860160599091,0.0258841241782158,0.223060021599619
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36795,0.00321197517280635,0.00263728237271612,-0.00195709827771724,0.00838104862332993,0.223280016660761
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,36855,0.0049709284736186,0.00409234711657239,-0.00305007187486328,0.0129919288221005,0.224506852147878
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,39133,0.00375419211478451,0.00309150797036433,-0.00230516350712957,0.00981354773669859,0.224630478828986
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,36855,-0.00394304079637684,0.00325374184255759,-0.0103203748077897,0.00243429321503604,0.225592574685084
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,36896,0.00615057747225016,0.00508802221228255,-0.00382194606382364,0.016123101008324,0.226748307659023
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37203,0.00722920200870827,0.00598227591574934,-0.00449605878616044,0.018954462803577,0.226900730260097
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,37220,0.00407996980016828,0.00337797907839597,-0.00254086919348783,0.0107008087938244,0.227140266305261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,39860,0.00631166774070262,0.00524732765418391,-0.00397309446149783,0.0165964299429031,0.229058095777125
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36855,0.00403561483557388,0.00335642889006473,-0.002542985788953,0.0106142154601008,0.229248411291018
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39557,-0.00383973885771761,0.00319619688080811,-0.0101042847441015,0.00242480702866629,0.229635076340685
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36896,0.00488560648340921,0.00408008830346112,-0.00311136659137459,0.012882579558193,0.231162072792285
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39637,0.00576505180977378,0.00483545684816295,-0.0037124436126256,0.0152425472321732,0.233182917706243
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39594,0.00275740591406145,0.0023216269821918,-0.00179298297103449,0.00730779479915738,0.23496793210826
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36855,0.0105655494226363,0.00891301458715707,-0.00690395916819156,0.0280350580134642,0.235878261760981
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36827,0.00874236150863921,0.0073785430619504,-0.00571958289278358,0.023204305910062,0.236104114480483
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,37268,0.00303855747737231,0.00257044919724322,-0.0019995229492244,0.00807663790396902,0.237182437658763
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,39401,0.00809432648331424,0.00684842767959859,-0.005328591768699,0.0215172447353275,0.237253626677571
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36877,-0.00404472092592584,0.00342416291985873,-0.010756080248849,0.00266663839699729,0.23753330003777
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36855,0.00488166881988086,0.00413670291830931,-0.00322626890000539,0.0129896065397671,0.237987265472623
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36877,0.00557510673959021,0.00474054329761975,-0.00371635812374449,0.0148665716029249,0.239597179929543
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36896,0.00496815232053078,0.00425689421614123,-0.00337536034310602,0.0133116649841676,0.24319787305867
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,36877,0.00621177516383264,0.00532825697739258,-0.00423160851185682,0.0166551588395221,0.243709605620069
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39743,0.00290398873125018,0.00249214091870771,-0.00198060746941694,0.00778858493191729,0.243931816054915
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36896,0.00987429809009455,0.00851241712674945,-0.00681003947833437,0.0265586356585235,0.246075109636788
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36855,-0.00339482836085754,0.00293174345212854,-0.00914104552702948,0.0023513888053144,0.246903491178806
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,39401,0.00339988906639074,0.00293698862416838,-0.00235660863697929,0.00915638676976077,0.247040785739663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,39302,0.00540789202314681,0.00467651436302625,-0.00375807612838463,0.0145738601746783,0.247538022781409
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,36795,0.0036605448944082,0.00316941652899078,-0.00255151150241374,0.00987260129123013,0.248128713533131
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,39266,0.00890159652016709,0.00773299650417982,-0.00625507662802536,0.0240582696683595,0.24970129013474
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36877,-0.00659525924837696,0.00573311921910419,-0.0178321729178212,0.00464165442106725,0.250008988899872
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,36958,0.00344099731237504,0.00299817846744027,-0.00243543248380789,0.00931742710855798,0.25111506172002
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AFM,Afamin,37285,0.00193090208696315,0.00168408537202274,-0.00136990524220143,0.00523170941612773,0.251584647509593
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36877,-0.00418863017403656,0.0036535181611501,-0.0113495257698908,0.00297226542181764,0.251623934225573
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,36920,0.0084153801882816,0.00735897020402408,-0.0060082014116056,0.0228389617881688,0.252829587140281
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,39673,-0.00780485357538472,0.0068313437706926,-0.0211942873659422,0.00558458021517279,0.253260910058731
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36877,0.00341010374145714,0.00299290863911921,-0.00245599719121652,0.0092762046741308,0.254559601398149
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,37215,-0.00723306893206284,0.00635966021294575,-0.0196980029494365,0.00523186508531083,0.255418359158731
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36855,0.00330874558646794,0.00291156743500265,-0.00239792658613725,0.00901541775907314,0.255804353938867
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,39401,0.00800276456355521,0.00704433781034955,-0.0058041375447299,0.0218096666718403,0.25595050812407
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39695,0.0120399156924235,0.0106714101559077,-0.00887604821315549,0.0329558795980026,0.259235514392084
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,36827,0.0111618901163102,0.00991998809850215,-0.00828128655675405,0.0306050667893744,0.260528556899761
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36880,-0.00333313788848449,0.00296484698081211,-0.00914423797087622,0.00247796219390725,0.260940774008476
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,36827,0.00486614143848496,0.00433844694706613,-0.00363721457776465,0.0133694974547346,0.262039659520718
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36855,0.00489594053224008,0.00436781667027654,-0.00366498014150194,0.0134568612059821,0.262345800987447
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,39567,-0.00597171892883621,0.00533734877586827,-0.016432922529538,0.00448948467186561,0.263219148443008
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,36855,0.00752890046310381,0.00673066361737229,-0.00566320022694588,0.0207210011531535,0.263332759755554
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,39668,-0.00473302552275504,0.00423398786575343,-0.0130316417396318,0.00356559069412169,0.263641776751279
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36896,0.00672072352599779,0.00602389517457699,-0.00508611101617312,0.0185275580681687,0.264580826167462
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37005,0.00628055185777596,0.00563275287934358,-0.00475964378573745,0.0173207475012894,0.26486834140541
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37244,0.0114642108509611,0.0102927449883658,-0.00870956932623588,0.0316379910281581,0.265378683645963
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39668,0.00328381221370875,0.00295463788539153,-0.00250727804165864,0.00907490246907615,0.266409086492186
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36880,0.00205866068143038,0.0018530774345329,-0.00157337109025411,0.00569069245311486,0.266614032534193
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39581,0.00459647766917683,0.00413750121706963,-0.00351302471627963,0.0127059800546333,0.26661511324954
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,36880,-0.00175160071885141,0.00158109221933723,-0.00485054146875237,0.00134734003104956,0.26795042655874
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39630,-0.0027918158564951,0.00252275262950355,-0.00773641101032206,0.00215277929733186,0.268460162318766
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,36827,0.00468478157039372,0.00423400767367199,-0.00361387347000337,0.0129834366107908,0.268545803714781
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39860,0.00306795807181699,0.00278085759541002,-0.00238252281518664,0.00851843895882063,0.269938807875374
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36855,0.00508179834946827,0.00461753472483626,-0.0039685697112108,0.0141321664101473,0.271115723643455
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36855,0.00605394570658806,0.00552192067025918,-0.00476901880711994,0.0168769102202961,0.27294690490845
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37005,0.00427260397574165,0.00390805085717341,-0.00338717570431824,0.0119323836558015,0.274289777740238
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36855,0.00382544246151581,0.00352354864123155,-0.00308071287529804,0.0107315977983296,0.277641212072812
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,37267,-0.00724043130140511,0.0066926613134294,-0.0203580474757267,0.00587718487291652,0.279340259369655
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36880,-0.024624057131113,0.0228783060753488,-0.0694655370387966,0.0202174227765706,0.281810387768069
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36896,0.0028258699930187,0.00262715158826695,-0.00232334711998453,0.00797508710602193,0.282108085647498
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,39401,0.00593853353559999,0.00552775122951252,-0.00489585887424456,0.0167729259454445,0.282699219059193
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36877,-0.00490601339814737,0.0045747094385546,-0.0138724438977144,0.00406041710141965,0.283550966330037
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36855,0.00843251215677637,0.00790033040312951,-0.00705213543335748,0.0239171597469102,0.285828246470667
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36795,0.00305929363662222,0.00286835123870769,-0.00256267479124485,0.00868126206448929,0.286186549607075
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39302,0.00507824436657885,0.00479232034950495,-0.00431470351845085,0.0144711922516086,0.289314533652275
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,37005,0.00372940170982404,0.00353992486128529,-0.00320885101829513,0.0106676544379432,0.292119500330239
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36896,0.00389507936371484,0.00370113207768357,-0.00335913950854496,0.0111492982359746,0.292634588502579
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,37244,-0.00419440866388145,0.0039873215323464,-0.0120095588672804,0.00362074153951749,0.292847721224373
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,36827,-0.00354714477735529,0.00337340326755992,-0.0101590151817727,0.00306472562706216,0.293047074452362
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,36880,0.00483892407810761,0.00460337758153423,-0.00418369598169948,0.0138615441379147,0.293200859433083
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,36855,0.0103150067208347,0.0098207094220387,-0.00893358374636113,0.0295635971880306,0.293584966284302
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36880,0.00383179281405125,0.00365828952878388,-0.00333845466236517,0.0110020402904677,0.294921927641726
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39673,0.0138337304134211,0.0132531344547649,-0.0121424131179182,0.0398098739447604,0.296590093800069
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36877,-0.00268712622429937,0.00257453884953602,-0.00773322236938996,0.00235896992079121,0.296629206740473
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,39673,0.0087300542499506,0.00837718900376856,-0.00768923619743577,0.025149344697337,0.297370980496204
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36880,0.00578189234292266,0.00555658967138334,-0.00510902341298868,0.016672808098834,0.298105192539412
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36855,-0.00367547721547425,0.00353858137701634,-0.0106110967144263,0.00326014228347777,0.298969820284509
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,39799,0.00389472106845326,0.00375714029565403,-0.00346927391102863,0.0112587160479352,0.299929422609442
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36855,0.00185913048239407,0.0017966634009254,-0.00166232978341972,0.00538059074820786,0.30079634718085
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,39401,0.00455069184491298,0.00439916673525627,-0.00407167495618931,0.0131730586460153,0.300944717487894
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,37244,0.00232494439485846,0.00224806778530355,-0.00208126846433649,0.00673115725405342,0.301062879658194
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36855,-0.00474385904044421,0.00459480424139342,-0.0137496753535753,0.0042619572726869,0.301885321684648
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36877,0.00308019102203088,0.00300678958730355,-0.00281311656908407,0.00897349861314584,0.305659802000271
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,39836,0.00546814559527664,0.00534930372559645,-0.00501648970689241,0.0159527808974457,0.306694004191657
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,39302,0.00290652710101992,0.0028459119612014,-0.00267146034293483,0.00848451454497466,0.307128789401596
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,36877,-0.0043835687820419,0.00429576974551099,-0.0128032774832434,0.00403613991915964,0.307539512820249
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,39680,0.00558872489192227,0.00548714843381309,-0.00516608603835139,0.0163435358221959,0.308450417856266
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36896,0.00452149988482129,0.00446564927326853,-0.00423117269078502,0.0132741724604276,0.311314628752443
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36855,0.00644314947586447,0.0063670603964651,-0.00603628890120712,0.0189225878529361,0.311580598507434
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39673,-0.0055789105375438,0.00551430778141813,-0.0163869537891233,0.00522913271403574,0.311689592342664
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,39865,0.00352965044280708,0.00349792848822597,-0.00332628939411583,0.01038559027973,0.31295690261978
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,36765,-0.00315248940848007,0.00314411889322913,-0.00931496243920917,0.00300998362224903,0.316042636356939
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36795,-0.00567939052534736,0.00567041528629159,-0.0167934044864789,0.00543462343578415,0.3165638584148
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36958,-0.00345215501990827,0.00345953109479005,-0.0102328359656968,0.00332852592588023,0.31836185468543
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,36877,0.00595351684546356,0.00598224799465268,-0.00577168922405569,0.0176787229149828,0.319658830502949
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37203,0.00505992578171144,0.00509699548972789,-0.00493018537815523,0.0150500369415781,0.32086094448701
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,36795,0.00528417687720753,0.00532789139032579,-0.00515849024783102,0.0157268440022461,0.321316012895264
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39673,0.00462035059800306,0.00466459944234345,-0.0045222643089901,0.0137629655049962,0.32193815315218
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,39860,0.00149088554219159,0.00150517299367573,-0.00145925352541283,0.00444102460979601,0.321940972989544
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39817,0.00407397002402028,0.00411892201765746,-0.00399911713058834,0.0121470571786289,0.322635835814065
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,39401,0.00275167521507968,0.00279091476542204,-0.00271851772514751,0.00822186815530687,0.324177780801804
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36827,0.00492821507106952,0.00501376877429575,-0.00489877172655015,0.0147552018686892,0.325657155025682
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39836,-0.00324758806756646,0.00331486785305512,-0.00974472905955449,0.00324955292442158,0.327247269131549
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,36827,0.00414463949171615,0.00425615251333862,-0.00419741943442754,0.0124866984178598,0.330174231210468
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36855,0.00317501544584087,0.00326217170468208,-0.00321884109533601,0.00956887198701776,0.330430909703496
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36765,-0.0076082354806155,0.00781981397849087,-0.0229350708784576,0.0077185999172266,0.33059972762296
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36958,-0.00243859111912565,0.00250723710291618,-0.00735277584084135,0.00247559360259006,0.330759729916982
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36795,0.00486766904219722,0.0050048479945666,-0.00494183302715333,0.0146771711115478,0.330774910938001
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,39401,0.0123950968729033,0.012781504820366,-0.012656652575014,0.0374468463208206,0.332177141068655
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36827,0.00416507107293724,0.00431969268701396,-0.00430152659361011,0.0126316687394846,0.334960931729099
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TTN,Titin,36855,-0.00585843018352273,0.0060871377311875,-0.0177892201366502,0.00607235976960477,0.335852694835508
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,36880,-0.00361710407852725,0.00376961446069557,-0.0110055484214906,0.00377134026443606,0.337303498971118
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,36827,0.00630522108829734,0.00658267768658488,-0.00659682717740903,0.0192072693540037,0.338156009989764
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,37244,-0.00310968053547922,0.00325002444054049,-0.00947972843893859,0.00326036736798015,0.338676617171441
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36795,0.00432114569452155,0.00451631013950817,-0.00453082217891447,0.0131731135679576,0.338692783515671
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36855,0.00405044667370873,0.00424215583385655,-0.00426417876065011,0.0123650721080676,0.339692281892994
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37220,0.00327007541348388,0.00342722810519505,-0.00344729167269841,0.00998744249966617,0.340027091940659
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36896,0.00318099069857135,0.0033378210039222,-0.00336113846911615,0.00972311986625886,0.340600563596987
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37005,0.0071198024583163,0.0074755155627277,-0.00753220804462999,0.0217718129612626,0.340903436275067
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39743,0.00227228164819274,0.00238746974266709,-0.00240715904743476,0.00695172234382024,0.341236712431984
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36880,0.00203613518468561,0.00214490867943793,-0.00216788582701274,0.00624015619638395,0.342491984523091
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36827,0.00463436590364533,0.00488377275936759,-0.00493782870471515,0.0142065605120058,0.342673127175397
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39401,-0.00226268840103364,0.00238578256981756,-0.00693882223787605,0.00241344543580877,0.342938001632686
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36795,0.00303460751427561,0.00321022734921065,-0.00325743809017727,0.00932665311872848,0.344526638638353
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39401,-0.00442806669204377,0.00469452888027094,-0.0136293432973748,0.00477320991328727,0.34557289991086
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39820,0.00517995107638609,0.00551136308499391,-0.00562232057020197,0.0159822227229742,0.347299750801671
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36827,0.0087969133918635,0.00937234538453195,-0.00957288356181912,0.0271667103455461,0.347951990203664
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,37260,-0.00311621788527771,0.00333548888591388,-0.00965377610166891,0.00342134033111348,0.350186002439532
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,36896,0.00524676037746847,0.00562916214948822,-0.00578639743552843,0.0162799181904654,0.351318786191326
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36855,0.00405148472052717,0.00435028265312559,-0.00447506927959899,0.0125780387206533,0.351707799797986
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36855,-0.00392464635902038,0.00421497017616314,-0.0121859879043001,0.00433669518625936,0.351808382976362
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39302,0.00578530684640711,0.0062243003990996,-0.0064143219358281,0.0179849356286423,0.352659565627471
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,36877,0.00496927799854654,0.00537307974827254,-0.00556195830806763,0.0155005143051607,0.355062515973291
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36896,0.00353890534111589,0.00384069557561567,-0.00398885798709083,0.0110666686693226,0.356846663029111
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,39401,0.00883603625473644,0.00960353249561635,-0.0099868874366716,0.0276589599461445,0.357544252341416
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,39737,0.00222107926485461,0.00241502138304382,-0.00251236264591127,0.00695452117562049,0.357746966739207
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39738,0.00471053849315955,0.00513856331423873,-0.00536104560274836,0.0147821225890675,0.359312003541969
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,36827,0.0047410335805476,0.00519274239823281,-0.0054367415199887,0.0149188086810839,0.361253462392455
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,37005,0.013395179487645,0.0146918525671267,-0.0154008515439234,0.0421912105192134,0.361921252649338
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,39401,0.00392903319071832,0.00432166732921038,-0.00454143477453402,0.0123995011559707,0.363286353516099
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37203,0.00788767813328288,0.00868034115702549,-0.00912579053448709,0.0249011468010528,0.363533911162946
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39302,0.00556007576759163,0.00612254858636241,-0.00644011946167868,0.0175602709968619,0.363823220454223
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36855,-0.0052192129242113,0.0057599051472713,-0.0165086270128631,0.00607020116444045,0.3648847606319
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39860,0.00252842433314229,0.00279756274259876,-0.00295479864235129,0.00801164730863586,0.366117509402224
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36985,0.00435995373438729,0.00482542434441217,-0.00509787798066056,0.0138177854494351,0.366257070324207
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,39836,0.00321014986332489,0.00356126158320354,-0.00376992283975405,0.0101902225664038,0.367384990821652
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,36855,0.00379672565141484,0.00423454064749979,-0.00450297401768475,0.0120964253205144,0.369944405237753
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,36855,0.00269506147868307,0.00301755670751313,-0.00321934966804267,0.00860947262540881,0.371805684967553
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,36827,0.00763281042995471,0.00858639747399856,-0.00919652861908246,0.0244621494789919,0.37405067360764
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39649,0.00517100230403592,0.00581724961787424,-0.00623080694699758,0.0165728115550694,0.37406582931573
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39738,0.00303784658234538,0.00341789769723302,-0.00366123290423134,0.0097369260689221,0.374121035160462
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37005,0.00563137218195438,0.00635085033205176,-0.00681629446886707,0.0180790388327758,0.375250453919609
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37267,-0.00280895518740492,0.00317530254613411,-0.00903254817782778,0.00341463780301795,0.376374243491309
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39673,0.00362989910482423,0.00410778543118966,-0.0044213603403075,0.011681158549956,0.376891448025976
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36795,0.00342255483827881,0.00387553636327434,-0.00417349643373889,0.0110186061102965,0.377189083042653
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36877,0.00474434550497045,0.00537273538591782,-0.00578621585142846,0.0152749068613694,0.377230439355694
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,36795,0.00559050676453591,0.00635911745386899,-0.00687336344504731,0.0180543769741191,0.379345773990636
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,36896,0.00795610898149577,0.00906068207735657,-0.00980282789012311,0.0257150458531147,0.379910184904167
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36795,0.0051337604339413,0.00585587751858937,-0.00634375950249387,0.0166112803703765,0.380673995369574
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,39401,0.00701721504593389,0.00801068131498015,-0.00868372033142721,0.022718150423295,0.381053194900734
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,37220,-0.00209344090255819,0.0023913795954353,-0.00678054490961138,0.002593663104495,0.381365849920196
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37005,-0.00666540811494481,0.00762902149509883,-0.0216182902453385,0.00828747401544889,0.382302464427757
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,36855,-0.00333557626392903,0.00382656254711316,-0.0108356388562708,0.00416448632841276,0.383393627220529
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,37267,0.00610255611413832,0.00700642988754225,-0.00763004646544448,0.0198351586937211,0.383773202198603
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37244,0.00282014140495088,0.00327537372792279,-0.00359959110177778,0.00923987391167954,0.389245963398299
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36896,0.00222914761517846,0.00259888649411466,-0.00286466991328629,0.0073229651436432,0.391056339905923
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37277,0.0046384031382859,0.00542021930038341,-0.00598522669046559,0.0152620329670374,0.392146207262566
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,37220,0.00171643170428609,0.00200708644030617,-0.002217457718714,0.00565032112728619,0.392463664486334
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37175,-0.00366306764507871,0.00429469836222012,-0.0120806764350301,0.00475454114487273,0.393714683722758
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,39666,0.0143427196883766,0.0168260861675595,-0.0186364092000401,0.0473218485767933,0.393999633189547
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39860,0.00510859090003144,0.00600116487527433,-0.00665369225550625,0.0168708740555691,0.394634043481806
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36896,0.00682987462514264,0.00805063825973878,-0.00894937636394536,0.0226091256142306,0.396250658178342
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36827,-0.00537836605398526,0.00635272673274754,-0.0178297104501704,0.00707297834219992,0.397220783056111
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,39401,0.00401187786378158,0.00474797431769793,-0.00529415179890636,0.0133179075264695,0.39814271308928
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,36855,0.00456719728492558,0.00541023789969199,-0.00603686899847072,0.0151712635683219,0.398586159953871
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36795,-0.0059803417049538,0.00712767697212536,-0.0199505885703195,0.0079899051604119,0.40146743756822
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,39714,0.0111929812523601,0.0133769987065538,-0.0150259362124854,0.0374118987172055,0.402755067256339
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,36795,0.00310548916009574,0.00373421054239188,-0.00421356350299235,0.0104245418231838,0.405632018677051
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39860,0.00167013300168933,0.00201626382338885,-0.00228174409215281,0.00562201009553146,0.407495659059343
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,36896,0.00343647720299499,0.00415017664040609,-0.00469786901220095,0.0115708234181909,0.40766779006228
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36827,0.00360325201619876,0.00436456968056302,-0.00495130455770476,0.0121578085901023,0.409063997746776
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36795,-0.00596755957888394,0.00724274892327395,-0.0201633474685009,0.008228228310733,0.409991272109051
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39288,-0.00236904817715621,0.00287599576701198,-0.00800599988049969,0.00326790352618726,0.410104895824678
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36795,0.00633360550572117,0.00771603950704191,-0.00878983192808099,0.0214570429395233,0.411754632063186
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36880,-0.00252818497207387,0.00308148398098583,-0.0085678935748061,0.00351152363065837,0.411978074212402
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37005,0.00478232435672038,0.00584510439190226,-0.00667408025140805,0.0162387289648488,0.413271505881522
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36880,0.00297128165771536,0.00363929922910851,-0.00416174483133731,0.010104308146768,0.41426154814096
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37005,0.00285971841759017,0.00350332199894834,-0.00400679270034859,0.00972622953552892,0.414350438571172
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37005,0.00326234519863017,0.00399889921519622,-0.00457549726315442,0.0111001876604148,0.414623133044374
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,39401,0.0051345085477149,0.00632298181306087,-0.0072585358058844,0.0175275529013142,0.41678162573588
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39529,0.00330688764299405,0.0040827482677349,-0.00469529896176636,0.0113090742477545,0.417971966716295
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36976,-0.00464118578628998,0.00573694214299168,-0.0158855923865537,0.00660322081397372,0.418529861613751
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36877,0.00451234851558783,0.00558837838591642,-0.00644087312080835,0.015465570151984,0.419420747426081
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,39592,0.00512593655644232,0.00635436580958811,-0.00732862043035037,0.017580493543235,0.419863359340397
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36896,0.00261526442375094,0.00324346622988836,-0.00374192938683025,0.00897245823433212,0.420074361806793
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,39668,0.00520414460685851,0.00645877029708493,-0.00745504517542795,0.017863334389145,0.420399986756953
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,37005,0.00368950522697926,0.00458552624927649,-0.00529812622160267,0.0126771366755612,0.421066250948194
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37005,0.00417794205435438,0.00522714081114527,-0.00606725393549035,0.0144231380441991,0.424143297295654
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36827,0.00290128633256804,0.00363033148617568,-0.0042141633803363,0.0100167360454724,0.424201002159411
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36795,0.00184103803462071,0.00230832972851736,-0.0026832882332733,0.00636536430251473,0.425138857790664
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,36795,0.00324467780705153,0.00406851059523562,-0.00472960295961029,0.0112189585737133,0.425169547887409
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37262,-0.00767926071821158,0.00965581118296338,-0.0266046506368198,0.0112461292003966,0.426453454366976
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37244,0.00277526655335861,0.00350827568907372,-0.00410095379722587,0.00965148690394309,0.428921336098192
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37005,0.00523644234460715,0.00662697540971398,-0.00775242945843225,0.0182253141476466,0.429442290878917
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,36855,0.00335304265025326,0.00424581802314595,-0.00496876067511281,0.0116748459756193,0.429700869450717
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,39401,0.00583260527385835,0.00740177735930846,-0.00867487835038623,0.0203400888981029,0.430708351893944
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,39401,-0.00327364616972182,0.00419196863193878,-0.0114899046883218,0.00494261234887818,0.434853862865422
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,39673,0.00233673735138196,0.00299247654339478,-0.00352851667367181,0.00820199137643573,0.434890216557893
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37005,-0.00304260048508605,0.00391745986548033,-0.0107208218214275,0.0046356208512554,0.437363409013144
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39738,0.00224904755761728,0.00290286673701692,-0.00344057124693588,0.00793866636217044,0.438488440642225
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39302,0.00339149634130001,0.00440260770830488,-0.00523761476697756,0.0120206074495776,0.441111161832363
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,37267,0.00340197532399946,0.00443023575887809,-0.00528128676340159,0.0120852374114005,0.442560485662386
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36827,0.00415828837380141,0.00545132983131651,-0.00652631809557895,0.0148428948431818,0.445595027661001
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,39720,0.00585948940620073,0.00776239971016173,-0.00935481402571626,0.0210737928381177,0.450346952134484
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,37244,-0.00541031881948252,0.00717200995798158,-0.0194674583371264,0.00864682069816139,0.450642891284291
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37005,0.00526675874421262,0.00698300973740394,-0.00841994034109909,0.0189534578295243,0.450727791463084
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36877,0.00236297058116216,0.00314122043827444,-0.00379382147785575,0.00851976264018007,0.451916723518417
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39675,0.0196308578951467,0.0261109255435495,-0.0315465561702102,0.0708082719605037,0.452167233647783
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37244,0.00158637255792775,0.00212431145078086,-0.00257727788560272,0.00575002300145823,0.455215384037467
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36855,0.00232628743023018,0.00312883463712241,-0.00380622845852975,0.00845880331899011,0.457192680331032
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39401,-0.003280535452457,0.00443495898585335,-0.0119730550647296,0.00541198415981556,0.459493728763264
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,36855,0.00308291887577838,0.00416982004795397,-0.00508992841821139,0.0112557661697682,0.459713320461948
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,39302,0.00512503939042467,0.00694455149607977,-0.00848628154189168,0.018736360322741,0.460529130096024
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,37285,0.0013365224469036,0.00182120041315309,-0.00223303036287646,0.00490607525668366,0.463041424462901
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,37277,-0.00405649359875788,0.00553618818970097,-0.0149074224505718,0.00679443525305603,0.463740063152995
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37285,-0.00213667296163189,0.00291988559318777,-0.00785964872427991,0.00358630280101613,0.464324186045158
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37203,0.00497394094767279,0.00682605053353304,-0.00840511809805197,0.0183529999933975,0.466216094033521
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,39680,0.00451480112862649,0.00620083977957221,-0.00763884483933505,0.016668447096588,0.466566142580342
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36827,0.00369907124542125,0.00513058221305387,-0.00635686989216433,0.0137550123830068,0.470931930072504
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,39658,0.00184842554205781,0.00257233361273728,-0.00319334833890725,0.00689019942302287,0.47241083335855
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,36795,0.00459429150304555,0.00643354068844879,-0.00801544824631408,0.0172040312524052,0.475168611488095
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,37244,0.00223535154620687,0.00313469242014944,-0.00390864559728602,0.00837934868969977,0.475795842152434
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36827,-0.00419455095122038,0.00588581490190025,-0.0157307481589449,0.00734164625650412,0.476072561789099
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,39302,0.00269471274133509,0.00379085548977711,-0.00473536401862805,0.0101247895012982,0.477190689050318
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,39220,-0.00743182966729281,0.0104859276241959,-0.0279842478107168,0.0131205884761312,0.478494621228674
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36827,-0.00189386725554663,0.00268164685114736,-0.00714989508379546,0.0033621605727022,0.480055996830005
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39401,0.00757555297767293,0.01076359483378,-0.0135210928965359,0.0286721988518817,0.481560070348139
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36827,0.00729249466538041,0.0103650673184319,-0.0130230372787461,0.0276080266095069,0.481716582568648
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39721,0.00177555505752438,0.00253982322693889,-0.00320249846727585,0.00675360858232461,0.484508489645252
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39401,0.00521211841459376,0.00745810538037985,-0.00940576813095074,0.0198300049601383,0.484654436217494
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37139,0.00187682394154411,0.00269802421512808,-0.00341130352010692,0.00716495140319514,0.486673360666122
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36827,0.0046523638555174,0.00669466914669843,-0.00846918767201152,0.0177739153830463,0.487108119160014
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39401,0.00372145893084603,0.00538555829995681,-0.00683423533706932,0.0142771531987614,0.489571410827284
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36896,0.00570950438518484,0.00828621385300902,-0.0105314747667128,0.0219504835370825,0.490812516552473
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36827,0.00269892829446949,0.00396973647815295,-0.00508175520271029,0.0104796117916493,0.49659515816903
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,39557,-0.00212775741844602,0.00314322007644495,-0.00828846876827813,0.00403295393138608,0.498456821151179
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,36896,0.00184480621212668,0.00274037752681342,-0.00352633374042761,0.00721594616468097,0.500835694942426
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,39622,-0.00354472206182865,0.00529754375750477,-0.013927907826538,0.0068384637028807,0.503425171195987
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,36795,0.00355768380048541,0.00532513967834779,-0.00687958996907625,0.0139949575700471,0.504086718786967
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36855,0.00376989627404516,0.00566290539853095,-0.00732939830707551,0.0148691908551658,0.505603383302717
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,39673,0.00200710907833711,0.00302236398930255,-0.00391672434069588,0.00793094249737011,0.506645065584888
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37104,0.00372291650676914,0.00562519288008115,-0.00730246153818993,0.0147482945517282,0.508092250022261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36958,-0.00189892769884497,0.00291051468322265,-0.00760353647796135,0.00380568108027142,0.514130700639701
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36855,-0.00300513174864798,0.00461029641594588,-0.0120413127239019,0.00603104922660594,0.514522061188858
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36877,0.00392912878915446,0.00606049965720136,-0.0079494505389602,0.0158077081172691,0.516790967713252
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,39579,0.00390117265596287,0.00601918557422046,-0.00789643106950922,0.015698776381435,0.516914861048856
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36795,-0.00279383066407978,0.00434850584618109,-0.0113169021225947,0.00572924079443516,0.520572565752013
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36877,0.00183346979709469,0.00285991214555264,-0.00377195800818849,0.00743889760237787,0.521473516717036
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36855,-0.00222415198090797,0.00347691661321303,-0.00903890854280552,0.00459060458098957,0.52238483766162
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36827,-0.00243230587326632,0.00382034980916558,-0.00992019149923086,0.00505557975269822,0.52435041600307
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37268,0.0019224775218508,0.00303150203373928,-0.00401926646427819,0.0078642215079798,0.525982881622804
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39738,0.00232528218321339,0.00368755891176304,-0.00490233328384218,0.00955289765026895,0.528327574045284
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,36896,0.0027366361795013,0.0043752976780294,-0.00583894726943633,0.0113122196284389,0.531670770895876
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36877,0.00377663317200787,0.00605243312987887,-0.00808613576255472,0.0156394021065705,0.532647753811135
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39302,0.00315400119289763,0.00506281082139924,-0.00676910801704488,0.0130771104028401,0.533310589034043
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39810,-0.00258626460028749,0.00415468816636194,-0.0107294534063569,0.00555692420578191,0.533626596736674
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36855,-0.00534307024884715,0.00866652519586305,-0.0223294596327387,0.0116433191350444,0.537563383727488
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39647,0.00398127998057822,0.006469082332195,-0.00869812139052398,0.0166606813516804,0.53827836574709
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36827,0.00380644744674393,0.00618981550316916,-0.00832559093946763,0.0159384858329555,0.538596355192661
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,39401,0.0026959478461423,0.00441612941376171,-0.00595966580483065,0.0113515614971153,0.541554440410147
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,37267,-0.00424930741609276,0.00696365529802877,-0.0178980718002291,0.00939945696804363,0.541731592193402
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39288,0.00422744185708249,0.00694090163308689,-0.0093767253437678,0.0178316090579328,0.542492080354661
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,39860,0.00279956284912321,0.00460751159008525,-0.00623115986744388,0.0118302855656903,0.543455836652912
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36877,0.00195483082181153,0.00324811941545043,-0.00441148323247132,0.00832114487609438,0.547294687459628
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,36546,0.00374660385636332,0.00624414248342366,-0.00849191541114705,0.0159851231238737,0.548504319344835
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37255,0.00129690511549208,0.00217180350699737,-0.00295982975822277,0.00555363998920693,0.550413442574316
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,39401,-0.00212967379195813,0.00356849232117711,-0.00912391874146526,0.00486457115754901,0.550650065331332
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,39865,0.00411209798582673,0.00690527617668654,-0.00942224332047889,0.0176464392921323,0.551517136340647
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,39668,-0.00237825852851991,0.00399741747455307,-0.0102131967786439,0.0054566797216041,0.551886245169502
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36795,-0.00138403766842869,0.00232899268846157,-0.00594886333781338,0.00318078800095599,0.552345613712691
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36827,-0.00210798105690772,0.00354839149065312,-0.00906282837858784,0.0048468662647724,0.552477897009695
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39669,0.00225030420128781,0.0037999420238754,-0.00519758216550798,0.0096981905680836,0.553728920806464
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,36896,0.00250528336002269,0.00423645256789684,-0.00579816367305511,0.0108087303931005,0.554287154017759
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39401,0.00197873290050106,0.00335528430714384,-0.00459762434150086,0.00855509014250298,0.555376038572248
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39288,-0.0063034068928919,0.010704946894999,-0.02728510280709,0.0146782890213062,0.555983124238432
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39736,-0.0042030396450643,0.00715270124515655,-0.0182223340855711,0.00981625479544255,0.556798618787149
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,39694,0.00481289252805823,0.00821764553901953,-0.01129369272842,0.0209194777845365,0.558100405159331
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36795,0.00204528871645816,0.00350423166859514,-0.00482300535398832,0.00891358278690464,0.559457559303158
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37267,0.00207175476295205,0.0035714267685934,-0.00492824170349101,0.00907175122939511,0.561862578766678
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,37262,0.00289131911480796,0.0049999526022735,-0.0069085879856481,0.012691226215264,0.563092031108067
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36795,0.00237784124332685,0.0041201132819047,-0.00569758078920636,0.0104532632758601,0.563861640403087
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39401,-0.0031762955450544,0.0055148016361589,-0.0139853067519258,0.00763271566181704,0.564651736097679
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37244,0.00212583110278649,0.00370277684554327,-0.00513161151447832,0.0093832737200513,0.56589755305005
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,36827,-0.00327628216635123,0.00570995721032821,-0.0144677982985945,0.00791523396589206,0.566123919513338
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37203,0.00270795811424063,0.00475402162554491,-0.00660992427182738,0.0120258405003086,0.568949000251438
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,36880,-0.0011511935723598,0.00202793576453162,-0.00512594767084177,0.00282356052612218,0.570270435612412
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,37220,-0.00283437235346268,0.00501386801402135,-0.0126615536609445,0.00699280895401916,0.571874777317288
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36795,0.00181584403733386,0.0032244504735195,-0.00450407889076436,0.00813576696543207,0.573343615704706
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39594,0.00527837096352536,0.00939056593315267,-0.0131271382654539,0.0236838801925046,0.574060694500301
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39860,-0.00116382097816076,0.00208503305322664,-0.00525048576248497,0.00292284380616345,0.576730194314859
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,39720,-0.00280841500348493,0.00505809452019973,-0.0127222802630764,0.00710545025610654,0.578743940654646
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36877,0.00247666513572071,0.00446634018392994,-0.00627736162478197,0.0112306918962234,0.579234053586855
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36927,0.00241965376842841,0.00436401770739405,-0.00613382093806392,0.0109731284749207,0.579276618118416
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39288,-0.00171518783743292,0.00310820046103498,-0.00780726074106147,0.00437688506619564,0.581075121635165
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36880,-0.0012992435048346,0.00236061677488519,-0.00592605238360958,0.00332756537394038,0.582066101170081
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37268,0.00141356066758559,0.00259641792199008,-0.00367541845951496,0.00650253979468614,0.586156552275463
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,39302,0.00188328140889884,0.00347539630964874,-0.00492849535801269,0.00869505817581038,0.58790232227762
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36795,-0.00296197831764487,0.00547414743105063,-0.0136913072825041,0.00776735064721437,0.588458408448712
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,36795,0.00551069016035888,0.0102941276944082,-0.0146658001206811,0.0256871804413989,0.592435268298057
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,39668,0.00159980672533282,0.00299729008558792,-0.0042748818424195,0.00747449529308514,0.593521290437161
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39302,0.0015455966876704,0.00290246493396803,-0.00414323458290694,0.00723442795824774,0.594379266479999
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39653,-0.0028663230531627,0.00538746527512599,-0.0134257549924096,0.00769310888608424,0.594708857505015
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36795,0.00376276154065089,0.00708649935239934,-0.0101267771900518,0.0176523002713536,0.595444481957932
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,36855,-0.00146206344798716,0.00277383323254949,-0.00689877658378417,0.00397464968780985,0.598139164741078
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36983,0.00239122154661212,0.0046685379175443,-0.00675911277177471,0.0115415558649989,0.608520198641125
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39401,-0.00270027603964723,0.00531963560932182,-0.013126761833918,0.00772620975462355,0.611737269548901
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37244,0.00157759108455661,0.00319676400911416,-0.00468806637330714,0.00784324854242037,0.621670078827276
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36827,0.00401724809838217,0.00817778039490827,-0.012011201475638,0.0200456976724024,0.623265435042021
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ERVV_1,,36855,0.00209961058791908,0.00427745240447664,-0.00628419612485514,0.0104834173006933,0.623537015998664
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36877,0.00161031373100814,0.00328863950613425,-0.00483541970101499,0.00805604716303127,0.62438308336353
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36795,0.00218406072561011,0.00447344008807313,-0.00658388184701323,0.0109520032982335,0.625396310207529
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,36795,-0.00176618427416433,0.00362632689329719,-0.00887378498502682,0.00534141643669815,0.626234715506838
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36795,0.00358950857719347,0.00738217669918854,-0.0108795577532161,0.018058574907603,0.626805349513945
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37244,0.00334303138790667,0.00688007780942298,-0.0101419211185624,0.0168279838943757,0.627045860193965
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38883,0.00123875611342375,0.00257556319589625,-0.0038093477505329,0.0062868599773804,0.630548279109135
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36795,-0.00173724360595312,0.00361898226153855,-0.00883044883856868,0.00535596162666245,0.631209551112192
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39511,-0.00264289306382056,0.00558882518951018,-0.0135969904352605,0.0083112043076194,0.636299081452198
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,36877,0.00205450585506786,0.00434491034817331,-0.00646151842735182,0.0105705301374876,0.636325664601198
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39615,0.00780597143366589,0.0165885646053392,-0.024707615192799,0.0403195580601308,0.637959060488064
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,39401,0.00179969116002599,0.00384097630945957,-0.00572862240651477,0.00932800472656675,0.639397577079416
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36998,-0.00411978728868409,0.00881789036327538,-0.0214028524007038,0.0131632778233356,0.6403589512354
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,39860,0.00205798925353906,0.00442518324937937,-0.00661536991524451,0.0107313484223226,0.6418926291295
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37005,0.00356550679420252,0.00769611913362749,-0.0115188867077074,0.0186499002961124,0.643166812551108
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36673,-0.00131264678354773,0.00284546126254857,-0.00688975085814292,0.00426445729104747,0.644582265218408
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37267,0.00121185016326792,0.00263049783640409,-0.00394392559608409,0.00636762592261993,0.645026834784538
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,37244,-0.00631066417824135,0.0139769871082937,-0.033705558910497,0.0210842305540143,0.65163373117128
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39302,0.0021545048457643,0.00485656638365972,-0.00736436526620875,0.0116733749577373,0.657318367544883
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36877,0.00190232127897703,0.00430806809788004,-0.00654149219286785,0.0103461347508219,0.658806446657528
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39401,-0.00129972073058735,0.00294777138401231,-0.00707735264325147,0.00447791118207677,0.659279657593134
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39643,0.000764040939862261,0.00174420907390987,-0.00265460884500108,0.00418269072472561,0.661360124835262
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,36795,0.00278125145286486,0.00638492746207941,-0.00973320637281079,0.0152957092785405,0.663136847575298
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37005,0.00209227945568159,0.00481385470995791,-0.00734287577583592,0.0115274346871991,0.663833055508636
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,39860,0.00163614766076848,0.00376675524830642,-0.00574669262591211,0.00901898794744907,0.664029070819253
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,37005,0.00136410776787887,0.00315694325797445,-0.00482350101775107,0.0075517165535088,0.665677529038257
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36765,0.00202106009889873,0.00469183241454116,-0.00717493143360194,0.0112170516313994,0.666649094122183
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36765,0.00302145783672682,0.00703901068334207,-0.0107750031026236,0.0168179187760773,0.667752341678053
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36855,0.00441882936711443,0.010298419433207,-0.0157660727219713,0.0246037314562002,0.667873281368833
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36795,-0.000972466177004645,0.00227001024473028,-0.00542168625667599,0.0034767539026667,0.668369049782682
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37220,0.0010431360674174,0.00249325379723603,-0.00384364137516522,0.00592991351000001,0.675673526843669
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,39817,-0.00281111743102465,0.0067280297001785,-0.0159980556433745,0.0103758207813252,0.676083038095651
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,36827,0.00161485603293375,0.00386838445880741,-0.00596717750632877,0.00919688957219627,0.676356400868184
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,39673,0.00214058086100118,0.00512808504927079,-0.00791046583556958,0.0121916275575719,0.676374670935696
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,39401,0.00115340409213477,0.00276987149658886,-0.00427554404117941,0.00658235222544894,0.677115260334024
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,36855,0.00142462943872468,0.00342231380362759,-0.00528310561638541,0.00813236449383476,0.677214427355412
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36877,0.00173673077357204,0.00418637355140345,-0.00646856138717872,0.00994202293432281,0.678256154316567
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37285,0.000702277381993725,0.00169759413995444,-0.00262500713231698,0.00402956189630443,0.679107905490763
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,37285,0.00152053016649677,0.00367656683520447,-0.005685540830504,0.00872660116349754,0.679193179240978
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,37005,0.00215807800437985,0.00522730023137242,-0.0080874304491101,0.0124035864578698,0.679725057062742
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36880,-0.00309145330465541,0.00753078553512411,-0.0178517929534987,0.0116688863441878,0.681439546245815
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37215,-0.00179916410811303,0.00445069576080441,-0.0105225277992897,0.00692419958306361,0.686040261408897
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,36827,0.00223161830583594,0.00552473147342724,-0.00859685538208145,0.0130600919937533,0.686269056280545
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39720,0.0017566065935853,0.00436890621275222,-0.00680644958340906,0.0103196627705797,0.687637849035849
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,37203,0.00178647139074182,0.0044459539695489,-0.00692759838957402,0.0105005411710577,0.687823241237389
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39720,0.00318259087288214,0.00796234913817836,-0.0124236134379474,0.0187887951837117,0.689379181319097
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,38538,0.00139228424583397,0.00349407741123068,-0.00545610748017817,0.0082406759718461,0.690289728414721
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36855,-0.00204323887667945,0.0051384798327475,-0.0121146593488646,0.00802818159550566,0.690905867563666
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,36855,-0.00132964076700586,0.00334534528532827,-0.00788651752624928,0.00522723599223755,0.691034843375288
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,36934,0.0019781868409209,0.00506497257718684,-0.0079491594103653,0.0119055330922071,0.696127232912538
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36855,-0.00176349094099452,0.00453313215499037,-0.0106484299647756,0.0071214480827866,0.697265788595038
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,36795,-0.00184512138730448,0.00479325425225587,-0.011239899721726,0.00754965694711702,0.700287256241773
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,36795,0.00106013157508753,0.00275896676952294,-0.00434744329317743,0.0064677064433525,0.700799856899407
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36855,0.00295513624858988,0.0077502527809574,-0.0122353592020866,0.0181456316992664,0.702990250991321
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37215,0.00111441469279457,0.00293402173635319,-0.00463626791045768,0.00686509729604681,0.704081391672814
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36877,-0.00120224705741772,0.00319707540110801,-0.00746851484358942,0.00506402072875399,0.706888910241414
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36795,0.00198820840712321,0.00530908848164203,-0.00841760501689517,0.0123940218311416,0.708044832582438
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37220,0.000890242950540096,0.00238369292014589,-0.00378179517294584,0.00556228107402604,0.708802985602333
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36795,-0.00189592370366428,0.00511674089215998,-0.0119247358522978,0.00813288844496929,0.71099111814231
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37005,0.00141945923411848,0.0038497734646015,-0.00612609675650045,0.00896501522473742,0.712348039162377
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,36827,0.00293194914334131,0.00805869272008375,-0.0128630885880228,0.0187269868747054,0.715995063331261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36795,-0.00119719654969828,0.00330917628690386,-0.00768318207202983,0.00528878897263328,0.717521726775864
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39401,0.00192818329402819,0.00532984626268409,-0.00851831538083261,0.012374681968889,0.717528156096581
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,39529,-0.00402211653648694,0.0111723011692292,-0.0259198268281762,0.0178755937552023,0.718846087637963
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,36877,-0.0012441508115234,0.00346711745200382,-0.00803970101745088,0.00555139939440408,0.719718366102533
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,39860,0.00230962737788567,0.00648938517860558,-0.0104095675721813,0.0150288223279526,0.721913778477078
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37203,0.00140158492637548,0.00394113583887529,-0.00632304131782009,0.00912621117057105,0.722123525944406
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37203,0.00264739927934094,0.00744779481064985,-0.0119502785495328,0.0172450771082146,0.722250007972663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36795,-0.00177042627105853,0.00501204031773502,-0.0115940252938192,0.00805317275170211,0.723918294865027
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36958,-0.00115115511354325,0.00330792440259602,-0.00763468694263145,0.00533237671554494,0.727846361296915
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36855,0.00105990407485045,0.00307555155466912,-0.00496817697230103,0.00708798512200192,0.730383811875611
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36795,-0.00147431772866237,0.00431583363415475,-0.00993335165160568,0.00698471619428094,0.732652436031186
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37220,-0.0018786406106195,0.00550163629461646,-0.0126618477480678,0.00890456652682876,0.732755584876822
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37203,-0.00144854005186423,0.00427326681899724,-0.00982414301709883,0.00692706291337037,0.734632235063581
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36855,0.00151980366281616,0.004520790878365,-0.00734094645877925,0.0103805537844116,0.736739863626821
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,36795,-0.00236441918175681,0.00708642650533641,-0.0162538151322162,0.0115249767687026,0.738645579963401
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39668,0.00104841302761422,0.00315518047710878,-0.00513574070751898,0.00723256676274742,0.739679934871255
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36855,0.00248638195315799,0.00757953731112959,-0.012369511176656,0.017342275082972,0.742887648170504
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,39616,0.000859688640323497,0.00266004418224827,-0.00435399795688311,0.00607337523753011,0.746558785307596
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36795,-0.00189569716829626,0.00592757800800806,-0.0135137500639921,0.00972235572739954,0.749117730482378
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39288,0.000995113369243263,0.00316494949410384,-0.00520818763920025,0.00719841437768678,0.753208731153537
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36795,0.00177476342739604,0.00565146192909013,-0.00930210195362061,0.0128516288084127,0.753498636232847
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36880,0.00112604142387754,0.00361252478233452,-0.00595450714949812,0.0082065899972532,0.75526984767394
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36855,-0.00155324158003404,0.00500435946975115,-0.0113617861407463,0.00825530298067822,0.756278728049192
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36827,0.000896386064194775,0.00288854033581215,-0.00476515299399703,0.00655792512238658,0.756318865776199
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,37005,-0.00146293212288255,0.0047168469780031,-0.0107079521997686,0.00778208795400352,0.756451480255747
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36877,0.00232120941956502,0.00755252874701486,-0.0124817469245841,0.0171241657637141,0.758587973924124
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39743,-0.000706519883262678,0.00231514814890411,-0.00524421025511473,0.00383117048858938,0.760238664591233
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36855,0.00192383697371543,0.00637762986147044,-0.0105763175547666,0.0144239915021975,0.762920735074895
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37268,0.000680168182669855,0.00227242223466401,-0.0037737793972716,0.00513411576261131,0.764704980506685
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39302,0.0014302314138419,0.00479347541295485,-0.00796498039554961,0.0108254432232334,0.76542445485504
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36877,-0.00133877823699445,0.0045607669169484,-0.0102778813942133,0.00760032492022441,0.769112313780781
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,37005,0.00111967995698795,0.0038299321114014,-0.0063869869813588,0.0086263468953347,0.770023786110219
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39668,0.00103040190942968,0.0035582871164621,-0.00594384083883603,0.0080046446576954,0.772142845193744
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39675,-0.000862154063482505,0.00302024385198189,-0.00678183201336702,0.00505752388640201,0.775296687578079
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36827,-0.00216021107145604,0.007591068234963,-0.0170387048119835,0.0127182826690714,0.775976044244792
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36855,0.00169554268055457,0.00598844289719269,-0.0100418053979431,0.0134328907590522,0.777077235393191
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39673,0.00126699105752992,0.00449334669809323,-0.00753996847073281,0.0100739505857927,0.777969847347402
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36855,-0.00161281289539941,0.00574532222988027,-0.0128736444659647,0.00964801867516591,0.778931500366781
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36827,0.00086195026409206,0.00307191779749732,-0.00515900861900268,0.0068829091471868,0.779029151167899
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37244,0.0012939220151191,0.00463801185584726,-0.00779658122234152,0.0103844252525797,0.780262917175137
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37005,0.00167889752831601,0.0060515124662972,-0.0101820669056265,0.0135398619622585,0.7814509589158
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36896,0.00112202233193173,0.00404985732055029,-0.00681569801634683,0.00905974268021029,0.781744331663792
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,39614,0.00112875020621194,0.00412816328832624,-0.00696244983890749,0.00921995025133136,0.784528788847877
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,37005,0.00137591987510822,0.00510315002590891,-0.00862625417567324,0.0113780939258897,0.787455552997901
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36896,0.00174241832884771,0.00649526415329517,-0.0109882994116108,0.0144731360693062,0.788503584215674
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,37005,0.00172820668841952,0.00647770352137785,-0.0109680922134811,0.0144245055903201,0.789632642051613
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36827,0.00146122447269626,0.00549056276959884,-0.00930027855571747,0.01222272750111,0.790140376588128
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,39668,-0.000604094260425417,0.00228546164009531,-0.00508359907501221,0.00387541055416138,0.791536445633257
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36827,0.00126814263943897,0.00481102395134882,-0.00816146430520471,0.0106977495840827,0.792099278714917
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,39401,-0.000665683981629593,0.00253457289645753,-0.00563344685868635,0.00430207889542717,0.792830405551894
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37220,0.00133995139998613,0.00512038651703313,-0.00869600617339881,0.0113759089733711,0.793564868565777
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36855,-0.00108339303067027,0.00414697806135937,-0.00921147003093463,0.0070446839695941,0.793904789624378
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39288,0.00139522837217105,0.00534850327682476,-0.00908783805040547,0.0118782947947476,0.794201386545212
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36795,0.0021148849538205,0.00813410115414153,-0.0138279533082969,0.0180577232159379,0.794866142883196
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37203,-0.00121225536002803,0.00474816535567601,-0.010518659457153,0.00809414873709694,0.798487406641774
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,36929,-0.00316969010957005,0.0126264291229471,-0.0279174911905464,0.0215781109714063,0.801790109639619
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,39600,-0.00166034786023513,0.00667896280521233,-0.0147511149584513,0.011430419237981,0.803678350481887
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37244,-0.00065479529861646,0.00264465539321766,-0.00583831986932307,0.00452872927209016,0.804453963330109
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39401,0.00119808310079133,0.00486116862930912,-0.00832980741265454,0.0107259736142372,0.805329502755169
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36855,0.000877038375043546,0.00365344254718371,-0.00628370901743652,0.00803778576752361,0.810289023834279
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,38940,0.000597936103511854,0.00249509111289494,-0.00429244247776222,0.00548831468478593,0.810608735105759
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,36958,0.00110950793265467,0.00470592775042099,-0.00811411045817047,0.0103331263234798,0.813616261590953
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36877,-0.000886382778585055,0.00380942514510511,-0.00835285606299107,0.00658009050582096,0.816012389616685
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,37285,0.00045690918129708,0.00197244372286596,-0.00340908051552021,0.00432289887811437,0.816816316681661
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36972,-0.0010455515140681,0.0045238048948404,-0.00991220910795527,0.00782110607981908,0.817223513806522
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36827,0.000573626010151923,0.00251108604593895,-0.00434810263988841,0.00549535466019226,0.81930980594226
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,36737,0.000696792837253745,0.00305524312692616,-0.00529148369152152,0.00668506936602901,0.819599632084636
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36795,-0.00101337586642847,0.00444766715064145,-0.00973080348168571,0.00770405174882877,0.81977084208491
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,39594,-0.00147817078801012,0.00679878644769291,-0.0148037922254882,0.011847450649468,0.827886313771526
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37267,-0.00114015413888842,0.00526664125763176,-0.0114627710038467,0.00918246272606983,0.828612224687704
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37203,0.000867956442299478,0.00410358573171926,-0.00717507159187027,0.00891098447646923,0.83249122465366
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37268,0.000561589239369537,0.0026565197465281,-0.00464518946382554,0.00576836794256461,0.832578086249837
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39302,-0.000869841077993097,0.00416411435952817,-0.00903150522266831,0.00729182306668211,0.834537010532998
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36855,0.00100766459236731,0.00483562753791936,-0.00847016538195464,0.0104854945666893,0.83493286884628
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36855,-0.000725599574347354,0.00358867071926664,-0.00775939418410997,0.00630819503541526,0.83976999598004
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,36877,-0.00106104375403773,0.00525310455059566,-0.0113571286732052,0.00923504116512976,0.839932287051394
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36877,0.000756378038497581,0.00386057783327732,-0.00681035451472596,0.00832311059172113,0.844673077846735
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,36877,0.00138234851072076,0.00711959666026646,-0.0125720609434015,0.015336757964843,0.846052793611295
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37203,-0.000760148798556271,0.00395189789896602,-0.00850586868052967,0.00698557108341713,0.847470737149799
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37005,-0.000466679385255166,0.0024662836802937,-0.00530059539863081,0.00436723662812048,0.8499203949963
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36827,0.000974344314936567,0.00528632999904356,-0.00938686248318881,0.0113355511130619,0.853770060251863
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,39793,0.00117098654876572,0.00636758389528762,-0.011309477885998,0.0136514509835295,0.854095739431869
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37244,-0.000515797664407119,0.0028322557144901,-0.00606701886480772,0.00503542353599348,0.855494843291274
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36877,0.00050903573740141,0.00282987512604352,-0.00503751950964388,0.0060555909844467,0.857250187127942
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,36795,0.000839210920634684,0.00471494097100742,-0.00840207338253985,0.0100804952238092,0.858733853388559
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37220,0.000569647375656017,0.00321107147094288,-0.00572405270739203,0.00686334745870406,0.859196090300721
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,37267,0.000700485187714341,0.00395425267266478,-0.00704985005070862,0.0084508204261373,0.859395364713183
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36877,-0.000742568822356443,0.00430935793955811,-0.00918891038389034,0.00770377273917745,0.863192241290142
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,36795,0.000668355532289463,0.00392506826530202,-0.00702477826770249,0.00836148933228141,0.864793622525361
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36855,0.000537330330728359,0.00328536574547244,-0.00590198653039763,0.00697664719185435,0.870085852234285
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39288,0.000753523049940792,0.00463533639373776,-0.00833173628178522,0.0098387823816668,0.870866542505441
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36827,0.000486169541170946,0.00301186626600928,-0.00541708834020725,0.00638942742254914,0.87176667605999
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37005,0.000572882297185162,0.00355178348832065,-0.00638861333992332,0.00753437793429365,0.871864120992608
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,39607,0.000453363859325272,0.0028620889458231,-0.005156330474488,0.00606305819313854,0.874141175458427
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,36795,0.00076095831071773,0.00483931809503875,-0.00872410515555821,0.0102460217769937,0.875054261663381
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39302,0.000657142147441893,0.00418240269849676,-0.00754036714161176,0.00885465143649555,0.875151757824356
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36855,-0.00064669775719896,0.00412740373297212,-0.0087364090738243,0.00744301355942639,0.875496402022243
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39798,0.000857227628891891,0.0055293572254044,-0.00998031253290073,0.0116947677906845,0.876798007557076
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36855,-0.000577466406221134,0.00386578341025479,-0.00815440189032053,0.00699946907787826,0.88125699208022
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,39288,0.00181527740200362,0.0122531264832576,-0.0222008505051813,0.0258314053091886,0.882227826369362
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36896,0.000286352078456837,0.00193672982457694,-0.00350963837771396,0.00408234253462764,0.882460756477649
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36855,-0.000425230280626196,0.00297911235374261,-0.00626429049396171,0.00541382993270932,0.886499916036448
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,36795,0.000554131263908664,0.00400394838895365,-0.00729360757844049,0.00840187010625782,0.889929450099436
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39817,-0.000868822085680482,0.00629903736242588,-0.0132149353160352,0.0114772911446742,0.890297999935135
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,36896,-0.000522161557659437,0.00387917284570666,-0.00812534033524448,0.00708101721992561,0.892925145835883
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,37268,0.000309732231515656,0.00231620856284371,-0.00423003655165802,0.00484950101468934,0.893622984319701
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36855,0.000316164477273693,0.00248336108379788,-0.00455122324697015,0.00518355220151754,0.898694536974986
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,36877,-0.00104367996155403,0.00822320639283388,-0.0171611644915084,0.0150738045684004,0.899006581447422
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,39741,-0.000713493849989478,0.00571920466838783,-0.0119231350000296,0.0104961473000507,0.900719858058976
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36827,0.000356337450140928,0.00302590436158441,-0.00557443509856452,0.00628710999884637,0.90625782767275
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,39680,-0.000449486978652145,0.00382054035989074,-0.007937746084038,0.00703877212673371,0.906346395260304
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,39675,0.000361254026452612,0.00311587571629618,-0.0057458623774879,0.00646837043039313,0.907701719722374
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36896,0.000353278267785785,0.00322195592675296,-0.00596175534865001,0.00666831188422158,0.912690907709199
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36795,-0.000290172527903363,0.00271067726767971,-0.0056030999725556,0.00502275491674887,0.914752575451182
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36880,0.000335762568629355,0.00319700705558525,-0.00593037126031774,0.00660189639757645,0.916358357849563
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36877,0.000591336678916066,0.00611294605846322,-0.0113900375956718,0.012572710953504,0.92293822403116
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39288,0.000283644425435909,0.00306753764681499,-0.00572872936232147,0.00629601821319328,0.926328618367638
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36827,0.00062974798050699,0.0068490751057894,-0.0127944392268402,0.0140539351878542,0.926742025022104
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36827,0.000262559595113535,0.00286899770679783,-0.00536067591021021,0.00588579510043728,0.927083896010404
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36827,0.000585722509458362,0.00653708321585993,-0.0122269605936271,0.0133984056125438,0.928606486040654
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36827,0.000592208755337434,0.0066852729343766,-0.0125109261960407,0.0136953437067156,0.929413828303995
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,36877,0.000272531660468515,0.00312901826737183,-0.00586034414358027,0.0064054074645173,0.930594846241667
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37005,0.000335350337012569,0.00388120349656837,-0.00727180851626143,0.00794250919028657,0.931146822895876
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36855,0.000350896657825135,0.00406653796364544,-0.00761951775091992,0.00832131106657019,0.931238175520468
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36877,0.000391540953474019,0.0045598796440398,-0.00854582314884399,0.00932890505579203,0.931573854499628
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,36827,0.000346949393934208,0.004177884114388,-0.00784170347026627,0.00853560225813469,0.933817609682056
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36896,-0.000564983473611972,0.00683871449133038,-0.0139688638766195,0.0128388969293956,0.934158584550261
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39401,0.000414485274929255,0.00503406324024952,-0.00945227867595981,0.0102812492258183,0.934380486361793
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37267,0.000184671137123066,0.0022667758850622,-0.00425820959759885,0.00462755187184498,0.93507048370757
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,39817,-0.000219366520443622,0.00274830823557331,-0.0056060506621673,0.00516731762128006,0.936382414673031
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,36795,0.000327933290998766,0.00417285621422014,-0.00785086488887272,0.00850673147087025,0.9373621454794
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39401,-0.000228358698174237,0.00297638036250995,-0.00606206420869373,0.00560534681234526,0.938844395565266
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39594,0.000139008183719516,0.00184300794841527,-0.00347328739517442,0.00375130376261345,0.939877825859937
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,36827,-0.000430877466577504,0.00572744510279728,-0.0116566698680602,0.0107949149349052,0.940032629860246
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37244,-0.000223766724699841,0.00297892201812402,-0.00606245388022293,0.00561492043082324,0.940123001193657
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36855,-0.000287956932222232,0.00419920860383964,-0.00851840579574792,0.00794249193130346,0.945329694093078
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39302,-0.000385288142544372,0.00575199502266985,-0.0116591983869773,0.0108886221018885,0.946595791234512
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39673,0.000134595341261125,0.00217032975296109,-0.00411925097454262,0.00438844165706487,0.950550811302223
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39697,0.000257006355622988,0.00417021409487843,-0.00791661327033873,0.0084306259815847,0.950859015723588
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,39860,0.00021948870672344,0.00384849487693968,-0.00732356125207834,0.00776253866552522,0.954520137679825
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36827,0.00026398550253684,0.00469336242853758,-0.00893500485739681,0.00946297586247049,0.955146255041987
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39401,-0.000275437203068434,0.00520531521751576,-0.0104778550293993,0.00992698062326245,0.95780062702403
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36855,0.000189369486588964,0.00370307426321699,-0.00706865606931633,0.00744739504249426,0.959215981538808
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36795,-0.000178958640913702,0.00352345734514681,-0.00708493503740146,0.00672701775557405,0.95949313655788
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36877,-0.000176195778075049,0.00361999240770083,-0.00727138089716868,0.00691898934101858,0.961180664718953
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,39302,-0.000316025486452026,0.00649723756138929,-0.013050611106775,0.012418560133871,0.961206839544267
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36827,0.00025455211258497,0.00523459276749599,-0.0100052497117072,0.0105143539368771,0.961215844457507
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,39401,-0.000114172587396054,0.00242985691858134,-0.00487669214781548,0.00464834697302337,0.962523897009369
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,37215,-0.000188584196880665,0.00401749062842273,-0.00806286582858922,0.00768569743482789,0.962561117493083
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36931,0.000116223264883902,0.00251779196619133,-0.0048186489888511,0.0050510955186189,0.963182799792699
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36855,0.000191361743701173,0.00452420298848156,-0.00867607611372268,0.00905879960112502,0.966262317061857
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37244,0.000284950134359695,0.006778746480606,-0.0130013929676281,0.0135712932363474,0.966470773972684
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36877,0.00014986277472249,0.00373894401050167,-0.00717846748586079,0.00747819303530577,0.968028703588851
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39245,0.000296684979593371,0.00773245565124863,-0.014858928096854,0.0154522980560407,0.969394141155513
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39720,0.000259774600181068,0.00680920561752311,-0.0130862684101642,0.0136058176105264,0.969568167429321
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36855,0.000159326182374366,0.00442648705313414,-0.00851658844176855,0.00883524080651729,0.971287838792127
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,37005,7.23637205432981e-05,0.00202226065324095,-0.00389126715980896,0.00403599460089556,0.971455471389009
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36855,0.000115374609006276,0.0032258786062608,-0.00620734745926489,0.00643809667727744,0.971470028320306
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,36827,-0.000246452509268571,0.00689135366630268,-0.0137535056952218,0.0132606006766847,0.97147223025384
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,39860,0.000148062629580279,0.00483035611164342,-0.00931943534924082,0.00961556060840138,0.975547032244359
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36877,-8.82747567449836e-05,0.00326516740921782,-0.00648800287881192,0.00631145336532195,0.978431999211129
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,37244,-8.11583458311322e-05,0.00394476599583463,-0.007812899697667,0.00765058300600473,0.983586044529663
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39448,0.000309426656196237,0.0152480752138434,-0.0295768007629368,0.0301956540753293,0.983810032132387
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,39127,0.000120770475517385,0.00815095845915332,-0.0158551081044231,0.0160966490554579,0.988178593406087
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,36855,-7.06089832717913e-05,0.00550621277609653,-0.010862786024421,0.0107215680578774,0.989768795365245
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39401,5.63962382600744e-05,0.00537279823923249,-0.0104742883106356,0.0105870807871558,0.991625194988544
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,36855,3.4205513782909e-05,0.0035996715981457,-0.00702115081858267,0.00708956184614849,0.992418442957866
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36855,2.41412851425148e-05,0.00274085465605391,-0.00534793384072315,0.00539621641100818,0.992972506213948
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,36877,3.31181271836404e-05,0.00411781718704535,-0.00803780355942524,0.00810403981379253,0.993583092988022
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39689,-2.28468332281978e-05,0.00433379145757285,-0.00851707809007099,0.00847138442361459,0.995793807032657
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39302,-3.62842412702017e-05,0.00706073199197643,-0.013875318945544,0.0138027504630036,0.995899852901989
NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37020,1.42943965701957e-05,0.00371854850683535,-0.00727406067682709,0.00730264946996748,0.996932934032167
